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Previous research has suggested that depressive disorders are common in youth 
and are associated with many negative outcomes. As a result, understanding how to treat 
depression effectively is very important. It is unclear; however, whatfactors predict 
treatment success or failure for depressed youth. Researchers are starting to investigate 
whether comorbid anxiety is a possible moderator of treatment outcome for youth with 
depression. Studies of the relation between comorbid anxiety and treatment outcome have 
produced mixed findings and have almost exclusively focused on older depressed 
adolescents. There is also limited research exploring whether parent intervention 
moderates the effect of comorbid anxiety on treatment outcome in depressed youth. This 
study focused on investigating the relation between comorbid anxiety and treatment 
outcome in a sample of 84 depressed female early adolescents who received either group 
cognitive behavioral therapy (CBT) or group CBT plus a parent intervention. The 
addition of parent intervention was explored as a moderator of the relation between 
anxiety and treatment outcome. Treatment outcome was measured by changes in 
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depression severity and global functioning during treatment. The depression severity and 
global functioning scores of depressed girls with comorbid anxiety were also compared to 
depressed girls without comorbid anxiety prior to treatment to determine whether the first 
group of girls entered treatment with a different level of psychopathology. Particip nts 
and their primary caregivers were administered a semi-structured diagnostic interview 
which was used as a measure of depression severity, global functioning, anxiety severity, 
and to determine whether participants met diagnostic criteria for depressive and anxiety 
diagnoses. The results of this study suggested that depressed youth with comorbid 
anxiety or higher anxiety severity started out treatment with higher depression severity 
and lower functioning. Results also suggested that comorbid anxiety was not related to 
negative treatment outcome and that youth with comorbid anxiety actually experienced 
larger reductions in depression severity over the course of treatment than youth without
comorbid anxiety. Parent intervention did not significantly moderate the effect o  
comorbid anxiety on treatment outcome. The study’s limitations, implications of the
results, and recommendations for future research were discussed. 
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Depressive disorders are common in youth (Birmaher, Ryan, Williamson, Brent, 
Kaufman, Dahl et al., 1996) which is a serious concern given that child and adolescent 
depression has been found to be a debilitating disorder that is associated with many 
negative outcomes (Lewinsohn, Rohde, & Seeley, 1998). Depression is an especially 
common disorder in females and the lifetime risk of major depression for females is twice 
that of males (American Psychiatric Association (APA), 2000). Depression in youth has 
been found to be related to substance abuse, suicidal behaviors, and future social, 
academic, and work related difficulties (Fergusson & Woodward, 2002; Office of 
Applied Studies (OAS), 2006; Weissman et al., 1999). In addition, depressive disorders 
in youth increase the risk of experiencing future psychopathology including depression 
recurrence (Lewinsohn, Rhode, Klein, & Seeley, 1999; Rao et al., 1995).  
Early adolescence is a significant period in the development of depression in view 
of the fact that the overall rate of depression drastically increases between early and late 
adolescence (OAS, 2006; Saluja et al., 2004). The gender difference in depression also 
first emerges during early adolescence (Hankin et al., 1998). This suggests that early 
adolescence is a time that females are especially vulnerable to depression. Given that 
depression is common in females and is associated with so many negative outcomes, 
developing effective early interventions for girls with depression is imperative. The 
importance of early adolescence in the development of depression suggests that 
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interventions developed for girls at this specific developmental stage may be especially 
beneficial. 
Research suggests that psychotherapy is an effective initial treatment for 
depressed children and adolescents (Birmaher, Ryan, Williamson, Brent, & Kaufman, 
1996) and reviews of psychotherapy treatment studies suggest Cognitive Behavioral 
Therapy (CBT) is both the most frequently investigated and the most empirically 
supported treatment for depressed youth (Curry, 2001). Treatment outcome studies 
investigating CBT with depressed children and adolescents have produced positive 
results, however, approximately one third to one half of youth do not recover from their 
depressive episodes at the end of these interventions (Clark et al., 1992). It is still unclear; 
however, what factors predict treatment success or failure for depressd youth (Brent et 
al., 1998). One factor that researchers are starting to investigate as a possible moderator 
of treatment outcome is the presence of comorbid conditions (Brent et al., 1998, Clarke et 
al., 1992, Curry et al., 2006; Jayson, Wood, Kroll, Fraser, & Harrington, 1998; Rohde, 
Clark, Lewinsohn, Seeley, & Kaufman, 2001; Young, Mufson, & Davies, 2006). The 
study of comorbidity has been identified as an important area of research espeially in 
children and adolescents with depression given that comorbidity in depressed youth is 
very common (Hammen & Rudolph, 2003).  
The most common comorbid condition in youth with depression is anxiety 
(Garber, 2006). Comorbid anxiety appears to be especially prevalent in females (National 
Institute of Mental Health (NIMH), 2003). Research also suggests that comorbid anxiety 
is likely to develop by age 12 in children with depression (Kovacs, Gatsonis, Paulauskas, 
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& Richards, 1989). Depressed children and adolescents who have comorbid anxiety also 
experience more negative outcomes than children without comorbid anxiety including 
increased depressive symptomatology and depression severity, earlier depression on et, 
and increased suicidal ideation (Ghaziuddin, King, Naylor, & Ghaziuddin, 2000; Kendall, 
Kortlander, Chansky, & Brady, 1992; Kovacs et al.; Mitchell, McCauley, Burke, & Moss, 
1988; Rohde et al., 2001). These results suggest comorbid anxiety commonly occurs in 
depressed youth starting prior to early adolescence and is especially common in females. 
Given these findings, it is important to determine how comorbidity may influence the 
nature and treatment of depression in young adolescent girls. 
One limitation in the current literature on the relation between comorbid anxiety 
and treatment outcome is that research in this area has focused almost exclusively on 
older adolescents. Although research suggests the importance of early adolescence in the 
development of depression, only one study of the relation between comorbid anxiety and 
treatment outcome included both younger and older adolescents (Jayson et al., 1998). 
Results of this study suggested that comorbid anxiety was not related to treatment 
outcome. This study, however, used a very brief individual CBT intervention and their 
small sample size may have restricted their findings. There have been no studies of group 
CBT with children or early adolescents evaluating comorbid anxiety as a possible 
moderator of treatment outcome. Four studies have investigated whether comorbid 
anxiety impacts treatment outcome specifically in group CBT treatments for depressed 
adolescents (Brent et al., 1998, Clarke et al., 1992, Curry et al., 2006; Rohde et al., 2001). 
Three of the four studies found that individuals with comorbid anxiety and depression 
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were less likely to improve from treatment than depressed individuals without comorbid 
anxiety (Brent et al.; Clark et al; Curry et al.). The other study found that the presence of 
comorbid anxiety was related to more post-treatment change (Rohde et al.). This study, 
however, was limited by the fact that they used measures of lifetime comorbidity instead 
of current comorbidity and excluded people experiencing common current anxiety 
disorders.  
There is also very limited research about whether the relation between comorbid 
anxiety and treatment outcome in depressed youth may be moderated by including 
parents in treatment. Only one study has explored this (Rohde et al., 2001), but these 
researchers did not find that parent intervention was a moderator. As previously 
discussed, however, this study had limitations which may have influenced the results. 
The co-occurrence of anxiety and depression has been found to be associated with many 
negative family factors (Stark, Humphrey, Crook, & Lewis, 1990). As a result of these 
findings, Stark, Laurent, Livingston, Boswell, & Swearer (1999) suggest that the 
treatment of comorbid anxiety and depression may need to involve the parental system in 
addition to working with the children. Research has also suggested a benefit to receiving 
parent intervention for children with anxiety (Barrett, Dadds, & Rapee, 1996; 
Thienemann, Moore, & Tompkins, 2006). This information suggests that receiving a 
parent component in addition to CBT therapy may be especially beneficial for children 
with comorbid anxiety and depression.  
Overall, the literature on depression and the experience of comorbid anxiety in 
depressed youth suggests there is a need for research that provides more informatio  
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about the link between comorbid anxiety and treatment outcome especially for female
children and early adolescents. In addition, research is also needed to determine whether 
parent intervention moderates the relation between comorbid anxiety and treatment 
outcome in order to develop the most effective interventions for youth with both anxiety 
and depression. This study, therefore, investigated the relation between comorbid anxiety 
and treatment outcome in a sample of young female adolescents who received either 
group CBT or group CBT plus a parent intervention.  
The primary goals of this investigation were to determine whether comorbid 
anxiety moderated treatment outcome in girls with depression who received group CBT 
treatment and to determine whether including parents in treatment changed the relation 
between comorbid anxiety and treatment outcome. Treatment outcome was measured 
both by changes in depression severity and global functioning during treatment. In 
addition, the depression severity and global functioning scores of depressed girls with 
comorbid anxiety were compared to depressed girls without comorbid anxiety prior to 
treatment to determine whether the first group of girls entered treatment with a different 
level of psychopathology. This study aimed to further develop our understanding of the 
symptomatology and functioning of girls with comorbid anxiety and depression and to 
provide information that could be used to determine how to most effectively treat young
adolescents who have both depression and anxiety. 




Review of the Literature 
Child and Adolescent Depression 
Overview of Depression in Youth 
Historically depression was viewed as an adult disorder and many professionals 
thought that children either did not have the capacity to experience depression or that 
experiencing depressive symptoms was just a typical part of development (Chris ner & 
Walker, 2007). More recently, however, it has been recognized that depressive disorders 
are common in youth. In fact, in 2005 it was estimated that approximately 13.7% of 
American adolescents aged 12 to 17 had experienced at least one episode of major 
depression in their lifetimes (OAS, 2006). These results suggest that many youth 
experience depressive disorders. There is also a literature base suggesting that the 
prevalence of depression is increasing at an especially high rate in younger people while 
the age of onset of depression is decreasing over time (Birmaher, Ryan, Williamson, 
Brent, Kaufman, Dahl, et al., 1996; Seligman, 1998). Seligman explained that during the 
past approximately fifty years there has been at least a tenfold increase in the rate of 
depression and the rate is still continuing to rise. This is a serious concern given that 
depression in youth has been found to be a debilitating disorder that is associated with 
many negative outcomes (Lewinsohn et al., 1998). Depression in youth has been found to 
be related to substance abuse, suicidal behaviors, and future social, academic, and work 
related difficulties (Fergusson & Woodward, 2002; OAS; Weissman et al., 1999). In 
addition, depressive disorders in youth increase the risk of experiencing future 
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psychopathology including depression recurrence (Lewinsohn et al., 1999; Rao et al., 
1995). 
Prevalence of Depression in Youth 
NIMH (2003) reported that about 6% of 9 to 17 year old children experience 
major depression. Research suggests that the prevalence of depression is relatively low n 
childhood (Birmaher, Ryan, Williamson, Brent, Kaufman, Dahl et al., 1996; Kashani & 
Carlson, 1987) but this rate drastically increases between early and late adolescence 
(OAS, 2006; Saluja et al., 2004). Depression has been found to be very rare in preschool 
samples and affects approximately 1% of children in this age group (Kashani & Carlson). 
Reports from studies of child and adolescent depression have reported that approximately 
two percent of children and four to eight percent of adolescents experience Major 
Depressive Disorder (MDD) (American Academy of Child and Adolescent Psychiatry 
(AACAP; 1998) and the rates of Dysthymic Disorder (DD) in children range from .6% to 
1.7% and from 1.6% to 8% for adolescents (Birmaher, Ryan, Williamson, Brent, 
Kaufman, Dahl et al.).  
Lifetime estimates of depression in adolescents have been reported to range from 
approximately 15% to 20% which is similar to the rate in adults (Birmaher, Ryan, 
Williamson, Brent, Kaufman, Dahl et al., 1996). Some research, however, suggests the 
lifetime prevalence rate in adolescents may be a little higher (Lewinsohn et al., 1998) and 
other research suggests it may be a little lower (OAS, 2006). Based on results f om their 
study of 1,709 depressed adolescents, Lewinsohn and colleagues estimated that 28% of 
adolescents will experience a major depressive episode by the time they are nineteen 
    
  
8 
years old. The Office of Applied Studies (OAS) surveyed over 22,000 adolescents and 
indicated that 13.7% of 12 to 17 years olds reported having a major depressive episode in 
their lifetime. Saluja et al. (2004) studied the prevalence of depression in early 
adolescents by collecting data from a nationally representative sample of 9,863 students 
in grades six, eight, and ten. Their results suggested that approximately one out of every 
six young adolescents in the U.S. experiences significant depressive symptoms. 
Research has also suggested that the prevalence of depression increases rapidly 
during adolescence. The Office of Applied Studies (OAS; 2006) found that the 
prevalence of a major depressive episode in the past year increased from 4.3% in 12 year 
olds to 11.9% in 17 year olds. Research by Saluja et al. (2004) indicates that the 
prevalence of significant depressive symptoms approximately doubles for boys between 
grades six and ten and triples for girls during this time.  
Gender Differences 
According to the DSM-IV-TR, the lifetime risk of major depression for femal s is 
twice that of males (APA, 2000) and being female is related to increased depression 
severity (McCauley et al., 1993). Research by Hankin et al. (1998) suggests that in 
childhood the rates of depression are relatively similar in boys and girls. During 
adolescence, the rates of major depressive episodes and significant depressive symptoms 
are higher for females than males (OAS, 2006; Saluja et al., 2004). The Office of Applied 
Studies (OAS) found that in adolescents from 12 to 17 years old, 13.3% of females 
reported experiencing a depressive episode in the past year whereas only 4.5% of 
adolescent males reported this. 
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Hankin et al. (1998) found that the gender difference in the rates of depression 
begins sometime between 13 and 15 years old. Then between 15 to 18 years of age the 
rate of depression in both genders increases but in females the rate increases to twice that 
of the males (Hankin et al.). Petersen, Sarigiani, and Kennedy’s (1991) research 
suggested that by 12th grade, girls have significantly poorer emotional tone and more 
depressed affect than boys. Their findings indicated that the difference in depressive 
features between genders begins in about eighth grade and then continues to increase 
over time.  
Research suggests some possible reasons for the gender differences in depression 
(Petersen et al., 1991). Girls appear to have different coping styles than boys that often 
emerge during adolescence (Nolen-Hoeksema, 1987) which may impact the way they 
experience stressful events. Whereas males tend to try to actively problem solve stressful 
situations using instrumental coping strategies, females more often ruminate about how 
they feel and the cause of their stress (Nolen-Hoeksema). Research suggest  that the use 
of less instrumental coping is related to depression (Marcotte, Alain, & Gosselin, 1999). 
Hankin and Abramson (2002) also found that girls are more likely to have more negative 
thoughts about themselves and approach events more negatively. They found that this 
cognitive style mediated the differences between gender and depressive symptoms. Stress 
is related to depressive symptoms in girls but not boys (Rudolph & Hammen, 1999), 
which provides further evidence that stressful events seem to have a more negative 
impact on girls.  
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Research has suggested that low self-esteem is a significant predicor of 
depression (Allgood-Merten, Lewinsohn, & Hops, 1990) and girls appear to view 
themselves more negatively than boys (Cole, Jacquez, & Maschman, 2001). Cole et al. 
found that girls’ self ratings of their competence were often lower than pare t, teacher, 
and peer ratings of their competence, whereas boys often provided self ratings of their 
competence that were higher than parent, teacher, and peer ratings. Body image also 
appears to be a major factor in the self-esteem of adolescents especially for girls 
(Allgood-Merten et al.). These authors found that body image was a major contributor to 
self-esteem in adolescence and in turn self-esteem was related to depression. Other 
studies have suggested that body image is a mediator between gender and depression 
(Siegel, Yancey, Aneshensel, & Schuler, 1999). 
Puberty also appears to be exceptionally stressful for girls. When girls experi nce 
menarche or puberty earlier than their peers they are more likely to experience 
psychopathology, especially depression (Ge, Conger, & Elder, 2001; Stice, Presnell, & 
Bearman, 2001). Some theorize that gender differences in depression during adolescence 
are related to the stressful changes youth experience during early adolescence (Petersen et 
al., 1991). Petersen and colleagues found that experiencing peak pubertal change at least 
six months before or within six months of changing from elementary to middle 
school/junior high school was strongly related to depression and emotional tone for both 
genders. The authors suggested that since pubertal change and school change occur more 
often at similar times in girls, this suggests why girls may be more at risk fo  depression. 
They also indicated that these findings highlight the importance of developing 
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interventions for early adolescents when they are experiencing so many stressful changes 
during puberty to prevent future negative mental health outcomes.  
Depressive Disorders 
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV-TR; APA, 2000), there are three types of depressive disorders. These three types are 
bipolar disorders, depressive disorders, and mood disorders based on etiology. Bipolar 
disorders include episodes of depression as well as mania, whereas depressive disorders 
do not include manic episodes. Mood disorders based on etiology include Mood Disorder 
Due to a General Medical Condition and Substance-Induced Mood Disorder (APA). This 
review will focus on the category of depressive disorders. 
There are three major depressive disorders which differ based on duration, 
symptom severity, and the presence of specific symptomatology (APA, 2000). People 
who have Major Depressive Disorder (MDD) experience at least one major depressive 
episode characterized by several severe depressive symptoms that last for two weeks or 
longer (see Appendix A). Dysthymic Disorder (DD) is similar to MDD but includes less 
depressive symptoms which are often not as severe, however, in order to meet criteria for 
DD depressive symptoms must be present for two years or longer in adults and one year 
or longer in children and adolescents (see Appendix B). The third depressive disorder, 
Depressive Disorder Not Otherwise Specified (DDNOS), is diagnosed when someone is 
experiencing features of depression but does not fully meet criteria for MDD, D , 
Adjustment Disorder with Mixed Anxiety and Depressed Mood, or Adjustment Disorder 
with Depressed Mood (see Appendix C; APA).  
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Children and adolescents meet criteria for MDD when they experience one or 
more major depressive episodes (APA, 2000). These episodes involve experiencing a 
primary mood symptom of depressed mood, irritability, or anhedonia more often than not 
for a period of two weeks or more accompanied by four or more specific accompanying 
symptoms. These symptoms include concentration or thinking difficulties, trouble 
making decisions, guilt or feelings of worthlessness, a lack of energy or fatigue, sleep 
disturbance (insomnia/hypersomnia), psychomotor retardation or agitation, appetite or 
weight changes, or recurrent suicidal ideation, suicidal plans, or suicide attempts. In order 
to meet diagnostic criteria, the symptoms must have started occurring with the depressive 
episode or become worse compared to before the episode began. The youth must also be 
experiencing these symptoms almost every day for the majority of the day and the 
symptoms must create either impairment or distress in social, academic, occupational, or 
other areas of functioning. If the symptoms are a result of the physiological effects of a 
medical condition or substance, there is a history of a manic episode, or the symptoms fit 
better with the criteria for a Schizoaffective Disorder then the child does not meet criteria 
for MDD. In addition if the symptoms occur within the period of two months after the 
loss of a loved one, then the child does not meet criteria for MDD unless the symptoms 
are very severe. MDD in partial remission is diagnosed if the person has had a major
depressive episode and some symptoms of the episode are still present but the person no 
longer meets the full criteria or if there are not any symptoms of an episode but the 
person has been without symptoms for less than two months (APA).  
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The diagnostic criteria for DD in children and adolescents include experiencing 
depressed mood or irritability more often than not for at least one full year (APA, 2000). 
The child or adolescent must also experience at least two other symptoms. These 
symptoms include sleep disturbance, lack of energy or fatigue, low self-esteem, 
concentration difficulties or trouble making decisions, hopelessness, or appetite 
disturbance and must cause impairment or distress in social, academic, occupatinal, or 
other areas of functioning. During this year long period, the youth cannot experience a 
symptom free period for more than two months and cannot experience a major depressiv  
episode during the first year of experiencing Dysthymia in order to meet criteria. In 
addition, children and adolescents with a history of a Manic Episode, Cyclothymic 
Disorder, or depressive symptoms associated with a  Psychotic Disorder do not meet 
criteria for DD. Depressive symptoms that are a result of the physiological effects of a 
medical condition or substance do not meet criteria for DD as well (APA).  
The diagnosis of DDNOS is given when a person is experiencing depressive 
symptoms but the symptoms do not meet the diagnostic criteria for MDD, DD, 
Adjustment Disorder with Mixed Anxiety and Depressed Mood, or Adjustment Disorder 
with Depressed Mood (APA, 2000). Examples of this include a Minor depressive 
disorder that lasts for two weeks but has less than the five required symptoms (APA). 
Youth meeting criteria for Adjustment Disorder with Depressed Mood also meet 
eligibility for this study. In order to meet criteria for an Adjustment Disorder, a person 
must develop symptoms as a result of a specific identifiable stressor and the symptoms 
must occur within three months of when the stressor began and end within six months of 
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when the stressor or consequences of the stressor are no longer present (APA, 2000; see 
Appendix D). The symptoms must either cause excessive distress that is more than 
expected as a result of the stressor or cause serious social, occupational, or academic 
impairment. If the symptoms from the stressor meet criteria for another Axis I disorder, 
are related to a previous Axis I or II disorder, or meet criteria for Bereavement then the 
person does not meet criteria for Adjustment Disorder. In order to meet criteria for an 
Adjustment Disorder with Depressed Mood, the emotional or behavioral symptoms the 
person is experiencing are usually symptoms such as hopelessness, depressed mood, or 
tearfulness (APA). Appendices A through D include more detailed information about the 
diagnostic criteria for the disorders discussed in this section. 
Depressive Symptomatology in Children and Adolescents 
Children and adolescents with depression experience similar symptoms to adults 
with depression, however, there are slight differences. According to the DSM-IV-TR, 
research suggests that depressive symptoms often change with age (APA, 2000). Certain 
depressive symptoms such as irritability occur more commonly in depressed children 
(APA). Depressed children often express their emotions with behavior problems or 
temper tantrums instead of talking about their feelings (AACAP, 1998). As a result, the 
DSM-IV-TR has a modification in the criteria for depressive disorders allowing children 
and adolescents to meet diagnostic criteria with a primary mood symptom of irritabil ty 
(APA). In DD specifically, the diagnostic criteria for the length of the disorder differs for 
children and adults. In order to meet criteria, children and adolescents need to have 
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experienced symptoms for at least one year as opposed to the two years required for 
adults (APA). 
Other symptoms that are common in depressed children but decrease with age are 
low self esteem, depressed appearance, and somatic complaints (Carlson & Kashani, 
1988). Guilt also appears to be more common in depressed children and adolescents than 
adults (Mitchell et al., 1988). Depressed children have also been shown to exhibit more 
anxiety symptoms (AACAP, 1998).  
Some depressive symptoms increase as people get older (Carlson & Kashani, 
1988). Suicidal ideation, sleep and appetite disturbances, and delusions are all more 
common in adolescence than childhood (AACAP, 1998). Anhedonia is not very common 
among preschoolers with depression but the rate of anhedonia is much higher in children 
and continues to increase into adulthood. Hopelessness is not very common among 
children but becomes much more common in adolescence and even more common in 
adults (AACAP). Psychomotor retardation also increases with age being less common 
among children but increasing into adolescence and then adulthood (Carlson & Kashani). 
Depressed adolescents also seem to experience less neurovegetative symptom  than 
depressed adults (AACAP). 
Some children and adolescents also experience psychotic symptoms as part of 
their depressive disorders. Approximately one third (27%-38%) of depressed youth 
experience hallucinations, which are most commonly auditory and are similar to the type 
of hallucinations experienced by depressed adults (Chambers, Puig-Antich, Tabrizi, & 
Davies, 1982; Mitchell et al., 1988). Although hallucinations appear among depressed 
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children and adolescents, the presence of hallucinations decreases with age appearing less 
commonly in adults (Carlson & Kashani, 1988). Delusions occur much less often in 
youth than hallucinations and they are found to appear in approximately 7% of depressed 
youth (Chambers et al.; Mitchell et al.). The presence of delusions increases with age and 
becomes more common in adulthood (Carlson & Kashani). 
Suicidal ideation is also common among depressed children and adolescents and 
occurs in over 60% of depressed youth from preschool through adolescence (Kashani & 
Carlson, 1987; Mitchell et al., 1988; Ryan et al., 1987). Rates of suicidal ideation are 
similar between youth and adults but suicidal attempts appear to happen more often in 
children and adolescents with depression than in depressed adults (Mitchell, et al.). 
Clinical Course 
 The clinical course of child and adolescent depressive disorders can be impacted 
by many different factors (Christner & Walker, 2007). These factors can alter the course 
and symptoms of depression. As a result, the clinical presentation of depression varies 
between different individuals (Christner & Walker). Research findings, however, have 
begun to shed light on some of the common characteristics of the experience of 
depression in youth. Research has suggested that the average age of MDD onset in 
community samples is between 14 and 15 years old and earlier onset is associated with 
being female (Lewinsohn et al., 1998). In addition, the median length of a depressive 
episode has been found to fall between seven and nine months for youth who are 
clinically referred and one to two months for community samples (AACAP, 1998). 
Research has also suggested that some possible predictors for longer depressive episodes 
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are comorbid psychiatric disorders, decreased social functioning, increased depr ssion 
severity, negative life events, and parent psychopathology. The recurrence of depression 
is very common in youth and research with community and clinical samples have 
suggested that 20% to 60% of depressed youth experience recurrence within one to two 
years of remission and 70% experience recurrence after five years (AACAP). 
Dysthymic disorder has an average length of three to four years and an average 
age of onset of 8.7 years in youth (Kovacs, Akiskal, Gastonis, & Parrone, 1994). 
Lewinsohn et al. (1998) reported that in adolescents, DD occurs much less often than 
MDD. Experiencing both MDD and DD in youth is relatively common and about 70% of 
people diagnosed with DD at a young age eventually experience MDD as well (Birmaher, 
Ryan, Williamson, Brent, Kaufman, Dahl et al., 1996). The presence of both MDD and 
DD is often referred to as “Double Depression” (Keller & Shapiro, 1982). Youth with 
“Double Depression” have been found to have more negative outcomes and shorter 
remission periods between major depressive episodes (Kovacs et al., 1994).  
Research has produced some results suggesting that an earlier age of depression 
onset is related to longer depressive episodes (Kovacs et al., 1984; Lewinsohn et al.). 
Other findings, however, indicate that the age of onset is not related to the length of 
depression (McCauley et al., 1993).  
Implications of Depression 
Mental health intervention for children and adolescents with depression is 
important because research suggests that the presence of depression in childhood and 
adolescence is related to negative future outcomes (Fergusson & Woodward, 2002; OAS, 
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2006; Weissman et al., 1999). Depressed adolescents are more likely to experience social 
difficulties and academic and employment struggles in the future (Capaldi & Stoolmiller, 
1999; Kandel & Davies, 1986; Weissman et al.). In addition, adolescent depression is 
related to psychopathology and depression recurrence in adulthood (Kandel & Davies; 
Lewinsohn et al., 1999; Rao et al., 1995). Research has also suggested that the outcomes 
of adolescent depression may be impacted by gender. For example, Kandel and Davies 
found that for females, depression in adolescence predicted experiencing psychiatric 
hospitalization sometime before early adulthood but this relationship was not found for 
depressed boys. 
Weisman et al. (1999) found that depression in adolescence was related to social 
difficulties in adulthood across work, social, and family settings. Depressive symptoms in 
early adolescence have been found to be predictive of difficulties with peers in later 
adolescence (Capaldi & Stoolmiller, 1999). Adolescents with depression are also more at 
risk of experiencing school failure, are not as likely to participate in higher education, and 
are more likely to have experience with unemployment in late adolescence and early 
adulthood (Fergusson & Woodward, 2002). 
Depression in youth has also been found to be related to substance use and 
dependence (Fergusson & Woodward, 2002; Kandel & Davies, 1986; OAS, 2006). The 
Office of Applied Studies (OAS) surveyed over 22,000 12-17 year old adolescents and 
learned that of the adolescents who reported having a major depressive episode in the 
past year, 19.8% suffered from illicit drug or alcohol dependence, 38% reported the use
of illicit drugs in the past year, and 5.3% used cigarettes daily. Substance use in the 
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depressed adolescents was much more common than in adolescents who did not report 
depression. The answers of the non-depressed adolescents suggested that 6.9% of them 
were dependent on drugs or alcohol, 18% percent of them reported the use of illicit drugs 
sometime in the past year, and 2.5% reported using cigarettes daily. In addition, of he 
adolescents who reported experiencing alcohol or drug dependence, 21.7% reported 
experiencing a major depressive episode in the past year.  
The risk of suicide is also a significant concern for depressed adolescents. 
Fergusson and Woodward’s (2002) study found a relationship between depression at 14 
to 16 years of age and suicidal behaviors at 16 to 21 years of age. In addition, Weissman 
et al.’s (1999) study included 73 adults who were depressed as adolescents and they 
found that 50.6% made a suicide attempt before they were assessed at follow-up, 22% 
reported multiple suicide attempts before follow-up, and seven of their original group of 
91 adolescents had committed suicide by the time of follow-up. Suicide is a very 
significant concern in our current society given that the risk of suicide in adolescence has 
increased four fold since 1950 and 12% of deaths among adolescents can be attributed to 
suicide (Birmaher, Ryan, Williamson, Brent, Kaufman, Dahl et al., 1996). 
Rao et al. (1995) and Lewinsohn et al. (1999) determined that adolescent 
depression was related to future psychopathology when they looked at psychopathology 
in adults who were depressed in adolescence. Rao et al. followed up with 12 to 18 year 
old depressed and non-depressed adolescents when they were adults. They found that the 
depressed adolescents were more likely to have experienced new episodes of depression, 
dysthymic disorder, and bipolar disorder during the follow-up period than the non-
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depressed adolescents. Lewinsohn et al. compared adult psychopathology in four groups 
of participants. The groups included adults who had four different types of 
psychopathology in childhood or adolescence; MDD, Adjustment Disorder with 
Depressed Mood, a non-affective disorder, or no psychiatric disorder. The MDD group 
had a significantly higher prevalence of MDD in adulthood than those in the non-
affective disorder and the no diagnosis group. The researchers found that 45% of the 
adolescents with MDD experienced depression recurrence when they were betwe n 19 
and 24 years old. 
Assessing Depression in Youth 
 There are many different methods used to assess depression in youth. The most 
common measures of depressive symptoms and diagnoses are self-report questinnaires, 
observational methods, ratings scales completed by parents and teachers, projective 
techniques, and diagnostic interviews. Self-report measures of depressive symptoms are 
often used to screen youth for psychopathology and to monitor progress during therapy 
(Lewinsohn et al., 1998). The Children’s Depression Inventory (CDI; Kovacs, 1981) and 
the Beck Depression Inventory for Youth (BDI-Y; Beck, Beck, & Jolly, 2001) are 
common self-report instruments used to screen for depressive symptoms in research. In 
addition, diagnostic interviews such as the Schedule for Affective Disorders and 
Schizophrenia for School-Age Children (K-SADS-IVR; Ambrosini & Dixon, 2000) are 
often used to determine depressive diagnoses in youth. 
Self report measures are often effectively used to screen depressive symptoms 
quickly and efficiently, monitor symptom improvement, and determine the severity of 
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specific depressive symptoms (Birmaher, Ryan, Williamson, Brent, & Kaufm n, 1996). 
These authors explain, however, that self-reports are not designed to diagnose depre sion. 
Although popular measures such as the CDI have shown good reliability, they have not 
produced results suggesting they are able to accurately discriminate between non-
depressed and depressed children (Stark, 1990). In addition, self report measures do not 
provide enough data to determine whether a child or adolescent meets criteria for a 
depressive disorder (Klein et al., 2005). Semi-structured clinical interviews provide much 
more detailed information that allows a clinician to more accurately determin  the 
presence and severity of a depressive disorder (Stark). In addition, Lewi sohn et al. 
(1998) recommend using a semi-structured assessment tool when assessing depression 
because these measures can provide information about many different psychiatric 
disorders which is important since comorbidity is so common in depressed youth.  
Lewinsohn et al. (1998) suggest that the assessment of psychopathology in youth 
needs to include multiple informants because children who are young may not have the 
ability to provide certain information reliably or validly and children may mini ze or 
deny symptoms that are undesirable. Adults may not know about all of the situations in 
which the behavior occurs since they are often not present in every setting or situation. In 
addition, adults and children may have different beliefs about what level of behavior is a 
problem (Lewinsohn et al.). These researchers found that agreement between adolescents 
and their parents was low when determining the presence of MDD and parents reported 
lower rates than their children. Achenbach, McConaughy, and Howell (1987) completed 
a meta-analysis of consensus in ratings from multiple informants. They found that the 
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mean correlation between parent and youth reports of adjustment in the youth was .25. 
These researchers also suggested that there is less consensus between parents and 
children on internalizing symptoms than externalizing symptoms. Children have been 
reported to be more accurate reporters of subjective symptoms such as worthlessness, 
anhedonia, and sadness (Kendall, Cantwell, & Kazdin, 1989) but less accurate reporters 
of the duration and onset of symptoms (Stark, Sander, Yancy, Bronik, & Hoke, 2000). 
Therefore, in order to provide the most accurate assessment of depression in youth t is 
important to integrate both parent and child reports of symptoms. Clinicians must often 
rely on their clinical judgment to determine which informant is the more accurte reporter 
when reports are inconsistent between parent and child (Klein, Dougherty, & Olino, 
2005). 
 Combining different methods of assessment through the use of a multiple gate 
procedure has been suggested to be an accurate, efficient, and effective way to identify 
youth that are clinically depressed in school settings (Reynolds, 1986). According to 
Reynolds, three stages of assessment should be used in the multiple gate procedure. Th  
first stage involves using a self report measure of depression to screen a large group of 
youth for depressive symptoms. The next stage involves identifying those youth who 
scored above a specific cutoff on the self report measure and reassessing them with the 
same self report measure from three to six weeks later in order to determin  whether the 
youth’s distress was not just specific to the day they were assessed. The last stage 
involves identifying the youth who still scored above the cutoff in the second assessment 
of the self report measure and conducting diagnostic interviews with those youth. The 
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current study will use a modification of the procedure outlined by Reynolds. Youth that 
score above the cutoff on the first self report measure will be administered a brief DSM-
IV symptom interview on the same day they complete the first questionnaire instead of 
completing the self report measure for the second time three to six weeks lat r. The 
interview was used instead of the second self report measure in order to provide the most 
ethical treatment of the participants. The brief symptom interview often allowed youth to 
talk about possible suicidal ideation, self harm behaviors, or abuse and it was imperative 
that the youth in significant distress receive a full assessment of their depressive 
symptoms as soon as possible rather than waiting three to six weeks.  
Summary of Depression in Youth 
Depressive disorders are common in youth (Birmaher, Ryan, Williamson, Brent, 
Kaufman, Dahl et al., 1996) which is a serious concern given that child and adolescent 
depression has been found to be a debilitating disorder that is associated with many 
negative outcomes (Lewinsohn et al., 1998) including future psychopathology (Rao et al., 
1995). Depression is especially common in females and the lifetime risk of major 
depression for females is twice that of males (APA, 2000). In addition, early adolescence 
appears to be a significant period in the development of depression. The overall rate of 
depression drastically increases between early and late adolescence (OAS, 2006; Saluja et 
al., 2004) and the gender difference in depression also first appears during this age period 
(Hankin et al., 1998) suggesting that girls are especially vulnerable to depression at this 
time. 
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Many different theories have emerged to explain the gender difference in 
depression and these have included theories about differences in boys and girls that make 
girls more vulnerable to stress and depression (Petersen et al.’s 1991; Nolen-Hoeksema, 
1987). These theories suggest that boys and girls have differences in coping and co nitive 
styles (Hankin & Abramson, 2002; Nolen-Hoeksema), different levels of self-e teem and 
body image (Allgood-Merten et al., 1990; Cole et al., 2001), and different levels of stress 
during puberty (Petersen et al.). 
 There are many different methods used to assess depression in youth including 
self-report questionnaires, observational methods, ratings scales completed by parents 
and teachers, projective techniques, and diagnostic interviews. Different assssment 
methods may be most useful depending on the purpose of the assessment. Self report 
measures can be effectively used to screen depressive symptoms quickly and efficie tly, 
monitor symptom improvement, and determine the severity of specific depressive 
symptoms (Birmaher, Ryan, Williamson, Brent, & Kaufman, 1996). Self report 
measures, however, do not have the discriminant validity necessary to diagnose 
depression (Stark, 1990) and they do not provide enough data to determine whether a 
child or adolescent meets criteria for a depressive disorder (Klein et al., 2005). In order to 
more accurately determine the presence and severity of a depressive disord r, semi-
structured clinical interviews are much more useful (Stark, 1990). In addition, semi-
structured assessments can provide information about comorbid disorders which is 
important given that comorbidity is so common in depressed youth (Lewinsohn et al., 
1998). Using multiple informants is also important in the assessment of depression 
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(Lewinsohn et al.). Parents and children, for example, may each be better reporters of 
different information (Kendall et al., 1989; Stark et al., 2000). By collecting information 
from both parents and children a clinician can integrate this information to make a more 
accurate assessment. When reporters are inconsistent, clinicians must rely on their 
clinical judgment to make a determination (Klein et al.). In order to identify clinically 
depressed youth in large groups of children or adolescents, such as school settings, the 
use of a multiple gate procedure which combines different methods of assessment has 
been suggested to be an accurate, efficient, and effective technique (Reynolds, 1986). 
 In summary, the research on depression suggests that depression is a common 
disorder in youth and is related to many negative outcomes. Girls appear to be especially 
vulnerable to depression and early adolescence seems to be a critical period in the 
development of depression especially among girls. This suggests the need for research to 
better understand how to treat depression in early adolescent girls. 
Treatment of Child and Adolescent Depression 
Overview of the Treatment of Child and Adolescent Depression 
 Research on the prevalence of depression in youth (OAS, 2006) and the negative 
outcomes associated with depression (Fergusson & Woodward, 2002; OAS; Weissman et 
al., 1999) suggests the need for early therapeutic mental health intervention for youth 
with depression. Early effective interventions for youth with depression are ecessary in 
order to improve the quality of life of these youth, provide relief from depressive 
symptoms, and have positive effects on the course of depression through the lifetime 
(Brooks & Kutcher, 2001). Birmaher, Ryan, Williamson, Brent, and Kaufman (1996) 
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reviewed the literature on the treatment of depression and explained that research 
findings suggest that psychotherapy, especially CBT, seems to be an effectiv  initial 
treatment for depressed children and adolescents. Reviews of child and adolescent 
depression research suggest that CBT is both the most frequently investigated and the 
most empirically supported treatment for this population (Curry, 2001). Research has also 
supported interpersonal psychotherapy as an efficacious treatment for youth (Curry), 
however, these studies have focused solely on older adolescents and this treatment has 
not been investigated with children.  
Cognitive Behavioral Models and Interventions 
Aaron T. Beck developed cognitive therapy in the 1960’s (Beck, 1995). The 
therapy was developed to be a short term-therapy for depression (Beck, 1964) but since 
it’s development, cognitive therapy has been adapted to be used with many different 
populations (Beck, 1995). According to Beck, Rush, Shaw, and Emery (1979), cognitive 
therapy is structured, time limited, active, and directive and it can be used as an 
intervention for many different psychiatric disorders such as depression and anxiety. 
Although cognitive therapy has been adapted in many ways, the interventions are still 
based on the same theory (Beck, 1995). Cognitive therapy is based on the theory that the 
way someone behaves and feels is significantly impacted by the way they view and 
organize the world (Beck, 1976). The person’s beliefs or assumptions which Beck calls 
“schemas” influence the person’s cognitions or thoughts (Beck et al.). People begin to 
develop beliefs (schemas) about the world, themselves, and others when they are children 
and these include beliefs that become central to the way they view the world called core 
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beliefs (Beck, 1995). These core beliefs impact the creation of other assumptions, rules, 
and attitudes called intermediate beliefs. The intermediate beliefs impact the automatic 
thoughts people have which then influence the person’s emotions and their behaviors. 
People with psychological disturbance have distorted thoughts and schemas and those 
negative cognitions then impact their affect and behavior (Beck, 1995).  
The goals of cognitive therapy are to identify cognitive distortions and 
maladaptive schemas and then test and correct these cognitions and beliefs (Beck et al., 
1979). The therapist works with the client to change their thinking about certain 
situations and their own difficulties which allows them to take charge of problems they 
thought they could not solve and develop a more realistic view of themselves. These 
changes in thinking are then expected to lead to symptom reduction. Clients are 
specifically taught to develop an awareness of their negative thoughts, to test their 
negative thoughts using evidence, and to replace distorted thoughts with more realistic
thoughts. They are also taught to understand that thoughts, feelings, and behaviors are 
related. Through therapy clients are encouraged to become aware of theirdistorted beliefs 
and how those beliefs change how they perceive their world and then work to change 
those beliefs (Beck et al.).  
There have been many different cognitive theories and interventions that have 
been developed from Beck’s early work but a discussion of all of these models is beyond 
the scope of this review. The specific intervention used in this study is based upon an 
integration of cognitive and attachment theories (Stark et al., 1999). Stark et al. suggest 
that Beck’s (1967) cognitive model of depression can be integrated with attachment 
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theory to create a possible explanation for why depression develops during childhood. In 
Stark et al.’s overview of the cognitive model they explain that in people with depression, 
stressful events activate cognitive distortions. These cognitive distortions are activated by 
core beliefs or schemas about the self, world, and future which filter how informati n is 
attended to, perceived, and interpreted. The self schema is believed to be the most central 
schema and in people with depression this schema is based upon a belief that they are 
unlovable or is based upon a sense of loss. The self-schemas of people with depression 
are also unrealistically negative. The self schema of a child impacts how they perceive 
their world and experiences and is also developed according to these experiences. 
Research has suggested that depressed youth have a lack of a positive self schema. If t is 
is true and the self schema influences how information is processed then these youth will 
process less positive information about themselves. This lack of positive information will 
continue to negatively influence their core schemas about themselves, the world, and the 
future and lead to depressive symptoms (Stark et al.).  
Attachment theory is integrated with cognitive theory to help explain how these
core schemas develop. Stark, Schmidt, and Joiner (1996) suggest that youth may 
internalize messages they receive from their parents and use those to develop their core 
schemas about the self, world, and future. According to attachment theory, interactions 
between children and caretakers are thought to be the basis of the “internal working 
model” of a child (Bowlby, 1980). This internal working model is an understanding of 
the self, others, and the relationship between a child and caregiver and guides how the
person continues to interact with and relate to others (Berman & Sperling, 1994). The 
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internal working model is equivalent to the idea of a core schema in cognitive theory
(Stark et al., 2006). Based upon these theories, the interaction between an individual and 
their caregivers heavily influences the model that an individual uses to interpret the world 
around them. Cognitive theories suggest that internal models or core schemas are related 
to the experience of depressive symptoms (Stark et al., 1999). Therefore it is not 
surprising that insecure attachment may be a risk factor for developing a depressive 
thinking style, decreased emotional regulation abilities, and a deficit in relia c  on social 
support which are all risk factors for developing depression (Stark et al., 2006) This link 
between attachment and cognitive theories emphasizes the impact that parent and child 
relationships can have on depression. An integration of the cognitive and attachment 
models suggests that both cognitions and the interpersonal context in which these 
cognitions are created and maintained are both integral when conceptualizing and treati g 
depression in youth (Stark et al, 1999).  
Cognitive Behavioral Interventions with Youth 
Cognitive behavioral interventions for youth with depression can include a variety 
of different components (Stark et al., 2006) but they are all based upon the goal of having 
clients develop skills that help them to change both their behaviors and cognitions in 
order to improve their moods (Compton et al., 2004). The CBT therapist creates a 
collaborative relationship with participants to assist them in developing different ways to 
think and act, decreasing their depressive symptoms, and reducing their risk of depression 
recurrence (Compton et al.). The skills that the therapist helps the youth to develop 
include regulating emotions, coping, social skills, developing effective problem-solving 
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skills, learning to restructure negative thoughts and beliefs, developing positive views of 
oneself and the future, and learning to associate positive results with global, sta le, and 
internal causes (Compton et al.; Stark et al.). The therapist also teaches the participant 
about depression and supports the participant in creating and making progress on 
individual goals (Compton et al.). Parent components are also sometimes part of a CBT 
intervention and often focus on training the parents in positive reinforcement, effec iv  
communication, parenting techniques, increasing the number of pleasant activities the 
family does together, and helping them to develop a positive environment within the 
family (Compton et al.).  
Efficacy of Cognitive Behavioral Therapy in Treating Child and Adolescent Depression 
Research results suggest that CBT is an effective treatment for depress d youth 
and a meta-analysis by Reinecke, Ryan, and Dubois (1998) found a moderate to large 
effect size for post-test scores from CBT trials with depressed adolescents. Studies 
evaluating the use of CBT with young adolescents and children have shown that CBT is 
superior to no treatment (Asarnow, Scott, & Mintz, 2002; Butler, Miezitis, Friedman, & 
Cole, 1980; De Cuyper, Timbremont, Braet, De Backer, & Wullaert, 2004; Stark, 
Reynolds, & Kaslow, 1987; Weisz, Thurber, Sweeney, Proffitt, & LeGagnoux, 1997) and 
attention control groups (Butler et al.). Liddle and Spence (1990) did not find that CBT 
was superior to no treatment or an attention control group, however, their small sample
size limited the power of their analyses. In addition, their results indicate  that the CBT 
group showed twice as much reduction in symptoms than the other groups.  
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Several studies have evaluated a cognitive behavioral treatment program called 
the Adolescent Coping with Depression Course (CWD-A; Clark, Lewinsohn, & Hops, 
1990) with depressed adolescents (Clarke et al., 1995; Clark et al., 2001; Clark et al., 
2002; Clark, Rohde, Lewinsohn, Hops, & Seeley, 1999; Lewinsohn, Clarke, Hops, & 
Andrews, 1990). Treatment outcome studies suggested this treatment was effective when 
used with adolescents alone or when combined with parent training (Clark et al., 1999; 
Lewinsohn et al., 1990). This treatment was also found to be effective for preventing 
depression in at risk adolescents (Clarke et al., 1995; Clark et al., 2001). Clark et al. 
(2002), however, compared the CWD-A treatment to a treatment as usual condition and 
did not find significant differences in terms of depressive symptoms, depressive 
diagnoses, or functioning scores between the two groups.  
Research has also been completed comparing CBT with other treatments. Studies
have suggested that CBT is superior to traditional school counseling groups (Stark, 
1990), systemic behavioral family therapy, and nondirective supportive therapy (Brent et 
al., 1997). Results from a study by Vostanis, Feehan, Grattan, and Bickerton (1996) 
suggested that CBT was not superior to non-focused supportive therapy but their results 
may be questionable since the treatment received as part of this study consisted of only 
two to nine therapy sessions given over one to five months. The Treatment for 
Adolescents with Depression Study (TADS) Team (2004) compared fluoxetine 
pharmacological treatment, CBT, a combination of both, and a control placebo group for 
depressed adolescents. They found that the combination of fluoxetine and CBT produced 
the most improvement. CBT was found to be less effective than fluoxetine and not 
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superior to the placebo group after 12 weeks of treatment. Kuehn (2007), however, cited 
research from the TADS team who reported new findings at the annual meeting of the 
American Academy of Child and Adolescent Psychiatry in 2005. These results suggested 
that after receiving 18 weeks of treatment, youth receiving CBT alone had just as much 
treatment response as those receiving fluoxetine and after 36 weeks of treatment the 
youth who received CBT alone had a treatment response that was comparable to the 
participants who received both CBT and fluoxetine. Rosello and Bernal (1999) compared 
individual CBT to interpersonal therapy and a control condition and found that the two 
treatments were equally efficacious and both were superior to the waitlist control 
condition. The results of this study were limited, however, due to a small sample size and 
outcome measures that were based on only self-report data. In addition, Stark et al. 
(2006) explained that the generalizability of the study by Rosello and Bernal may have 
been impacted by their use of a nonstandard CBT treatment protocol. 
Others have compared full CBT interventions to relaxation training which is one 
component of CBT programs. Kahn, Kehle, Jenson, & Clark (1990) compared three 
interventions; CBT, relaxation only, and self modeling only, to a waitlist control. They
found that all three interventions were superior to the control condition but there were no 
significant differences between the interventions. Reynolds and Coats (1986) compared 
CBT, relaxation training, and a waitlist control condition. Both the CBT and relaxation 
training showed significantly better results than the control condition but there was no 
difference between the treatments. Wood, Harrington, and Moore (1996), however, found 
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that CBT was superior to relaxation training in terms of self-esteem, reductions in 
symptoms, global functioning, and patient satisfaction.  
Birmaher, Ryan, Williamson, Brent, and Kaufman (1996) suggest that 
determining whether to include parents in the treatment of children and adolescents with 
depression is important because research has suggested that the families of youth who are 
depressed often have high rates of conflict and parental psychopathology (Birmaher, 
Ryan, Williamson, Brent, Kaufman, Dahl et al., 1996). Although several CBT studies 
included parent components, only two directly compared a parent training plus child CBT 
treatment condition with a child CBT only condition (Clarke et al., 1999; Lewinsohn et 
al., 1990). These studies found that although there was some more diagnostic 
improvement among youths in the CBT and parent training group, the differences were 
not statistically significant between the two groups. Lewinsohn et al.’s study, however, 
found that the parents of youth in the parent training condition saw their children more 
positively at the end of treatment than the parents of youth in the group without parent 
training.  
Summary of the Treatment of Child and Adolescent Depression 
Developing early effective interventions for depressed youth is important in order 
to provide these youth relief from their current depressive symptoms, improve their 
quality of life, and positively impact their future development (Brooks & Kutcher, 2001). 
Research on treating depression in youth suggests that psychotherapy is an effective 
initial treatment for depressed children and adolescents (Birmaher, Ryan, Williamson, 
Brent, & Kaufman, 1996). Reviews of psychotherapy treatment studies for children and 
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adolescents with depression suggest that CBT is both the most frequently investigated 
and the most empirically supported treatment for this population (Curry, 2001). Studies 
have generally found that CBT is superior to no treatment for young adolescents and 
children with depression (Asarnow et al., 2002; Butler et al., 1980; De Cuyper et al., 
2004; Stark et al., 1987; Weisz et al., 1997). CBT programs for older adolescents that 
either involve group therapy for adolescents only or group therapy and an additional 
parent training component have been found to be effective as well (Clark et al., 1999; 
Lewinsohn et al., 1990). When compared to other treatments, CBT has been generally 
found to be as effective (Kahn et al., 1990; Reynolds & Coats, 1986; Rosello and Bernal, 
1999) or more effective (Brent et al., 1997; Stark, 1990; Wood et al. 1996) at reducing 
depressive symptoms or diagnoses.  
Since research has suggested that the families of youth who are depressed oft n 
have high rates of conflict and parental psychopathology (Birmaher, Ryan, Williamson, 
Brent, Kaufman, Dahl et al., 1996), researchers have tried to determine whether adding a 
parent training component to CBT interventions for youth increases the efficacy of the 
interventions. Only two studies directly compared a CBT plus parent training component 
condition with a CBT only condition and both were with older adolescents (Clarke et al., 
1999; Lewinsohn et al., 1990). These studies found that although there was some 
additional diagnostic improvement among youths in the parent training group, the 
differences were not significant between the two groups. Lewinsohn et al.’s study,
however, found that the parents of youth in the parent training condition saw their 
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children more positively at the end of treatment than the parents of youth in the group 
without parent training.  
Overall, research suggests that CBT is generally an effective treatment for 
children and adolescents with depression. There is, however, a paucity of research 
investigating whether adding a parent training component to a CBT intervention 
enhances efficacy, so it is important to increase research in this area. 
Depression and Comorbidity in Youth  
Overview of Comorbidity 
 It has been recognized for a long time that the presence of more than one disorder 
at the same time can serve to make both diagnosis and treatment more complex (Angold 
& Costello, 1993). This simultaneous presence of two or more conditions that are 
unrelated is referred to as comorbidity (Caron & Rutter, 1991). According to research on 
child psychiatric disorders, comorbidity is very common and the rate of comorbidity in 
epidemiological studies is more than double the rate expected by chance (Caron & 
Rutter). Comorbidity is especially common in depression and it has been recognizd in 
the literature that in depressed youth comorbidity is the rule not the exception (Hammen 
& Rudolph, 2003). Depressed youth commonly experience comorbidity with anxiety 
disorders, attention deficit disorders, substance use disorders, eating disorders, an  
disruptive disorders (Hammen & Rudolph). Research suggests that depressed children 
with comorbid disorders are often more at risk for negative outcomes including higher 
depression severity, poorer overall functioning, increased suicidal ideation, increased 
suicidal attempts, lower treatment response, and future psychopathology (Brent et al., 
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1998, Clarke et al., 1992, Curry et al., 2006; Ghaziuddin et al., 2000; Lewinsohn et al., 
1999; Lewinsohn, Rohde, & Seeley, 1995; McCauley et al., 1993; Rohde et al., 2001; 
Rohde, Lewinsohn, & Seeley, 1991).  
Prevalence of Comorbidity in Depressed Youth 
Research studies have suggested that 40% to 90% of children and adolescents 
with MDD have comorbid psychiatric disorders and two or more comorbid diagnoses 
occur in 20%-50% of these youth (AACAP, 1998). Dysthymia and anxiety disorders are 
the most common comorbid diagnoses and both occur in 30% to 80% of youth with 
MDD. Disruptive disorders occur in 10% to 80% of depressed youth and substance use 
disorders in 20% to 30% of these youth. It is most common for MDD to begin after the 
comorbid conditions except in the case of substance abuse and occasionally conduct 
problems. Youth with DD also often experience comorbid disorders. Approximately 70% 
of children and adolescents with DD have comorbid MDD, 40% have anxiety disorders, 
30% have conduct disorder, 24% have attention deficit disorders, and 15% experience 
enuresis or encopresis. Approximately 15% of youth with DD have at least 2 comorbid 
disorders (AACAP). 
Comorbidity and Research 
Although the previous data indicate that comorbidity is a common phenomenon, 
Caron and Rutter (1991) explained that research has largely ignored the subject of 
comorbidity until recently. They described how excluding comorbidity from studies can 
have a substantial impact on research findings. For example, when participants with 
comorbid disorders are included in a study but comorbidity is not directly investigatd 
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then it is unclear whether the results of the research are due in part to the comorbid 
disorders rather than the disorder under investigation. Conversely, when researchrs 
exclude participants with comorbid disorders they are likely to end up with small samp es 
that are not representative of the wider population since comorbidity is such a common 
phenomenon (Caron & Rutter).  
  Although Caron and Rutter (1991) make a strong argument for the necessity of 
investigating comorbidity, they also explained that there are many complications and 
issues surrounding comorbidity that make the study of it complex and challenging. 
According to their review, there is much debate about the existence of true comorbidity. 
They explained that there is some speculation that the high rates of comorbidity that have 
been found are actually the result of the artificial creation of categories f mental illness. 
According to this belief, psychopathology is a mix of different personality and behavioral 
factors rather than concrete categorical disorders and many of these factors are the same 
across different categories of mental disturbance making it seem like peopl  have 
comorbid disorders. Other arguments against comorbidity are based on the idea that one 
specific disorder can look different during various stages of the disorder making it seem 
as if different disorders are occurring when they are not. Similar arguments have also 
been made that some disorders include symptomatology of other disorders in their criteria 
making it seem as if people are experiencing both disorders (Caron & Rutter).  
Caron and Rutter (1991) also presented possible explanations for the occurrence 
of true comorbidity. They suggested that comorbidity can occur as a result of common 
risk factors for different disorders or risk factors that commonly occur together but result 
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in different disorders. In addition, they indicated that some disorders create risk factors 
for other disorders thereby increasing the chance of developing a comorbid disorder n 
the future. They also explained that another argument for true comorbidity results from 
research suggesting that comorbid disorders can sometimes influence the course or 
treatment outcome of a primary disorder, which means that those comorbid disorders 
inherently change the meaning of the original disorder (Caron & Rutter).  
Comorbidity Terminology 
 There have been many types of comorbidity investigated in research and these 
types can be defined based upon the temporal relation between the disorders and the 
similarity of the comorbid conditions (Angold, Costello, & Erkanli, 1999). The temporal 
relation of the comorbid conditions determines whether the comorbidity is “concurret” 
or “successive”. “Concurrent comorbidity” occurs when multiple comorbid conditions 
occur at the same time and “successive comorbidity” occurs when a person experiences 
comorbid conditions but the conditions are not present at the same time. Research with 
children who meet diagnostic criteria for both anxiety and depression when they are 
assessed at one time point such as those children in this study are considered to have 
“concurrent comorbidity.” The similarity of the comorbid disorders determines whether 
comorbidity is “homotypic” or “heterotypic”. “Homotypic comorbidity” occurs when the 
comorbid disorders are part of one major diagnostic category. The comorbidity of MDD 
and DD is an example of this type of comorbidity. “Heterotypic comorbidity” refers to 
comorbidity between conditions from different diagnostic categories (Angold et al., 
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1999). The comorbidity of depressive and anxiety disorders, which is the focus of this 
study, is an example of this type of comorbidity. 
Gender Differences in Comorbidity 
Research suggests that comorbidity in youth with depression differs by gender 
(Lewinsohn et al., 1995). These authors found that in depressed youth, disruptive 
disorders were more common comorbid conditions in boys and comorbid anxiety was 
more common in girls. Depressed girls also experience lower rates of comorbid 
externalizing and substance use disorders than boys but higher rates of eating disorders 
(Kovacs, Obrosky, & Sherrill, 2003). The presence of multiple comorbid anxiety 
disorders in depressed youth has also been found to be much more common in females 
than males (Lewinsohn, Zinbarg, Seeley, Lewinsohn, & Sack, 1997). In addition, 
research by Kovacs et al. suggests that boys and girls have different rates of comorbid 
disorders at different stages of development. For example, the rate of externalizing 
disorders peaks around ages 13 to 15 for girls, which is earlier than the peak for boys. 
Summary of Depression and Comorbidity in Youth  
Comorbidity among people with depression is very common and most people 
with depression experience one or more comorbid psychiatric disorders during their lives 
(Rohde et al., 1991). Depressed youth with comorbid disorders are often more at risk for 
negative outcomes (Brent et al., 1998, Clarke et al., 1992, Lewinsohn et al., 1999). In 
addition, comorbidity can make it more difficult to accurately identify depression in 
youth (Stark et al., 2006).  
  Research suggests that comorbidity in youth with depression differs between boys 
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and girls (Lewinsohn et al., 1995). Disruptive disorders and substance use disorders are 
more common conditions in depressed boys and anxiety disorders and eating disorders 
are more common comorbid conditions in depressed girls (Kovacs et al., 2003; 
Lewinsohn et al., 1995). The presence of multiple comorbid anxiety disorders in 
depressed youth has also been found to be much more common in females than males 
(Lewinsohn et al., 1997). The high rates of comorbidity among depressed youth and the 
negative outcomes associated with the presence of comorbidity suggest the need to 
understand more about the impact of comorbidity on children and adolescents with 
depression.  
Depression and Anxiety Comorbidity 
Overview of Depression and Anxiety Comorbidity 
Research has suggested that in people with depression the most common 
comorbid disorder is anxiety (Garber, 2006). Comorbid anxiety appears to be especially 
prevalent in females (NIMH, 2003). For both genders the risk of comorbid anxiety 
declines between ages 12 and 13 to 15 and then is stable through young adulthood 
(Kovacs et al., 2003). Research by Kovacs et al. (1989) also suggested that for children 
with depression, if comorbid anxiety develops it is likely to develop by age 12 suggestin  
that children and young adolescents are definitely at risk for comorbid anxiety and 
depression. In fact, anxiety has been suggested to be a risk factor for developing later 
depression (Breslau, Schultz, & Peterson, 1995; Cole, Peeke, Martin, Truglio, & 
Seroczynski, 1998; Flannery-Schroeder, 2006). 
 




Garber’s (2006) review of the literature on the comorbidity of anxiety and 
depression suggests that between 30% to 75% of depressed preadolescents and 25% to 
50% of depressed adolescents experience comorbid anxiety. NIMH (2003) suggested that 
depressed youth experience anxiety disorders about eight times as often as youth without 
depression. In fact, depression and anxiety occur together so often that some people hav  
theorized that they may actually be the same disorder (Finch, Lipovsky, & Casat, 1989). 
Since anxiety has been found to usually precede depression (Kendall et al., 1992), some 
theories have suggested that anxiety and depression are the same disorder that is 
expressed differently over the course of development (Finch et al., 1989). Stark et al. 
(2006) suggest that differences in the presence of positive affect help to discriminate 
between the two disorders. Both disorders include the presence of negative affect, but a 
deficit in positive affect occurs in depression but not anxiety. This difference in positive 
affect between the two disorders is the major premise behind the tripartite model 
developed by Clark and Watson (1991).  
Differentiating Between Depression and Anxiety 
 Tripartite Model. The tripartite model provides a theoretical model for 
differentiating between depression and anxiety (Stark et al., 1999). This model developed 
by Clark and Watson (1991) is based upon the premise that depression and anxiety have a 
common component which is a high level of negative affect but also have other 
components unique to each disorder. This model suggests that people with anxiety have 
high levels of physiological hyper arousal and people with depression have low levels of 
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energy, engagement, and interest or a lack of positive affect. Empirical support for this 
model has been established for both youth (Joiner, Catanzaro, & Laurent, 1996; Lonigan, 
Carey, & Finch, 1994) and adults (Clark, Steer, & Beck, 1994; Watson et al., 1995). 
 Beck’s Cognitive Model. The cognitive model developed by Beck (1976) suggests 
that emotional disorders have specific cognitions associated with them which allow for a 
differentiation between disorders which is referred to as the cognitive-contnt specificity 
hypothesis. This hypothesis is based upon the premise that anxiety and depression exhibit 
differences in cognitions. Cognitions in anxiety are often focused on internal and/or 
external threat or danger and cognitions in depression often focus on loss (Beck). This 
model suggests that even if the behavioral symptoms are similar between anxity d 
depression the cognitions are the basis of these disorders and these cognitions are 
different between the two disorders (Stark et al., 1999). Jolly, Dyck, Kramer, and Wherry 
(1994) integrated the cognitive content specificity model with the tripartite model to see 
if this integrated model could discriminate between anxiety and depressions. They found 
that in adult psychiatric outpatients, combining negative affect and anxious cognitions 
predicted anxiety symptoms and negative affect, low positive affect, and depressive 
cognitions predicted depressive symptoms. 
Stark and Laurent (2001) also found that there were unique factors that 
differentiated depression and anxiety in youth when they did a joint factor analysis of the 
Children’s Depression Inventory (CDI; Kovacs, 1981) and the Revised Children’s 
Manifest Anxiety Scale (RCMAS; Reynolds & Richmond, 1978, 1985) which are self 
report measures used to identify anxious and depressed youth. They found a nine item 
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depression factor that was based mostly on items associated with a negative view of 
oneself which fits with Beck’s (1967) theory that depression is caused by the presence of 
a negative view of oneself, the world, and the future. They also found a seven item 
anxiety factor consisting of items focused on worry which has been identified as a 
significant symptom of anxiety in children (Laurent, Landau, & Stark, 1993; Silverman, 
La Greca, & Wassertein, 1995). 
Anxiety Disorders 
The DSM-IV-TR includes diagnostic criteria for many different anxiety disorders 
(APA, 2000). According to Kendall et al. (1991), clinical interviews, such as the K-
SADS, are one of the most common methods used to assess the presence of anxiety 
disorders in youth. This review will focus on only the anxiety disorders that are included 
in the K-SADS-IVR (Ambrosini & Dixon, 2000). These disorders include Generalized 
Anxiety Disorder (GAD), Panic Disorder, Separation Anxiety, Specific Phobia, Social 
Phobia, Obsessive Compulsive Disorder (OCD), and Post Traumatic Stress Disorder 
(PTSD). Anxiety Disorder Not Otherwise Specified (ADNOS) and Adjustmen  Disorder 
with Anxiety will also be discussed since these diagnoses can be determined based on the 
symptoms covered in the K-SADS-IVR. 
In order to meet diagnostic criteria for GAD, a person must experience worry and 
anxiety that is excessive and difficult to control (APA, 2000; see Appendix E). The 
anxiety must occur more often than not for 6 months or more about many different 
activities or events. An adult must also experience at least three symptoms related to the 
anxiety, however, a child must only experience at least one symptom. The symptoms 
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must have occurred more often than not for the past 6 months. These symptoms include 
sleep difficulty, irritability, muscle tension, becoming easily fatigued, restlessness, or 
concentration difficulties. The physical symptoms, anxiety, or worried feelings must be 
causing significant impairment or distress in academic/occupational, social, or other types 
of functioning. If the anxiety is about symptoms or features of another Axis I disorder or 
is due to the effects of a medical condition or substance, or occurs exclusively during a 
Psychotic Disorder, Pervasive Developmental Disorder, or Mood Disorder, then the 
person does not meet diagnostic criteria for GAD (APA). 
The diagnostic criteria for Panic Disorder include the presence of Panic Attacks 
that are both unexpected and recurrent (APA, 2000; see Appendix G). In addition, after 
one or more of the attacks the person must experience at least one month of worry about 
the occurrence of another attack or the consequences of the attacks, or a significant 
change in behavior due to the attacks. Panic Attacks include a specific period of extreme 
anxiety, fear, or discomfort when there is no actual danger that occurs with atleast four 
cognitive or somatic symptoms. These symptoms include fear of dying, numbness or 
tingling, chills or hot flushes, trembling, feeling short of breath or smothered, fe ling like 
one is choking, sweating, nausea or abdominal discomfort, depersonalization or 
derealization, heart palpitations or increased heart rate, chest pain or discomfort, feeling 
lightheaded or dizzy, or fear of losing control. If the panic attacks result from a medical 
condition or substance or another psychiatric disorder, then the child does not meet 
criteria for Panic Disorder (APA). 
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Separation anxiety involves anxiety that is excessive and developmentally 
inappropriate related to being separated from home or attachment figures (APA, 2000; 
see Appendix H). Three or more symptoms must occur related to this anxiety. These 
symptoms include excessive distress that is recurrent and happens when the person 
anticipates being separated from home or major attachment figures or is separated from 
them, anxiety that is excessive and persistent and is related to the loss of a maj r
attachment figure or harm to that person, worry about an event that would end in 
separation from an attachment figure such as being kidnapped or getting lost, refusal or 
reluctance to attend school or go somewhere else because of worry about separation, 
anxiety or reluctance about being without major attachment figures or alone at home or in 
other places, refusal or reluctance to sleep without being close to an attachment figur  or 
without being home, nightmares about separation, or physical complaints when 
separation is anticipated or occurs. These symptoms must occur for four or more weeks 
and must begin before eighteen years of age. The symptoms must also cause significant 
impairment or distress in social, academic/occupational, or other areas of functioning. In 
order to meet criteria, the symptoms cannot occur only during the course of a Psychotic 
Disorder or a Pervasive Developmental Disorder (PDD) and cannot be due to Panic 
Disorder With Agoraphobia in adolescents and adults. If onset occurs prior to six years of 
age, the disorder is labeled Early Onset (APA). 
 Specific Phobia is diagnosed based on the presence of an excessive or 
unreasonable marked and persistent fear that is caused by the anticipation of or presence 
of a specific situation or object (APA, 2000; see Appendix I). Being exposed to the 
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feared object or situation causes an anxious response that is immediate and may be 
similar to a panic attack. The anxiety response in children can involve tantrums, freezing, 
clinging, or crying. The person must realize that the fear is unreasonable or excessive, 
although children do not need to meet this criterion. Either the person avoids the feared 
stimulus or experiences extreme stress or anxiety when exposed to it. The distress during 
exposure, the fearful anticipation of encountering the stimulus, or the avoidance of the 
stimulus must create significant interference with the person’s academic/occupational 
functioning, daily routine, social functioning, or else create intense anxiety about the 
presence of the phobia. There are five subtypes of Specific Phobia based upon the feared 
stimulus, these include Animal Type, Natural Environment Type, Blood-Injection-Injury 
Type, Situational Type, or Other Type. In order to meet diagnostic criteria, the phobia 
must occur for at least six months in children and adolescents. If the panic attcks, 
anxiety, or avoidance are caused by another psychiatric disorder, then the child does not 
meet criteria for Specific Phobia (APA). 
Social Phobia is diagnosed based on a persistent fear of at least one performance 
or social situation (APA, 2000; see Appendix J). These situations involve experiences 
where the person is either around people who are unfamiliar or exposed to possible 
scrutiny by people. The person is afraid that they will behave in an embarrassing way and 
they either avoid the feared situation or experience intense anxiety or distress n the 
situation. To meet criteria, children must have the ability to engage in social relationships 
appropriate for their age and they must be anxious in settings with peers, not justs cial 
situations with adults. The situation the person fears leads to anxiety which may look like 
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a panic attack. Children may express this fear by shrinking from situations in which they 
have to interact socially with people they do not know, freezing, crying, or having 
tantrums. In order to meet criteria for Social Phobia, adults must realize that their fear is 
unreasonable but children do not need to meet this criterion. Similarly to Specific Phobia, 
the fearful anticipation of encountering the stimulus, the distress during exposure, r th  
avoidance of the stimulus must significantly interfere with the person’s 
academic/occupational functioning, daily routine, social functioning, or else create 
intense anxiety about the presence of the phobia. The phobia must occur for at least six
months in children and adolescents. The avoidance or fear must not be cause by or related 
to a medical condition, substance, or another mental disorder in order to meet criteria for 
Social Phobia. When most social situations are feared, the Social Phobia is labeled 
Generalized (APA). 
The diagnostic criteria for Obsessive-Compulsive Disorder (OCD) include 
recurrent obsessions or compulsions that take more than one hour each day, cause 
distress, or cause significant impairment in the person’s occupational/academi 
functioning, daily routine, or social functioning (APA, 2000; see Appendix K). In adults, 
the person recognizes that the obsessions or compulsions are excessive but this is not part 
of the criteria for children. The obsessions or compulsions must not be restricted to 
content related to another Axis I disorder or caused by a medical condition or substance 
(APA).  
PTSD involves experiencing helplessness, horror, or extreme fear related to th  
personal experience of a traumatic event (APA, 2000; see Appendix F). The event must 
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involve threatened or actual death, serious injury, or another threat to the physical 
integrity of themselves or someone else. The event can also involve learning about the 
unexpected or violent death, threat of death, or serious injury of a family member or 
person close to them. In children the response to the trauma may manifest as agitated or 
disorganized behaviors. The person re-experiences the trauma with at least one of he 
following symptoms: recollections of the trauma that are distressing, intrusive, and 
recurrent, nightmares about the traumatic event, reliving the trauma by acting or feeling 
as if it were happening, or distress or increased arousal when exposed to stimuli that are 
related to the trauma. In children, the trauma may be re-experienced through repetitive 
play, nightmares that do not have clear recognizable content, or trauma-specific 
reenactment. The person must also experience at least three symptoms of avoidance or 
numbing that were not occurring before the trauma. These symptoms include feelings 
that they will have a foreshortened future, detachment/estrangement from other people, 
restricted affect, avoidance of stimuli that remind the person of the trauma, voidance of 
thoughts, feelings, or conversations related to the trauma, not being able to remember part 
of the traumatic event, or decreased interest or participation in important activities. In 
addition, the person must experience two or more symptoms of increased arousal that did 
not occur prior to the trauma. These include exaggerated startle responses, concentration 
problems, hyper vigilance, sleep disturbance, or irritability. These symptoms must occur 
for at least one month and must cause social, academic/occupational, or other 
impairment. If the symptoms occur for under three months the disorder is labeled acute, 
for longer than three months it is labeled chronic. When the symptoms begin six months 
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or more after the trauma, the disorder is labeled as Delayed Onset (APA). ccording to 
Alloy, Jacobson, and Acocella (1999), PTSD differs considerably from the other anxiety 
disorders. They suggested that PTSD differs from other anxiety disorders because the 
stress a person experiences when they have PTSD is a reaction to an external traumatic 
event. As a result, although the symptoms may be similar to other anxiety disorders an  
are often debilitating, they are relatively understandable given the experinc  of the 
external trauma (Alloy et al., 1999). As a result of the differences between PTSD and the 
other anxiety disorders, the participants who met diagnostic criteria for PTSD prior to 
treatment were excluded from the present study. Given that PTSD is so different than the 
other anxiety disorders, it was unreasonable to put girls who met criteria for PTSD in the 
same group as girls who met criteria for other anxiety disorders. Since many of the 
symptoms of PTSD are similar to other anxiety disorders, however, these girls could not 
be grouped with girls who did not have anxiety disorders. In addition, there were not 
enough girls in the sample who met criteria for PTSD to treat them as a separ te group 
for the analyses. As a result, the four girls who met diagnostic criteria for PTSD were 
excluded from the present study. 
Adjustment Disorder with Anxiety is diagnosed when a person develops 
symptoms as a result of a specific identifiable stressor and the symptoms occur within 
three months of when the stressor began and end within six months of when the stressor 
or consequences of the stressor were no longer present (APA, 2000; see Appendix D). 
The symptoms must either cause excessive distress that is more than expected as a r sult 
of the stressor or cause serious social, occupational, or academic impairment. If th  
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symptoms from the stressor meet criteria for another Axis I disorder, are rel t d to a 
previous Axis I or II disorder, or meet criteria for Bereavement then the person does not 
meet criteria for Adjustment Disorder. In order to meet criteria for n Adjustment 
Disorder with Anxiety, the emotional or behavioral symptoms the person is experiencing 
are usually symptoms such as worry, jitteriness, and nervousness. Children may also 
experience fears about being separated from major attachment figures (APA).  
If a person experiences significant anxiety or phobia but does not meet the 
specific criteria for any of the anxiety disorders, Adjustment Disorder with Anxiety, or 
Adjustment Disorder with Mixed Anxiety and Depressed Mood, then they may be 
diagnosed with ADNOS (APA, 2000). An example of this would be a person who is 
experiencing severe anxiety but does not have enough symptoms to meet the full criteria 
of any of the anxiety disorders (APA). Appendices D through K include more detaile  
information about the diagnostic criteria for the disorders discussed in this section. 
Implications of Comorbid Anxiety  
 The presence of anxiety has been suggested to be a risk factor for developing later 
depression (Breslau et al., 1995; Cole et al., 1998; Flannery-Schroeder, 2006). Research 
by Breslau et al. suggested that the lifetime prevalence of MDD and the lifetime 
prevalence of anxiety disorders were approximately two times higher in f males than 
males. In addition, they found that the higher prevalence of MDD in females was mainly
in MDD that was comorbid with anxiety. Their results suggested that since anxiety is a 
risk factor for depression and more females have anxiety disorders, this may help to 
explain why more females experience depression. According to their results, more than 
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50% of the association between gender and depression can be explained by prior anxiety. 
These results suggest that anxiety plays a major role in the experience of depression for 
females. Depressed youth with comorbid anxiety also appear to experience more 
depressive symptomatology, more severe depression, earlier depression onset, and 
increased suicidal ideation compared to children without comorbid anxiety (Ghaziuddin 
et al., 2000; Kendall et al., 1992; Kovacs et al., 1989; Mitchell et al., 1988; Rohde et al., 
2001; Stark et al., 1993; Young et al., 2006). 
Summary of Anxiety and Depression Comorbidity in Youth 
In people with depression the most common comorbid disorder is anxiety 
(Garber, 2006) and comorbid anxiety appears to be especially prevalent in females 
(NIMH, 2003). Between 30% to 75% of depressed preadolescents and 25% to 50% of 
depressed adolescents experience comorbid anxiety (Garber). Research by Kovacs et al. 
(1989) suggested that for children with depression, if comorbid anxiety develops it is 
likely to develop by age 12. This suggests that children and young adolescents are 
definitely at risk for comorbid anxiety and depression. Depressed youth with comorbid 
anxiety also appear to experience more negative outcomes than children without 
comorbid anxiety including more depressive symptomatology, more severe depression, 
earlier depression onset, and increased suicidal ideation (Ghaziuddin et al., 2000; Kendall 
et al., 1992; Kovacs et al.; Mitchell et al., 1988; Rohde et al., 2001; Stark et al., 1993; 
Young et al., 2006). These findings suggest that many youth experience comorbid 
depression and anxiety and as a result it is important to better understand how to provide 
effective interventions for these youth. 
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Treatment of Anxiety Disorders 
 
Similar to the treatment of depressed children and adolescents, CBT has been 
found to be effective for treating youth anxiety disorders (Chorpita & Southam-Gerow, 
2006). CBT programs for anxious youth such as the Coping Cat program (Kendall, Kane, 
Howard, & Siqueland, 1990) include many similar components to programs designed for 
depressed youth. For example, this program incorporates affective education, problem 
solving, coping, positive reinforcement, and recognizing/restructuring dysfunctional 
cognitions. Although the skills taught in CBT programs for depressed and anxious youth 
are similar, the activities in which these skills are used differ (Stark e  al., 2006). In 
anxiety CBT programs, the skills learned are used in graded exposure activities, used to 
reduce stress, and utilized in the process of restructuring the idea that something bad is 
going to happen (Stark et al.). Research suggests that exposure activities may be a very 
critical component to the efficacy of CBT in anxious youth (Kendall et al., 1997). In 
depression CBT programs, the skills taught to youth are used to improve mood, 
restructure negative thoughts about oneself and others, and in stress reduction activities 
(Stark et al.).  
Research suggests that parental behavior is related to childhood anxiety and 
therefore changing these behaviors may reduce anxiety in youth (Chorpita & Southam-
Gerow, 2006). As a result, programs such as the Coping Koala program (Barrett et al., 
1996), integrate parent training components that are similar to those investigated for 
depressed youth. This program, for example, includes teaching the parent 
communication, problem solving, and positive reinforcement. In addition to these 
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components some parts of this training are specific to working with anxious youth such 
as using reinforcement to encourage courageous behavior and reduce fear behaviors and 
teaching parents skills they can use to manage their own anxiety. Barrett et al. found that 
adding a family component increased treatment outcome for anxious youth. Another 
study found that even a parent only intervention was effective in reducing anxiety i 
children and adolescents (Thienemann et al., 2006). According to Chorpita and Southam-
Gerow’s review of CBT efficacy studies, other studies have found less empirical support 
for adding parent training to CBT interventions for anxious youth and empirical support 
for parent training is just beginning to emerge.  
Comorbid Anxiety and the Treatment of Depression in Youth 
Overview of Comorbid Anxiety and the Treatment of Depression in Youth 
Although there have been mostly positive results in evaluations of cognitive 
behavioral interventions with depressed youth, approximately one third to one half of 
youth do not recover from their depressive episodes at the end of the intervention (Clark 
et al., 1992). It is still unclear, however, what factors predict treatment succes  or failure 
for adolescents with depression (Brent et al., 1998). It is important to know how different 
factors impact treatment outcome in order to inform the choice of treatments for different 
individuals, increase the understanding of how treatment works, and use this information 
in order to develop more effective interventions for people that are not responding well to 
existing interventions (Clark et al.). Stark et al. (1999) suggest that one factor that needs 
to be explored in terms of its relation to treatment outcome is the presence of comorbid 
conditions. Although comorbidity is very common in youth with depressive disorders 
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(Hammen & Rudolph, 2003), often manualized interventions are tested using clinical 
trials tailored to treat specific symptoms of a disorder and do not focus on comorbid 
symptoms (Clarkin & Kendall, 1992). Compton et al. (2004) explained that since 
researchers investigating treatment interventions in youth have often failed to assess 
whether comorbidity impacts treatment outcome, this has created major deficit in the 
depression and anxiety literature. 
Naturalistic Studies of Comorbid Anxiety and Depression Recovery in Youth 
In order to begin to understand the impact of comorbid anxiety on treatment 
outcome, some researchers have completed naturalistic studies of the relation between 
comorbid anxiety and depression recovery in youth (Goodyer, Herbert, Secher, & 
Pearson, 1997; Kovacs, Feinberg, Crouse-Novak, Paulauskas, & Finkelstein, 1984; 
Sanford et al., 1995; Weersing & Weisz, 2002).  
Goodyer et al.’s (1997) study involved investigating factors that predicted 
depression persistence in a clinical sample of 8-16 year old depressed children and 
adolescents. They identified 78 children who met criteria for MDD and after 36 weeks 
the children were reassessed for depression. In this study, the participants were in 
outpatient or inpatient care so they received a variety of different interventions duri g 
those 36 weeks including CBT, supportive measures, psychotherapy, family therapy, 
parent counseling, group therapy, and antidepressants. The researchers, however, did not 
control for treatment type but they indicated that treatment did not differ based on 
comorbidity. After the 36 weeks, 50% of the participants had recovered from depression. 
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The researchers found that the presence of comorbid OCD during the first assessment 
predicted not recovering from depression after 36 weeks. 
Sanford et al. (1995) completed a similar study with 13-19 year old adolescents 
who were referred for outpatient and inpatient treatment to determine factors predicting 
MDD remission. The presence of comorbid anxiety disorders was found to be one of the 
factors associated with continued depression after one year. Anxiety was only a 
significant factor when the effects of age and comorbid substance use disorders wer  
taken into account. Sanford et al. suggested that these results may indicate that depression 
persistence in younger adolescents without substance use disorders may be most 
impacted by comorbid anxiety. Goodyer et al. (1997) and Sanford et al.’s studies 
suggested that the presence of comorbid anxiety disorders predicts the persist nce of 
depression in clinical samples, however, two other studies suggested that anxiety was not 
a significant predictor of depression recovery (Kovacs et al., 1984; Weersing & Weisz, 
2002).  
Weersing and Weisz (2002) evaluated the efficacy of psychotherapy for depressed 
male and female youth who received outpatient services at community mental health 
centers and investigated factors predicting treatment response. Their partic pants ranged 
from 7 to 17 years of age. These participants received from 1 to over 90 treatment 
sessions and 35% received less than eight sessions. Therapy included psychodynamic, 
behavioral, and cognitive techniques. These researchers did not find that comorbid 
anxiety predicted the trajectory of depressive symptoms during treatment for their 
participants. 
    
  
56 
Kovacs et al. (1984) investigated depression recovery in a sample of children 
from 8 to 13 years of age who were receiving outpatient services through psychiatric 
clinics and medical clinics. They found that the presence of a comorbid anxiety disorder 
in children with MDD or DD did not impact recovery from their depression. Similar to 
the studies described above, treatment was not controlled in the study by Kovacset al. In 
this study, only 63% of the children received treatment, 23% had assessment services, 
and 14% did not experience either. Six of their cases received pharmacological 
treatments for either their depression or anxiety. The participants received treatment at 
different times during their episode and the length, format, and frequency of the treatment 
varied widely.  
The different results from these four studies (Goodyer et al., 1997; Kovacs et al., 
1984; Sanford et al., 1995; Weersing & Weisz, 2002) may be related to the fact that the 
treatment was not controlled for and the treatment received by participants varied widely 
both within and between these studies. Kovacs et al. suggested that since treatment w s 
not controlled for in their study, meaningful conclusions could not be made about the 
impact of treatment on recovery from depression. They suggested that research 
evaluating specific psychosocial therapies was needed to explain how treatment impacts 
depression recovery. 
Comorbid Anxiety and the Treatment Outcome of Depressed Youth 
 Some studies have investigated comorbid anxiety and its impact on the outcomes 
for specific treatments of depression, however, these studies have focused mainly on 
older adolescents. Young et al. (2006) investigated whether comorbid anxiety impacted 
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treatment outcome for male and female depressed adolescents aged 12 to 18receiving 
Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) or treatment as usual as 
part of the control group. Adolescents were considered to have comorbid anxiety if th y 
answered questions on a self report screening questionnaire in a way which suggested 
they had a current probable diagnosis of social phobia, panic disorder, or GAD. Changes 
in depression during treatment were measured by a rating scale that assessed depressive 
symptoms. Those adolescents who had any of the probable anxiety disorders also had 
higher depression severity scores before treatment but had no differences in global 
functioning scores. Controlling for baseline severity, the adolescents with probable 
anxiety disorders still had higher severity scores at post treatment but there was no 
difference in functioning scores.  
Jayson et al. (1998) investigated what factors may inhibit recovery in depressd 
youth treated with individual CBT. Their sample included 50 depressed male and female 
youth from 10 to 17 years of age who participated in two larger studies of treatment 
outcome in depressed youth (Wood et al., 1996; Kroll, Harrington, Jayson, Fraser, & 
Gowers, 1996). The participants all received 8 sessions of CBT. These researcher  found 
that the presence of a comorbid anxiety disorder was not related to depression mission. 
These authors, however, explained that their small sample size required them to us a
conservative data analysis approach and they suggested that a larger sample may have 
detected more predictors of remission. 
Four studies have investigated whether anxiety impacts treatment outcome 
specifically in group CBT treatments for adolescents (Brent et al., 1998, Clarke et al., 
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1992, Curry et al., 2006; Rohde et al., 2001). Brent et al.’s study tried to identify 
predictors of response to treatment for 107 male and female 13 to 18 year old adolescents 
diagnosed with MDD. These adolescents received 12 to 16 sessions of either CBT, 
systemic behavioral family therapy (SBFT), or nondirective supportive therapy (NST) as 
part of a study evaluating treatment outcome in depressed adolescents (Brent et al., 
1997). The researchers found that the presence of a comorbid anxiety disorder at intake
predicted depression at the end of treatment. Comorbid anxiety, however, was not a 
significant predictor of clinical remission which was measured by absence of MDD at 
post-treatment and consecutively low scores on a self report measure of depressiv  
symptoms (Beck Depression Inventory (BDI)) or of post-treatment levels of functional 
impairment. These authors also found that the presence of comorbid anxiety was related 
to better outcome from CBT than the two other treatments.  
A study by Clark et al. (1992) evaluated characteristics that were relat d to 
positive treatment outcome in depressed adolescents. The 37 depressed adolescents who 
were participants in the study were part of a larger study evaluating treatment outcome in 
male and female 14 to 18 year old depressed adolescents (Lewinsohn et al., 1990). These 
participants received either 14 sessions of CBT group therapy alone or these 14 sessions 
and an additional seven sessions of parent training. Results of the study suggested that 
lower state anxiety before treatment was related to recovery after treatment. State anxiety 
was not a predictor of change in BDI scores after treatment.  
Curry et al.’s (2006) study was aimed at identifying predictors and moderators of 
treatment outcome in the Treatment for Adolescents with Depression (TADS) study. In 
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the TADS study, 439 male and female depressed adolescents from 12-17 years of age 
were in one of four conditions, CBT, fluoxetine, a combination of both, or a pill placebo 
group for 12 weeks (Treatment for Adolescents with Depression Study (TADS) Team, 
2005). They found that the presence of a comorbid anxiety disorder predicted less 
improvement at post-treatment across conditions but the relation between comorbid 
anxiety and treatment outcome did not differ between treatment groups. 
Rohde et al. (2001) investigated whether comorbidity was related to treatment 
outcome in 151 male and female depressed adolescents from 14 to 18 years of age who 
participated in one of two studies evaluating treatment outcome in depressed adolescents 
(Clarke et al., 1999; Lewinsohn et al., 1990). These adolescents received either 14 to 16 
sessions of CBT group treatment or the CBT sessions and an additional 7 to 9 sessions of 
parent training. They found that the presence of lifetime anxiety comorbidity was related 
to significantly higher pre-treatment scores on a self report measure of depressive 
symptoms (Beck Depression Inventory (BDI)). As opposed to the findings from the 
previous studies (Brent et al., 1998, Clarke et al., 1992; Curry et al., 2006), comorbid 
anxiety was related to improved treatment outcome indicated by more post-treatment 
change on the BDI. The researchers, however, did not control for pre-treatment BDI 
scores and they suggested that the finding that the comorbid anxiety group had more 
change was probably related to the fact that they started out with higher scores at p e-
treatment. Lifetime anxiety comorbidity was not related to diagnostic recovery. 
Differences between the treatment conditions were not found for the relation between 
lifetime anxiety comorbidity and treatment outcome. The findings from this s udy were 
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very different from the results from the studies by Brent et al., Clark et al., and Curry et 
al. and there were several factors in Rohde et al.’s study that may help to explain these 
differences. Rohde et al. used measures of lifetime comorbidity instead of current 
comorbidity to test whether comorbidity was related to treatment outcome and exclu ed 
people experiencing common current anxiety disorders such as GAD and Panic Disorder. 
As a result, the findings from this study do not provide information about whether the 
concurrent comorbidity of anxiety and depression during treatment for depression 
influenced treatment outcome. 
Comorbidity and Parent Training 
Research has suggested that the co-occurrence of anxiety and depression is 
associated with maternal psychopathology and poor maternal health (Kovacs et al., 
1989), more family enmeshment, less democracy in terms of family decision making, less 
family involvement in recreational activities, less family emphasis on mrality and 
religion, and child reports of less family support and more family conflict (Stark e  al., 
1990). As a result of the relationship between comorbid depression and anxiety and 
negative family factors, Stark et al. (1999) suggest that treatment of comorbid anxiety 
and depression may need to include the parental system in addition to working with the 
children. In addition, some research suggests a benefit to receiving parent intervention for 
children with anxiety (Barrett et al., 1996; Thienemann et al., 2006). This informatin 
suggests that receiving a parent component in addition to CBT therapy may be especially 
beneficial for children with comorbid anxiety.  
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Only one of the previous CBT group therapy studies investigated whether parent 
training was a possible moderator between comorbid anxiety and treatment outcome 
(Rohde et al., 2001). These researchers did not find significant results suggesting a 
relation between comorbid anxiety, treatment condition, and treatment outcome. As 
mentioned previously, however, the specific methodology used in Rohde et al.’s study 
did not allow for conclusions to be made about the impact of experiencing concurrent 
anxiety and depression during treatment. 
Summary of Comorbid Anxiety and the Treatment of Depression in Youth 
Naturalistic studies of the relation between comorbid anxiety and depression 
recovery have shown mixed results. Two studies suggested that the presence of comorbid 
anxiety was related to continued depression (Goodyer et al.’s, 1997; Sanford et al., 1995) 
and two other studies suggested that anxiety was not a significant predictor of depression 
recovery (Kovacs et al., 1984; Weersing & Weisz, 2002). The different results from these 
four studies (Goodyer et al.; Kovacs, et al.; Sanford, et al.; Weersing & Weisz) may be 
related to the fact that the treatment was not controlled for and the treatment received by 
participants varied widely both within and between these studies.  
Studies investigating the impact of comorbid anxiety on treatment outcome from 
specific interventions have focused almost entirely on older adolescents. Only one study 
(Jayson et al., 1998) included children and adolescents in their study and their results 
suggested that comorbid anxiety was not related to treatment recovery using a br ef 
individual CBT intervention. These authors, however, explained that their small sample 
size required them to use a conservative data analysis approach and they suggested that a 
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larger sample may have detected more predictors of remission. Young, et al.’s (2006) 
study suggested that for adolescents who received an interpersonal therapy intervention 
or a treatment as usual control condition, the presence of probable comorbid anxiety 
disorders at pre-treatment was related to higher severity scores at post-treatment even 
after controlling for pre-treatment scores. 
Four studies have investigated whether anxiety impacts treatment outcome 
specifically in group CBT treatments for adolescents and all of these studies hav  focused 
on older adolescents (Brent et al., 1998, Clarke et al., 1992, Curry et al., 2006; Rohde et 
al., 2001). Brent et al.’s study found that the presence of a comorbid anxiety disorder at 
intake predicted depression at the end of treatment for adolescents who received ither 
CBT, systemic behavioral family therapy (SBFT), or nondirective supportive therapy 
(NST). Results from a study by Clark et al. suggested that lower state anxiety before 
treatment outcome was related to recovery after treatment for adolescents who received 
group CBT alone or group CBT and a parent intervention. Curry et al. found that the 
presence of a comorbid anxiety disorder predicted less improvement at post-treatment 
across conditions for adolescents receiving either CBT, fluoxetine, a combination of both, 
or a pill placebo. Only one group CBT study did not have results suggesting that 
comorbid anxiety was related to poorer treatment outcome (Rohde, et al.). These 
researchers found that the presence of comorbid anxiety was related to more post-
treatment change on the Beck Depression Inventory (BDI). This study, however, had 
limitations which may have influenced the results. 
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There is also very limited research evaluating whether parent intervention 
moderates the relation between comorbid anxiety and treatment outcome in youth. 
Although research has suggested that parent intervention may be especially b neficial for 
youth with comorbid anxiety and depression (Kovacs et al., 1989; Stark et al., 1999), 
only one of the previous studies investigated whether the relation between comorbid 
anxiety and treatment outcome was moderated by receiving parent intervention (Rohde et 
al., 2001). These researchers did not find significant results. As mentioned previously, 
however, the results of Rohde et al’s study were limited based on their methodology.  
In conclusion, there is a need for research that provides more information about 
the association between comorbid anxiety and treatment outcome especially for 
depressed children and early adolescents. Research is also needed to determine whether 
parent intervention moderates the relation between comorbid anxiety and treatment 
outcome for depressed youth. Therefore, this study focused on investigating the relation
between comorbid anxiety and treatment outcome in a sample of depressed femal  early 
adolescents who received either group CBT or group CBT plus a parent intervention. The 
inclusion of both treatment types allowed for an investigation of whether parnt 
intervention moderated the relation between comorbid anxiety and treatment outcome. 
Statement of the Problem 
Depressive disorders are common in youth (Birmaher, Ryan, Williamson, Brent, 
Kaufman, Dahl et al., 1996) and are associated with many negative outcomes (Fergusson 
& Woodward, 2002; OAS, 2006; Weissman et al., 1999). Depressive disorders in youth 
also increase the risk of experiencing future psychopathology, including depression 
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recurrence (Lewinsohn et al., 1999; Rao et al., 1995). Females are especially at risk for 
depression and the lifetime risk of major depression for females is twice that of m les 
(APA, 2000). In addition, early adolescence appears to be a significant period in the 
development of depression, especially in females. The overall rate of depression 
drastically increases between early and late adolescence (OAS; Saluja et al., 2004) and 
the gender difference in depression also first appears during this age period (Hankin et 
al., 1998). This research suggests the need to increase our understanding of depression in 
early adolescent girls. 
Considering that depressive disorders occur so often in youth, the development of 
effective interventions is very important in order to provide these youth relief from their 
current depressive symptoms, improve their quality of life, and positively impact their 
future development (Brooks & Kutcher, 2001). Research suggests that psychotherapy is 
an effective initial treatment for depressed children and adolescents (Birmahe , Ryan, 
Williamson, Brent, & Kaufman, 1996) and reviews of psychotherapy treatment studies 
for youth with depression suggest that CBT is both the most frequently investigated and 
the most empirically supported treatment for this population (Curry, 2001). Although 
there have been mostly positive results from CBT interventions with depress d youth, 
approximately one third to one half of youth do not recover from their depressive episode 
at the end of the intervention (Clark et al., 1992). It is still unclear what factors predict 
treatment success or failure for adolescents with depression (Brent et al., 1998). 
One factor that researchers are starting to investigate as a possible moderator of 
treatment outcome is comorbidity (Brent et al., 1998, Clarke et al., 1992, Curry et al., 
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2006; Jayson et al., 1998; Rohde et al., 2001: Young et al., 2006). The study of 
comorbidity has been identified as an important area of research especially in chi dren 
and adolescents with depression given that comorbidity in depressed youth is the rule not
the exception (Hammen & Rudolph, 2003). In people with depression the most common 
comorbid disorder is anxiety (Garber, 2006) and comorbid anxiety appears to be 
especially prevalent in females (NIMH, 2003). Research also suggests that for children 
with depression, if comorbid anxiety develops it is likely to develop by age 12 (Kovacs et 
al., 1989). Depressed youth with comorbid anxiety also appear to experience more 
negative outcomes than children without comorbid anxiety including more depressive 
symptomatology, more severe depression, earlier depression onset, and increased suicidal 
ideation (Ghaziuddin, et al., 2000; Kendall et al., 1992; Kovacs et al.; Mitchell et al., 
1988; Rohde et al.).  
One limitation in the current literature is that studies of the relation between 
comorbid anxiety and treatment outcome have almost exclusively focused on older 
depressed adolescents. There is only one study that included children in addition to 
adolescents (Jayson et al., 1998). Results indicated that comorbid anxiety was not related 
to treatment outcome for depressed youth. This study, however, used a very brief 
individual CBT intervention and their small sample size may have restricted their 
findings. There have been no studies of group CBT with depressed children or early 
adolescents evaluating comorbid anxiety as a possible moderator of treatment outcome. 
Four studies have investigated whether comorbid anxiety impacts treatment outcome 
specifically in group CBT treatments for depressed older adolescents (Brent et al., 1998, 
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Clarke et al., 1992, Curry et al., 2006; Rohde et al., 2001). Three of the four studies found 
that individuals with comorbid anxiety and depression were less likely to improve from 
treatment than depressed individuals without comorbid anxiety (Brent et al.; Clarke et al; 
Curry et al.). The other study, however, found that the presence of comorbid anxiety was 
related to more post-treatment change on the Beck Depression Inventory (Rohde et al.). 
The finding of this study are limited by the fact that they used measures of lifetime 
comorbidity instead of current comorbidity and excluded people experiencing common 
current anxiety disorders.  
There is also very limited research about whether the relation between comorbid 
anxiety and treatment outcome in depressed children and adolescents is moderated by 
receiving parent intervention. Only one study has explored this (Rohde et al., 2001), but 
these researchers did not find that parent intervention was a moderator. As previously 
discussed, however, this study had limitations which may have influenced the results. 
Research has suggested that the co-occurrence of anxiety and depression is ass ciated 
with many negative family factors (Stark et al., 1990). As a result of thesefindings, Stark 
et al. (1999) suggest that the treatment of comorbid anxiety and depression may need to 
include the parental system in addition to working with the children. Some research has 
also suggested a benefit to receiving parent intervention for children with anxiety (Barrett 
et al., 1996; Thienemann et al., 2006). This information suggests that receiving a parent 
component in addition to CBT therapy may be especially beneficial for children with 
comorbid depression and anxiety.  
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In conclusion, there is a need for research that provides more information about 
the relation between comorbid anxiety and treatment outcome especially for depressed 
female children and early adolescents. Research is also needed to determine whether
parent intervention moderates the relation between comorbid anxiety and treatment 
outcome in depressed youth. Therefore, this study focused on investigating the relation
between comorbid anxiety and treatment outcome in a sample of depressed young female 
adolescents who received either group CBT or group CBT plus a parent intervention. The 
inclusion of both treatment types allowed for an investigation of the impact of parent 
intervention on children with comorbid depression and anxiety. 
Research Hypotheses 
Hypothesis 1 
Depressed girls with a comorbid anxiety disorder as determined by meeting 
diagnostic criteria at pre-treatment for one or more anxiety disorders on the Schedule for 
Affective Disorders and Schizophrenia for School Age Children (K-SADS-IVR; 
Ambrosini & Dixon, 2000) will have a significantly higher continuous total depression 
score on the K-SADS-IVR prior to treatment than depressed girls without a comorbid 
anxiety disorder. 
Rationale. Previous research suggests that depressed youth with comorbid anxiety 
experience more severe depressive symptoms than depressed youth without anxiety 
(Mitchell et al., 1988; Stark et al., 1993; Young et al., 2006). This hypothesis will 
replicate previous research which found that the severity of depression was higher in 
depressed children with comorbid anxiety compared to those without comorbid anxiety. 




Depressed girls with a comorbid anxiety disorder as determined by meeting 
diagnostic criteria at pre-treatment for one or more anxiety disorders on the K-SADS-
IVR will have a significantly lower global functioning score on the Children’s Global 
Assessment Scale (CGAS; Shaffer et al., 1983) prior to treatment than depressed girls 
without a comorbid anxiety disorder. 
Rationale. This is an exploratory hypothesis given the limited research regarding 
the study of global functioning in youth with comorbid anxiety and depression. Research 
has suggested that depressed youth with comorbid anxiety appear to experience more 
depressive symptomatology, more severe depression, earlier depression onset, and 
increased suicidal ideation compared to children without comorbid anxiety (Ghaziuddin 
et al., 2000; Kendall et al., 1992; Kovacs et al., 1989; Mitchell et al., 1988; Rohde et al., 
2001; Stark et al., 1993; Young et al, 2006). Considering that comorbid anxiety has been 
found to be related to these negative outcomes, it would be expected that the overall 
functioning of these children is poorer than children without comorbid anxiety.  
Hypothesis 3 
 The presence of a comorbid anxiety disorder at pre-treatment as determined by 
meeting diagnostic criteria for one or more anxiety disorders on the K-SADS-IVR will be 
related to less reduction in depressive symptoms after treatment as measured by p e-
treatment and post-treatment continuous total depression scores on the K-SADS-IVR. 
 Rationale. Four studies have investigated whether anxiety impacts treatment 
outcome in group CBT treatments for older adolescents (Brent et al., 1998, Clarke et l., 
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1992, Curry et al., 2006; Rohde et al., 2001). Three of the four studies found that 
individuals with comorbid anxiety and depression were less likely to improve from 
treatment than depressed individuals without comorbid anxiety (Brent et al.; Clark et al; 
Curry et al.). Only one study found that the presence of comorbid anxiety was related to 
more post-treatment change on the Beck Depression Inventory (Rohde, et al.). This study, 
however, was limited by the fact that they used measures of lifetime comorbidity instead 
of current comorbidity and excluded people experiencing common current anxiety 
disorders. Although there have been no studies of the relation between comorbid anxiety 
and treatment outcome in CBT group therapy for depressed children and younger 
adolescents, the results of the research with older adolescents suggests that comorbid 
anxiety will most likely be associated with poor treatment response in this sample. 
Hypothesis 4 
The presence of a comorbid anxiety disorder at pre-treatment as determined by 
meeting diagnostic criteria for one or more anxiety disorders on the K-SADS-IVR will be 
related to less improvement in global functioning after treatment as measured by pre-
treatment and post-treatment scores on the CGAS. 
Rationale. This hypothesis is exploratory because there has been limited research 
about whether comorbid anxiety influences changes in overall functioning after 
treatment. Given that studies have found that comorbid anxiety is associated with reduced 
treatment outcome in terms of reductions in depressive symptoms and diagnostic 
recovery (Brent et al., 1998, Clark et al., 1992; Curry et al., 2006), it would be expected 
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that comorbid anxiety would also be related to less change in global functioning durin 
treatment. 
Hypothesis 5 
 The relation between the presence of a comorbid anxiety disorder at pre-treatment 
as determined by meeting diagnostic criteria for one or more anxiety disorder  on the K-
SADS-IVR and the change in depressive symptoms after treatment as measured by pre-
treatment and post-treatment continuous total depression score on the K-SADS-IVR will 
be moderated by treatment condition. Participants will either be in a CBT only treatment 
condition or a CBT plus parent training treatment condition. 
Rationale. Although there is very limited research about whether the relation 
between comorbid anxiety and treatment outcome is moderated by receiving pare t 
intervention, research suggests that that the co-occurrence of anxiety and MDD is 
associated with many negative family factors (Stark et al., 1990). These factors include 
maternal psychopathology and poor maternal health (Kovacs et al., 1989), more family 
enmeshment, less democracy in terms of family decision making, less family 
involvement in recreational activities, less family emphasis on morality and religion, and 
child reports of less family support and more family conflict (Stark, et al., 1990). As a 
result of these findings, it is suggested that the treatment of comorbid anxiety and 
depression may need to target the parental system in addition to working with the 
children (Stark et al., 1999). Some research has also suggested a benefit to receiving 
parent intervention for children with anxiety (Barrett, et al., 1996; Thieneman, et al., 
2006). These research findings suggest that receiving a parent component in addition to 
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CBT therapy may be especially beneficial for children with comorbid anxiety which 
would indicate that parent intervention would moderate the relation between comorbid 
anxiety and treatment outcome. 
Hypothesis 6 
 The relation between the presence of a comorbid anxiety disorder at pre-treatment 
as determined by meeting diagnostic criteria for one or more anxiety disorder  on the K-
SADS-IVR and the change in global functioning scores after treatment as measured by 
pre-treatment and post-treatment global functioning scores on the CGAS will be 
moderated by treatment condition. Participants will either be in a CBT only treatment 
condition or a CBT plus parent training treatment condition.  
Rationale. This hypothesis is exploratory give that there have been no studies 
investigating whether parent intervention moderates the relation between comorbid 
anxiety and global functioning after treatment. In spite of the lack of research in this area, 
research on the factors associated with comorbid anxiety and depression suggest that the 
presence of both of these disorders is related to many negative family factors in luding 
more family enmeshment, less democracy in terms of family decision making, less family 
involvement in recreational activities, less family emphasis on morality and religion, and 
child reports of less family support and more family conflict (Stark et al., 1990). These 
factors suggest that parent intervention may be especially beneficial for children with 
both depression and anxiety. In addition, a study of a parent-only group intervention for 
anxious children indicated that parent intervention was related to child improvements in 
global functioning (Thienemann et al., 2006). These research findings suggest that 
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receiving a parent component in addition to CBT therapy may be especially beneficial in 
improving functioning in depressed children with comorbid anxiety. This suggests that 
the parent intervention will moderate the relation between comorbid anxiety and ch nges 
in global functioning during treatment. 







 Participants included 84 girls who were 9 to 13 years old and their primary 
caregivers. The girls were all enrolled in grades 4 to 7. The mean age ofthese girls was 
10.54 (SD = 1.22) and the average grade level was 5.26 (SD = 1.10). All of the girls met 
criteria for a current depressive disorder prior to treatment including MDD (n=60), DD 
(n=17), DDNOS (n=1), Adjustment Disorder with Depressed Mood (n=1), or MDD in 
Partial Remission (n=11). The ethnicity of the girls was 47.6% European American, 31% 
Latina, 11.9% African American, 2.4% Asian, 1.2% American Indian, and 6% Multi-
racial. The ethnicity of the parents was 41.7% European American, 19% Latina, 7.1% 
African American, 1.2% American Indian, 4.8% Multi-racial, and 26.2% Unknown. The 
education level of the parents was 8.3% with an advanced degree, 16.7% with a 4-year 
degree, 28.6% with completion of some college or junior college, 15.5% with a high 
school degree or GED, 2.4% with completion of some high school, 1.2% with completion 
of less than high school, and 27.4% were unknown. The number of participants who met 
criteria for each depressive and comorbid diagnosis appears in Table 1. The demographic 









Major Depressive Disorder 60 71.4%
Dysthymia 17 20.2%
Depressive Disorder NOS 1 1.2%
Adjustment Disorder with Depressed Mood 1 1.2%
Major Depressive Disorder in Partial Remission 11 13.1%
Generalized Anxiety Disorder 29 34.5%
Specific Phobia 8 9.5%
Separation Anxiety 7 8.3%
Social Phobia 2 2.4%
Panic Disorder 0 0.0%
Anxiety Disorder NOS 1 1.2%
Adjustment Disorder with Anxiety 1 1.2%
Eating Disorder 1 1.2%
Oppositional Defiant Disorder 3 3.6%
Attention Deficit Disorders 9 10.7%
Note. Total sample included 84 participants.
Summary of Participant Diagnoses 
 
 

















European American 40 47.6%
Latina 26 31.0%
African American 10 11.9%
Asian 2 2.4%
American Indian 1 1.2%
Multi-racial 5 6.0%
Parent Ethnicity
European American 35 41.7%
Latina 16 19.0%
African American 6 7.1%
Asian 0 0.0%




Less than high school 1 1.2%
Some high school 2 2.4%
Finished high school/GED 13 15.5%
Some college/junior college 24 28.6%
Finished 4 year college 14 16.7%
Advanced Degree 7 8.3%
Unknown 23 27.4%
Note. Total sample included 84 participants.
Summary of Participant Demographic Variables
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Calculations of the prevalence of comorbidity in the sample for this study 
indicated that 57% (n=48) of the girls met criteria for at least one comorbid disorder and 
46% (n=39) met criteria for a comorbid anxiety disorder. Of the participants who 
received more than one diagnosis, 81% percent met criteria for a comorbid anxiety 
disorder. A total of 39 participants were diagnosed with both depressive and anxiety 
disorders and 45 met criteria for at least one depressive disorder but did not meet criteria 
for an anxiety disorder. Of the 43 girls who received both group treatment and the parent 
training component, 17 met criteria for a comorbid anxiety disorder and 26 did not. 
Twenty two of the 41 girls who received group therapy but no parent training met criteria 
for an anxiety disorder and 19 did not meet criteria.  
 Participants were excluded from the study if they met any of the following 
conditions: an IQ that was below 85 or a learning disability that would prevent them from 
being able to complete research measures or participate in the group, their depressiv  
disorder was not considered their primary diagnosis, they presented with current 
psychotic symptoms, they were actively suicidal or homicidal, they were receiving 
treatment for their depression from an outside therapist or through pharmacological 
treatment, or they had a severe medical disability that prevented them from being a l  to 
regularly attend group and complete group activities. Participants who were actively 
suicidal or homicidal or presented with severe psychotic features were ref rred for 
appropriate treatment. 
 There were also 25 participants who began treatment whose data were excluded 
from this study. Fourteen of these participants dropped out of the study prior to treatment 
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completion, three of the participants had post-treatment data that was either incomplete or 
unavailable, three of the participants did not receive standard treatment as a result of 
restrictions from their school, and one participant did not speak English well enough to 
fully participate in the treatment. As described earlier in the review of anxiety disorders, 
the four participants who met criteria for PTSD prior to treatment were also excluded 
from this study.  
Instrumentation 
Measures of Depression  
Children’s Depression Inventory (CDI; Kovacs, 1981). The Children’s 
Depression Inventory (CDI; Kovacs) is a 27 item self-report measure that assesses 
depressive symptoms in children from 7 to 17 years of age (MHS Inc., 1992). Depressive 
symptoms measured by the CDI include interpersonal behaviors, self evaluation, 
disturbed mood, hedonic capacity, and vegetative functions. The five factors measured by 
the CDI are anhedonia, interpersonal problems, ineffectiveness, negative mood, and 
negative self esteem. The CDI is designed to be used as a screening measure to identify 
youth with depressive disorders in many different clinical and non-clinical settings. The 
measure can also used to evaluate treatment progress or monitor symptoms. 
Administration time for the CDI is approximately 15 minutes (MHS Inc.). 
 The CDI is the most commonly used self report measure for screening depression 
in youth (Craighead, Craighead, Smucker, & Ilardi, 1998; Tibremont, Braet, & Dreesen, 
2004). Each of the 27 items on the test is made up of three statements that assess three 
levels of severity and each statement is assigned a numerical value from zero to two, with 
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two being the most severe (Craighead et al.). The participants are asked to choose the 
sentence that best describes how they have been feeling and thinking over the past two
weeks. The total CDI score is calculated by adding up the numerical values for each 
sentence which creates a possible score from 0 to 54. A score of 19 on the test is at the 
90th percentile and is often the cut-off used to determine that someone is experiencing a 
clinically significant level of depression (Craighead et al.). Finch, Saylor, and Edwards 
(1985) collected normative data for the CDI by administering the measure to a large 
group of children attending Florida public schools. Their sample included 705 boys and 
758 girls in grades 2 through 8 (ages 7 to 16). They found that the mean score for the 
girls was 9.01 (SD = 6.97) and for the boys was 10.33 (SD = 7.59).      
 Research has suggested that a score of 16 maximizes both the sensitivity and 
specificity of the CDI (Tibremont, et al., 2004). In addition, Finch et al.’s (1985) study 
found a mean of 9.01 and a standard deviation of 6.97 for the girls in their sample which 
suggests that for girls, a score of 16 is the cut-off point for scores that are one standard 
deviation or more above the mean. As a result, a score of 16 was used as a cut-off score 
for screening youth in this study.  
Studies of the discriminant validity of the CDI have produced mixed results 
(Saylor, Finch, Spirito, & Bennett, 1984; Timbremont et al., 2004). Saylor et al. did not 
find significant differences between the CDI scores of depressed and non-depressed 
children and adolescents. Timbremont et al., however, found that the CDI discriminated 
between depressive disorders and other psychiatric diagnoses well and in their study over 
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84% of participants were accurately identified as depressed or not depressed using their 
CDI scores.  
 The CDI has been shown to have good reliability (Kovacs, 1992). The test has 
been found to have an internal consistency from .71 to .94 (Kovacs, 1981; Saylor et al., 
1984; Smucker, Craighead, Craighead, & Green, 1986). Saylor et al. found that the CDI 
had a test-retest reliability of .87 with children who had emotional or behavior problems 
and .38 for children from regular classrooms with a 1 week time interval between 
administrations. These authors also found that the test-retest reliability for the children 
with emotional or behavior problems was .59 with a 6 week interval between 
administrations. Smucker et al. found a test-retest reliability from .74 to .77 with a 3 
week interval and from .41 to .69 for a 1 year interval in sample of children in regular 
classrooms. Finch, Saylor, Edwards, & McIntosh (1987) measured the test-retest 
reliability in a sample of children from regular classrooms and found a reliability 
coefficient of .82 for a 2 week interval, .66 for a 4 week interval, and .67 for a 6 week 
interval. Test-retest reliabilities for the CDI appear to vary widely depending upon the 
interval length between administrations and Kovacs (1992) suggested that this may occur 
because the CDI measures a mood state instead of a trait and mood symptoms may not be 
stable across a large range of time. As a result of this variability over time, Kovacs (1992) 
suggested that an interval of 2 weeks is most appropriate to determine test-retest 
reliability. In this study, the CDI was administered during the screening process. For the 
sample of girls screened in the present study, the Cronbach’s alpha for the CDI was .90. 
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Beck Depression Inventory for Youth (BDI-Y; Beck et al., 2001). The Beck 
Depression Inventory for Youth (BDI-Y; Beck et al., 2001) is one of five self-report 
scales that make up the Beck Youth Inventories of Emotional and Social Impairment 
(Beck et al., 2001). According to Steer, Kumar, Beck, and Beck (2001), these scales are 
designed for youth aged 7 to 14 and can be administered separately or together to scren 
for depression, anger, anxiety, self concept, and disruptive behaviors. The BDI-Y takes 
about 5 to 10 minutes to administer and measures the presence of depressive symptom  
with 20 items that ask children about their negative thoughts, their physiological 
depressive symptoms, and their feelings of sadness (Beck, Beck, Jolly, & Steer, 2005). 
For each item, the child is asked to mark how often a specific symptom has occurred for 
them in the past 2 weeks on a 4-point scale ranging from never to always (Steer et al.). 
Each of the frequency points has a numerical value from zero to three and the total score 
is calculated by adding up the values from the 20 statements to produce a score from 0 to 
60 (Steer et al.). Seven to ten year old children with scores of 20-24 are considered to 
have mildly elevated scores, with scores of 25-34 are considered to have moderately 
elevated scores, and with scores at or above 35 are considered to have extremely elevated 
scores (Beck et al., 2005). Eleven to fourteen year old adolescents with scores of 17-20 
are considered to have mildly elevated scores, with scores of 21-28 are considered to 
have moderately elevated scores, and with scores at or above 29 are considered to have 
extremely elevated scores (Beck et al., 2005). 
 Measures of the reliability of the BDI-Y suggest that the measure has high 
reliability (Beck et al., 2005). Research has suggested that the internal consistency is high 
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with coefficient alphas ranging between .90 to .95 for both male and female children and 
adolescents (Beck et al..; Stapleton, Sander, & Stark, 2007; Steer, et al., 2001). The test-
retest reliability has been found to range from .79 to .92 with an interval of 7 to 8 days 
between administrations (Beck et al.). The BDI-Y also shows good discriminant validi y 
since Beck et al. found that children with a mood disorder scored significantly higher 
than other children on the BDI-Y. Stapleton et al. tested the discriminant validity of the 
BDI-Y and reported that the scores on the BDI-Y for girls with depression or comorbid 
depression and anxiety were significantly higher than the scores for girls without a 
diagnosis with an effect size of .80. In addition, they found that using moderately or 
extremely elevated BDI-Y scores identified 81% of the participants with depression. The 
total score on the BDI-Y has been found to be significantly correlated with the otal score 
on the CDI with correlations ranging from .72 to .83 (Beck et al.; Stapleton et al.; S eer et 
al.). Steer et al. reported that the correlation between the BDI-Y and the CDI was much 
stronger than the relation between the CDI and the other Beck Inventories. The BDI-Y 
was used to screen participants for depression in this study and the Cronbach’s alpha for 
the sample of girls screened in this study was .93. 
Diagnostic and Statistical Manual Brief Symptom Interview for Depression (DSM 
Interview; Stark & Sander, 2002). The Diagnostic and Statistical Manual Brief Symptom 
Interview for Depression (DSM Interview; Stark & Sander) is a new semi-structured 
interview that was created in order to screen and monitor symptoms of depression for 
participants in a large depression study. The interview was created based upon the DSM-
IV (APA, 1994) criteria for depressive disorders and is designed to briefly assess current 
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symptoms of depression. Depressive symptoms are considered to be “present” when a 
child reports the symptom has been a problem for the majority of days in the past 2 
weeks and the symptom has created impairment or distress. The rating of “present” for a 
symptom is equivalent to receiving a score of 3 or more for a symptom on the K-SADS.  
The DSM interview was used as part of the screening process in this study. The 
DSM Interview had a Cronbach’s alpha of .86 for the sample of girls screened with this 
interview in the study. A total score was computed for the DSM. The total score for each 
participant was equal to the number of symptoms they endorsed during the interview. The 
DSM interview total score was found to be significantly correlated with the CDI (r=.51, 
p<.001) and the BDI-Y (r=.49, p<.001) for the sample of participants screened in this 
study. 
Measure of Depression and Anxiety 
The Schedule for Affective Disorders and Schizophrenia for School Age Children 
(K-SADS-IVR; Ambrosini & Dixon, 2000). The Schedule for Affective Disorders and 
Schizophrenia for School-Age Children IVR (K-SADS- IVR; Ambrosini & Dixon) was 
administered during the screening process of this study to determine whether t  
participants met diagnostic criteria for depressive or anxiety disorders. The interview was 
also administered to the participants after they completed treatment. The K-SADS- IVR 
is a semi-structured diagnostic interview that is based upon criteria from the DSM-IV 
(APA, 1994) and involves interviews with both children and their caregivers (Ambrosini, 
2000). The interview is designed to provide information about the presence, absence, and 
severity of symptoms of psychiatric diagnoses including depressive disorders, bipolar
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disorders, eating disorders, anxiety disorders, attention deficit disorders, psychotic 
disorders, conduct disorder, and oppositional defiant disorder. The interview also screens
for substance abuse disorders. During this interview, participants are asked screening 
questions for each diagnostic category and if they endorse the screening questions then 
they are administered all of the questions for that section of the interview. If the screening 
questions are not endorsed then that section of the interview is not administered and the 
interview continues with the next section (Ambrosini). 
The K-SADS- IVR was modified from its previous version to be compatible with 
the diagnostic criteria presented in the DSM-IV (Ambrosini, 2000; APA, 1994). The K-
SADS- IVR can be used with children and adolescents aged 6 to 18 who are of normal 
intelligence and the interview is administered by a clinical interviewer trained to 
administer the K-SADS-IVR (Ambrosini). Administration time is approximately 90 
minutes for the child interview and 90 minutes for the parent interview. For each 
symptom on the interview, a severity rating is given both for the highest severity of the 
symptom during the present episode and during the past week. Severity ratings typically 
range from zero to four or zero to six with higher scores indicating more severity. Ratings 
are given both from children and their caregivers during separate interviews and the 
interviewers provide a summary severity rating for each symptom by incorporating 
information from both child and caregiver. For this study, symptoms were considered 
clinically significant if they received a summary severity rating of 3 or more. Summary 
ratings of the presence and severity of symptoms in the present episode and the past we k 
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are utilized in order to determine if a participant meets criteria for a diagnosis and 
diagnoses are determined based on DSM-IV (APA) criteria (Ambrosini).  
There is limited psychometric information for the K-SADS- IVR since it is a 
recent version of the K-SADS, however, Ambrosini (2000) found perfect inter-rater 
agreement for the diagnoses of MDD, Minor Depression/Dysthymic Disorder, GAD
SAD, and Oppositional Defiant Disorder. They found a kappa of .80 for Attention Deficit 
Hyperactivity Disorder. In the present study, inter-rater agreement for the presence or 
absence of an anxiety disorder was computed for 20% of the pre-treatment K-SADS- 
IVR interviews (17 interviews) and there was agreement in 76.5% of the interviews. 
Additional psychometric information is available from other versions of this interv ew. 
The K-SADS IIIR has been found to have high inter-rater reliability when identifying 
depressive and anxiety disorders (Last & Strauss, 1990), good test-retest reliability 
(Apter, Orvaschel, Laseg, Moses, & Tyano, 1989), and high internal consistency 
(Ambrosini, Metz, Prabucki, & Lee, 1989). Internal consistency (coefficient alphas) have 
been reported to be at least .68 and test-retest reliabilities have been reported to be above 
.67 for the K-SADS IIIR depression summary scales (Chambers et al., 1985). Ambrosini 
et al. found that the depression scales had intraclass coefficients from .85 to .97 and the 
anxiety scales had intraclass coefficients from .86 to .98. They also reported coefficient 
alphas from .76 to .89 for the depression scales and .67 to .81 for the anxiety scales. 
Kaufman et al. (1997) investigated the psychometric properties of another version of the 
K-SADS, the K-SADS-P/L. They found test-retest reliabilities from .86 to 1.00 for 
lifetime diagnoses of depressive disorders and .90 for present diagnoses of MDD or 
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Dysthymia. In addition, they found test-retest reliabilities from .60 to .78 for lifetime 
diagnoses of anxiety disorders and from .67 to .80 for present anxiety diagnoses. They 
also determined that the average inter-rater agreement in assigning diagoses was 98%. 
In addition, by comparing diagnoses from the K-SADS-P/L to scores on other depression 
measures such as the CDI and BYI, the authors determined that the K-SADS-P/L had 
high concurrent validity. Ambrosini explained that since the different versions of the K-
SADS have stayed consistent with the current DSM criteria and reliability is high for the 
recent versions, these interviews can be used to help broaden our understanding of 
treatment outcome and psychopathology in youth.  
A continuous total depression score can be calculated based on the K-SADS 
interview. This score is made up of the severity ratings for 17 depressive symptoms and 
the total score ranges from 17 to 97 (Ambrosini et al., 1989; Ambrosini, Metz, Bianchi, 
Rabinovich, & Undie, 1991). The symptoms included in this score are depressed mood, 
irritability, diurnal mood variation (morning only), excessive guilt, anhedonia, fatigue, 
diurnal variation of fatigue (morning only), difficulty concentrating, psychomotor 
agitation, psychomotor retardation, insomnia, hypersomnia, loss of appetite, increased 
appetite, hopelessness, avoidant behavior when depressed, and suicidal ideation. For the 
symptoms that are determined based on summary information from multiple items such 
as insomnia, just the severity for the overall symptom is included. According to 
Ambrosini et al. (1991), the total depression score is correlated with the BDI-Y for 
female adolescents. Psychometric data on this total score suggests that it is internally 
consistent with Cronbach’s alphas ranging from .72 to .89 (Ambrosini et al., 1989; 
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Chambers et al., 1985). The test-retest reliability for this score has been reported to be (r 
= .81) (Chambers et al.).  
This study used a slightly modified version of the continuous total depression 
score described above. An item measuring self-esteem adapted from the rating of 
negative self image in the Overanxious Disorder section was added to the depression 
score. Although this item is not in the depression section of the K-SADS-IVR, low self-
esteem is a major symptom of Dysthymia making it an important symptom to include. 
The two anhedonia symptoms (loss of interest and loss of pleasure) were also added to 
the score. Social withdrawal was not included since this item was not included in the K-
SADS-IVR and diurnal mood variation and diurnal variation of fatigue were also not 
included in the score. These modifications made the scale more consistent with the 
diagnostic criteria for depression in children. Summary ratings for the last week for each 
symptoms were used to create the total score. Previous research using a sample of girls 
from the larger treatment outcome project that this study was part of found that this 
modified total depression score had high internal reliability from .88 to .92, an inter-rater 
reliability of .91, and a correlation with the BDI-Y from .52 to .61 (Graves, 2007; Gray, 
2006; Greenberg, 2008). In this study, the pre-treatment modified total depression score 
had an internal consistency (Cronbach’s alpha) of .74 and the post-treatment modified 
total depression score had an internal consistency of .80. Inter-rater reliability was 
computed for the modified total depression score on 20% of the 84 pre-treatment 
interviews (17 interviews) and 20% of the 84 post-treatment interviews (17 interviews). 
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The pre-treatment inter-rater reliability for this score was .95 and the post-treatment inter-
rater reliability was .91. 
The present study also used a continuous total anxiety score to measure the 
severity of anxiety symptoms reported by study participants during the K-SADS-IVR 
interview. This score was made up of the severity ratings of anxiety symptoms that the 
DSM-IV (APA, 2000) lists as diagnostic criteria for the anxiety disorders assessed in the 
K-SADS-IVR (GAD, PTSD, Panic Disorder, Separation Anxiety, Specific Phobia, Social 
Phobia, and OCD). When participants screened out of a specific anxiety disorder section 
based on their responses to screening questions, all of the symptoms in that section were 
assigned a severity rating of 1 indicating that the symptom was not present. Inter-rater 
reliability for the continuous total anxiety score was computed based on 20% of the 84 
pre-treatment interviews (17 interviews) in this study. The inter-rater eliability for the 
continuous anxiety score at pre-treatment was .91. The continuous total anxiety scor  had 
an internal consistency (Cronbach’s alpha) of .89 for the sample of girls in thi study. 
The K-SADS-IVR also includes a global assessment scale, global severity and 
improvement scales, and the time of onset and offset for each diagnosis (Ambrosini, 
2000). Participants scores on the CGAS (Shaffer et al., 1983), which is the global 
assessment scale included in the K-SADS-IVR, will be used in this study as a measure of 
the participants’ global functioning. According to Shaffer et al., the CGAS has high inter-
rater and test-retest reliabilities as well as good discriminant and concurrent validity. 
When determining a CGAS score, the instructions on the K-SADS-IVR protocol 
(Ambrosini & Dixon, 2000) instruct interviewers to provide a clinical rating of the 
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participant’s actual functioning not taking into consideration prognosis or treatment. 
Functioning is determined based on the clinical judgment of the interviewer taking into 
consideration information provided by children and their parents during the interview. 
Scores for the CGAS range from 0 to 100 and guidelines are presented for what 
functioning would look like for scores of 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100. 
Intermediary scores (i.e., 22, 46, 65) are given when participants’ functioning is between 
two levels of functioning. Ratings are given by the interviewer for the lowest level of 
functioning the participant has experienced during the present episode and the past wek, 
however, only scores for the past week will be included in this study. Inter-rater 
reliability was computed for the CGAS based upon 20% of the pre-treatment interviews 
(17) and post-treatment interviews (17). The CGAS had an inter-rater reliability of .71 at 
pre-treatment and .89 at post-treatment. 
Procedure 
Screening and Assessment of Participants 
 The 91 girls who participated in this study were identified using a multiple-gate 
screening, identification, and assessment procedure (see Figure 1). The procedure used in 
this study involved screening as the first gate, identification as the second gate, and 
assessment as the third gate. The screening stage included multiple screenings that 
occurred in six middle schools and 14 elementary schools in two suburban central Texas 
school districts. Seven cohorts of participants were included who participated over the 
course of five years. The process of screening participants was slightly different for the 
two school districts in order to collect data for another part of the larger project on the 
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psychometric properties of the Children’s Cognitive Style Questionnaire (CCSQ) and the 
BDI-Y. In one school district, the participants received the CCSQ and the CDI during 
screening and in the other school district participants received the BDI-Y and the CDI.  
 Girls in fourth through seventh grades who attended the elementary and middle 
schools in each district were invited to participate in the screening. Both researchers and 
staff from the school described the ACTION study to the girls and consent forms 
(Appendix L) along with letters explaining the study were sent home to the parents of all 
the girls in those grades (n=7,737). Classroom and homeroom teachers monitored the 
distribution and return of the consent forms. The 3,436 girls whose parents returned an 
affirmative consent form were invited to participate in the screening. During the first gate 
of screening, girls who received parental consent to participate attended a large group 
screening where they were first given an assent letter that was read aloud to them. They 
were asked to sign a child assent form (see Appendix M) if they agreed to participate. 
Girls at the screening then completed the CDI and the other measure (CCSQ or BDI-Y).
Graduate Research Assistants (GRAs) read aloud the instructions for the measures and 
participants filled out the measures independently. Those girls with difficulty reading 
were given additional assistance reading and filling out the measures when necessary. 
The GRAs scored the measures as they were completed. A total of 3,396 girls completed 
the CDI as part of this screening. 
The first cohort of the study was identified using a slightly different procedure 
than later cohorts. For girls in the first cohort, those who scored at least 16 on the CDI 
completed the CDI again 1 week later for the second gate of the screening (n=127) and 
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those who scored 16 or more on their second CDI (n=87) were invited to participate in 
the final gate, the diagnostic interview.  
The second gate of the identification and assessment process was modified for 
cohorts two through seven in order to increase the accuracy and efficiency of identify ng 
participants. For these cohorts, girls who scored 16 or more on the CDI completed the 
DSM Interview on the same day they completed the CDI. Some girls completed both the 
CDI and the BDI-Y. For these girls, participants with either a score of 16 or more on the 
CDI or a score of 25 or more on the BDI-Y completed the DSM Interview. In addition, 
participants who endorsed suicidal ideation on the self report measures were immediately 
administered the DSM Interview. The suicidal ideation item on the CDI, “I want to kill 
myself,” was endorsed by 1.4% of the girls who completed the measure (n=48). The 
DSM Interview was administered to a total of 726 girls. The 2,670 girls who scored less 
than the cut-off necessary to receive a DSM Interview and the 221 girls who received a 
DSM Interview but depression was ruled out during the interview were given feedback 
letters to bring home to their parents thanking them for their participation (Appendices N 
and O). 
 Participants in cohort one who scored 16 or more on their second CDI and 
participants from cohorts two to seven who reported significant depressive symptoms on 
the DSM Interview were invited to participate in the final gate, the diagnostic interview 
(n= 505). Parents of these girls were contacted by phone and provided feedback about 
their daughters’ reports on the self report measures and interview, provided with an 
explanation of the project, given information about safety concerns when relevant, and 
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were informed that a consent letter would be coming home with their daughters. 
Participants were given consent forms to bring home to their parents explaining that their 
daughter reported symptoms of depression and that she and her primary caregiver were 
being invited to complete the diagnostic interview (Appendix P). If parents gave consent, 
then the girl and her primary caregiver completed the K-SADS-IVR diagnostic interview 
independently with a doctoral student trained to administer this interview. The girls 
completed the interview at their school and the parents were interviewed over the phone 
or at a location convenient for them. Parental consent was given for 383 girls to 
participate in the K-SADS-IVR and 122 girls did not receive parental consent to 
participate.  
DSM-IV (APA, 2000) diagnoses were determined based on taking into 
consideration information from both the child and parent. In most cases the same 
interviewer completed the child and parent interviews, however, in some cases if the 
parent did not speak English a second interviewer conducted the parent interview in 
Spanish. When this occurred, the two interviewers met to determine summary scores and 
diagnoses. The K-SADS-IVR parent and child interviews were audio taped and 20% 
were randomly chosen for another interviewer to listen to and provide ratings so that
inter-rater reliability could be established. When the two raters had different ratings of 
symptoms or had assigned different diagnoses, the interviewers met to determine 
consensus ratings and diagnoses. This was very rare and did not occur at all for this 
sample. 
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Parents were given feedback about the results of the interview over the phone or 
in person in a location convenient for the parent. Parents of participants who received a 
primary diagnosis of a depressive disorder and who were eligible to participate in the 
study were told about the study during this feedback meeting and were sent home a letter 
explaining the treatment and the pre-treatment assessment with a consent f rm (see 
Appendix Q). A total of 383 K-SADS-IVR interviews were completed and 170 were 
invited to participate in treatment and 213 did not meet criteria. Girls who met criteria for 
comorbid psychiatric diagnoses were invited to participate in treatment as long as their 
depressive disorder was their primary diagnosis and their comorbid diagnosis was not 
expected to interfere with the treatment. When the possible impact of the comorbid 
condition on treatment was unclear, interviewers consulted with supervisors.  
When children met criteria to participate in treatment, the families were invit d to 
a meeting at the child’s school where the therapist that would be working with the 
participant met with the families to explain the treatment consent forms and the treatment 
process. Parents that consented were then asked to complete pre-treatment measures 
including an intake form with information about the child and her family. The girls also 
completed a battery of pre-treatment measures. These measures were administered in 
small groups at the participant’s school by trained doctoral students. Measures were read 
aloud for children with low reading levels. A total of 157 girls participated in the 
treatment portion of the study. They were each assigned to one of three groups, cognitive 
behavioral treatment, cognitive behavioral treatment plus parent training, or a minimal 
contact control group who received treatment after 11 weeks of being monitored. Within 
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2 days of completing treatment, the girls and their primary caregivers completed a post-
treatment K-SADS-IVR interview. The girls also completed a battery of post-treatment 
measures within 2 days of completing treatment. Within a week of their daughters 
completing treatment, the primary caregivers completed a battery of post treatment 
measures. 







































Figure 1:  Flowchart of Multiple Gate Screening Process 
 Study explained to girls at school and letter 
and consent forms sent home to parents 
(n= 7737) 
 
If: parents do not give consent 
Then: end of child’s participation 
(n= 1080) 
 
If: parents give consent 
Then: child completes self-report measures of 
depression at screening (CDI and/or BDI-Y) 
(n= 3396) 
If: child scores above cut-off   
Then: they complete a short 
diagnostic interview (DSM Interview) 
(n= 726) 
If: child scores below cut-off   
Then: end of child’s participation 
and letter sent home to parents 
(n= 2670) 
If: child does not endorse depressive 
symptoms on DSM Interview 
Then: end of child’s participation and 
letter sent home to parents 
(n= 221) 
If: child endorses depressive symptoms on 
DSM Interview 
Then: parent called for feedback and letter sent 
home with K-SADS-IVR interview consent 
(n= 505) 
If: parent gives consent 




If: parental consent not given 
Then: end of child’s participation 
(n= 122) 
 
If: does not meet criteria for depressive 
diagnoses or meets exclusionary criteria  
Then: end of child’s participation, 
feedback and referral provided to parent 
(n= 213) 
 
If: meets criteria for depressive diagnoses and 
meets criteria to participate in treatment 
Then: invited to participate in treatment and 
consent form given to parent 
(n= 170) 
If: parental consent given 




If: parental consent not given 
Then: end of child’s participation 
and referral provided to parent 
(n= 13) 




All 157 participants in the study received the ACTION treatment which is a 
cognitive behavioral intervention specifically designed for small groups of early
adolescent girls with depression. The participants were randomly assigned to th  
ACTION Treatment with Parent Training, the ACTION Treatment alone, or the Minimal 
Contact Control Condition. The 48 girls in the Minimal Contact Control group were not 
included in the sample for this study. One hundred and nine girls were originally in the 
first two groups, but as mentioned previously, data from 25 of them were excluded from 
the analyses due to early termination (moved or dropped out of treatment) (n= 14), 
incomplete or unavailable post-treatment data (n= 3), non-standard treatment 
administration (n= 3), meeting criteria for PTSD (n= 4), or not understanding English 
well enough to fully participate in group (n= 1), leaving a sample of 84. The majority of 
the 14 girls who dropped out of treatment were unable to continue because they moved 
out of the area or to a new school. Of the 84 girls in the sample for the present study, 43 
participated in the ACTION Treatment with Parent Training and 41 participated in he 
ACTION Treatment alone. 
ACTION Group Treatment. The treatment was conducted in the participants’ 
schools and followed a structured therapist’s manual which included objectives and 
activities for each session (Stark, Simpson, et al., 2004) as well as a structured workbook 
the girls used during treatment (Stark, Schnoebelen, et al, 2004). Each ACTION therapis  
also had a kit of supplies they used for treatment including special cards that illustrated 
different skills, personalized goal sheets for the participants, “Smile Balls” to toss to the 
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participants when giving them compliments, and jump ropes or hula hoops to use for 
completing coping activities in the groups. The girls received the treatment in small 
groups of two to six girls. Each group met for 20 sessions and each girl had two 
individual sessions with the therapist. Each of these meetings was approximately 60 
minutes long and the groups met two times per week for 10 weeks. When participants 
were absent for meetings, therapists met with them individually to cover the content of 
the meeting they missed to ensure that all of the girls received the full interve ion. 
The treatment was designed to appeal to young adolescent girls and involved fun 
activities that helped teach the girls specific skills they could use to reduce their 
depressive symptoms, social problems, and other difficulties they were experiencing. The 
meetings had a series of objectives that were met through activities and lessons. The girls 
practiced the skills they were learning in the groups and were assigned specific 
therapeutic homework to complete in their workbooks so they could apply the skills they 
were learning. An in session reward system was also part of the treatment and the girls 
were rewarded both for attending sessions and for completing their homework activities. 
Therapists reviewed completed homework and in group activities to monitor the progress 
of the participants.  
Each ACTION meeting began with a few minutes of unstructured time called 
“chat time” where the girls could talk about things going on in their lives and brig up 
issues they wanted to discuss in the meeting. An agenda was then created with the 
therapist and girls working together to make a list of what would be covered during the 
meeting. Every other meeting, the therapist did a goal check with the participan s to 
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determine the progress the girls had made on their individual goals. The girls r ceived 
stickers for making progress on their goals and they put the stickers on a goal tracking 
worksheet so they could see the progress they were making. Then the therapist reviewed 
the points of the last meeting and started the activities for that meeting. Most of the 
meetings included time for doing a group coping strategy where the girls rated their mood 
before and after the activity to determine the effect coping had on their moods. The end 
of each meeting included a review of what the participants learned during the meeting. 
The girls also received compliments from the therapist at the end of each meeting. As the 
meetings continued they were asked to compliment one another and eventually 
themselves at the end of each meeting. The girls were then assigned their therapeutic 
homework which consisted of specific worksheets for them to fill out to help them apply 
specific skills between meetings. Each of the group meetings was structured to meet 
certain objectives. However, the therapists also individualized each meeting in order to fit 
with the case conceptualizations of the participants in their group and to help the 
participants to achieve their individual goals. The individual meetings focused on 
creating and updating individual goals, practicing and reviewing the skills from the group 
meetings, checking in with the girls about how they were progressing and how they ere 
feeling about participating in ACTION, and addressing any issues the girl wanted to talk 
about without the other group members present. 
The treatment was designed to help the participants to be able to identify and 
understand their emotions so they could then use skills to change their mood when they 
were feeling down. The three major skills taught in the group were coping strategies, 
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problem solving, and cognitive restructuring. The girls were taught how and when to use
these skills. The main focus of the first set of meetings was on identifying and 
understanding emotions and the use of coping skills to maintain a positive mood and to 
use in situations that were upsetting them but that they could not change. The participants 
were taught that even when they could not change a stressful situation they could still 
change their mood.  
The next set of meetings focused on using problem solving. The girls were taught 
to use a five step process to solve problems. The steps included defining the problem, 
determining what they wanted to have happen (i.e., their goal or purpose), generating 
possible plans, using a rating system to complete consequential thinking, and then self-
reinforcement and self-evaluation of the progress they made towards goal attainment. The 
participants first learned to apply these steps to hypothetical problems and then learned to 
apply them to their own problems. They were taught to use problem solving when they 
had a problem that they could change.  
The last half of the treatment focused on learning and then using cognitive 
restructuring to reduce negative thoughts and continued use of previously learned skills. 
The participants were taught to use two questions to talk back to their negative thoughts; 
What’s another way of looking at it? and What’s the evidence? They practiced talking 
back to their negative thoughts in group and were encouraged to practice talking back 
outside of group with homework activities. They were taught to use cognitive 
restructuring when they determined that a negative thought was causing them to see a 
situation unrealistically.  
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Once the participants had learned all three skills they were taught to use them 
together or individually to help them when they were feeling down. They were also 
taught that certain skills could be integrated with other skills. For example, a coping skill 
could be used to raise a participant’s mood so that they would be able to use problem 
solving to change an undesirable situation. In addition, a main focus of the last half of t e 
treatment was on helping the participants to develop a positive sense of self by 
identifying their strengths. This was completed through an activity in which t e girls 
created a map of their strengths in different areas. The last meeting was a celebration of 
the progress the girls had made during group and focused on talking about how they 
could continue using the skills they had learned after group was over. All meetings were 
audio-taped and independent raters who were trained therapists listened to the full set of 
audio tapes for 15 of the 31 treatment groups and checked off whether the objectives for 
each meeting were covered. The 15 treatment groups that were rated included at least one 
group for each of the 12 therapists and an additional group for the three therapists that led 
four or more groups. The independent raters rated each of the objectives on a likert scae 
from zero to three. A rating of zero indicated that the objective was not covered, one 
indicated that the objective was minimally covered, two indicated the objective was 
adequately covered, and three indicated that the objective was completely covered (se  
Appendix R). Across the 15 groups that were rated, 83.99% of the objectives were 
adequately or completely covered (a rating of at least 2). In addition, in 13 of the 15
groups, 75% or more of the objectives were adequately or completely covered. The 
average score of all of the objectives across the 15 groups was 2.46. Refer to Tables 3 
    
  
100 
and 4 for additional information about the structure of the therapy sessions and the 
primary objectives and activities for each session. 
Table 3 
Outline of the Structure of Treatment Meetings 
Rapport Building (“Chat Time”) A 5-minute discussion led by the participants s a 
time to get to know each other. Topics may or may 
not be relevant to treatment. 
Goal Attainment Check-in Incorporated in meeting 6 and presented every 
other meeting. Participants share progress of 
treatment goals, which therapist notes on chart. If 
there is no progress, problem solve accordingly.  
Catch the Positive Check-in Incorporated in meeting 5 and presented every 
other meeting. Allows participants to share positive 
events from their Catch the Positive Diary.  
Set Agenda Outlines therapist’s plan for meeting and allows 
participants to add additional items to discuss. 
Review Previous Meeting and 
Homework 
Therapist encourages participants to recall main 
points from the last session and share therapeutic 
homework.  
Skill Building/Coping Skill 
Activity 
Varies session by session. See chart below. 
Review Therapist encourages participants to recall main 
points from the current meeting. 
Positive Behavior Review Meetings 1-3 the therapist identifies good 
participant behaviors; Meetings 4-10 participants 
compliment each other; Meetings 11-20 
participants compliment selves.  
Assign Homework Therapeutic homework assigned. Homework 
content reflects objectives of meeting.  
Rewards Participants are provided with small incentives (i.e. 
stickers) for attending the session. More desirable 
incentives (i.e. glitter pens) are given for 
completing homework.  
 




Objectives and Skill Building Activities by Meeting 
Meeting # Objectives Skill Building Activities 
1 • Discuss parameters of 
meetings 
• Introduce counselors and 
participants 
• Establish rationale for 
treatment 
• Discuss confidentiality 
• Establish group rules,  
• Build group cohesion 
• Establish within group 
incentive system 
Sunglasses Activity- Demonstration using 
dark vs. light sunglasses of how 
depression distorts the way we see things. 
Web Activity- Yarn is used to create web 
connecting group members as they share 
information about themselves (i.e. name 
and something they enjoy doing). 
2 • Introduce participants to 
chat time and agenda setting 
• Establish pragmatics of 
completing homework 
• Introduction to mood meter,  
3 B’s, and Take ACTION 
List 
• Complete within session 
coping activity 
Mood Meter- Participants introduced to 
rating their mood on a scale from 1 to 10 
and how mood relates to brain, body, and 
behavior 
Hula Hoop Activity- Illustrates how doing 
fun things leads to improvement in mood. 
Therapist induces negative mood and 
participants rate mood, activity occurs, 
and participants rate elevated mood. 
Take ACTION List- Illustrates how doing 
fun things elevates mood. Participants 
identify fun activities that they can use to 
elevate mood outside of group. 
3 • Discuss importance of 
thinking about meetings and 
doing practice 
• Focusing on the positive 
• Introduction to Catch the 
Positive Diaries 
• Educate clients about 3 B’s 
• Introduction to 5 coping 
strategies. 
Candy/Rock Activity- Illustrates how 
mood is affected by the situations one 
chooses to attend to. Participants choose 
to focus on the candy (positive) or rock in 
their shoe (negative). 
Catch the Positive Diaries- Participants 
use notebook to record daily positive 
events in their life. 
3 B’s- A human cutout is used to educate 
participants about how to identify feelings 
through their body, brain and behavior. 
Examples of 3 B’s are drawn onto cutout. 
 
 





• Review therapeutic concepts 





4 • Extend group cohesion 
• Review participant goals 
and strategies 
• Review and application of 
coping strategies 
• Complete coping skills 
activity 
Web Activity- 2nd web introduced to 
extend group cohesion and have 
participants share goals with group. 
Application of Coping- Participants share 
situations they have faced where they may 
use coping strategies. 
Coping Skill Activity- Use an activity (i.e. 
freeze tag) that illustrates the impact of 
the 5 coping strategies.  
5 • Catch the Positive Check-In 
• Experience impact of coping 
skills activity 
• Introduction, extension and 
application of problem 
solving 
• Introduction to 
brainstorming 
Candy/Rock Activity- Illustrates how 
problem solving can be used to handle 
unpleasant circumstances. Participants use 
problem solving steps. 
Solution Round Robin- Participants 
practice generating multiple solutions 
using a problem solving sheet. 
Coping Skills Activity 
6 • Goal Attainment Check-In 
• Demonstrate the role of 
cognition in emotion and 
behavior 
• Introduction to Thought 
Feeling-Coping Thought 
• Enactment of coping skills 
activity 
Thought Bubbles- Demonstrates how 
thoughts determine how a person feels and 
behaves through the use of thought 
bubbles and emotion cards. 
Coping Skills Activity 
7 • Catch the Positive Check-In 
• Apply problem solving to 
real life situations 
• Practice brainstorming 
activity 
• Experience coping skills 
activity 
Solution Race- Helps participants to feel 
better by generating solutions to an 
identified problem. Two teams create a 
list of possible solutions to the problem. 
Coping Skills Activity 
8 • Goal Attainment Check-In 
• Application of problem 
solving to teasing 
• Experience coping skills 
activity 
Application of Problem Solving- Group 
applies problem solving to personal 
teasing experiences. 
Coping Skills Activity 
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9 • Catch the Positive Check-In 
• Applying problem solving 
to interpersonal problems 
• Experience coping skills 
activity 
Application of Problem Solving- Elicit 
real life interpersonal difficulties and 
solve as a group. 





• Review therapeutic concepts 
• Goal attainment check-in 
• Identification of common 
negative thoughts 
• Individualizing Catch the 
Positive Diaries 
• Introduction to cognitive 
restructuring 
 
10 • Goal Attainment Check-In 
• Preparation for cognitive 
restructuring 
• Experience coping skills 
activity 
• Talking back to the Muck 
Monster 
Web Activity- 3rd web introduced to check 
in on cohesion and support in order to 
prepare for talking about more personal 
topics. 
Talking Back to Muck Monster- 
Participants use coping statements to talk 
back to their negative thoughts. 
Coping Skills Activity 
11 • Catch the Positive Check-In 
• Introduction of constructing 
perceptions 
• Illustration of how 
depression distorts thinking 
• Providing rationale for 
changing negative thoughts 
Storytelling Activity- Participants 
construct individual story based on a 
picture to illustrate that we construct own 
perceptions and people see things 
differently. 
Sunglasses Activity- Participants identify 
negative thoughts with dark glasses and 
coping thoughts with bright glasses 
illustrating how depression distorts 
perceptions. 
12 • Goal Attainment Check-In 
•  Catching negative thoughts 
of group members 
• Introduction of Self-Map 
• Talking back to the Muck 
Monster 
Catching Negative Thoughts- Participants 
are encouraged to catch negative thoughts 
of self or others for the remaining 
sessions. Participants are rewarded for 
catching and changing thoughts. 
Self-Maps- Participant strengths are 
identified in various categories (i.e. in 
school, as a person) to open themselves up 
to positive aspects of the self. Strengths 
are added to the map each meeting. 
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Catch the Positive- Group brainstorms 
meaningful compliments for each 
participant. Focusing on the positive (i.e. 
individual compliments) is used to 
enhance mood after focusing on negative 
thoughts. 
Talking Back to the Muck Monster 
13 • Catch the Positive Check-In 
• Catching negative thoughts 
• Continuation of self-maps 
•  Introduction to Alternative 
Interpretation 
• Using Thought Judge 
questions 
• Applying Alternative 
Interpretation 
Catching Negative Thoughts 
Self-Map 
Alternative Interpretation Round Robin- 
Using thought judge worksheet, 
participants identify difficult situation and 
participants provide alternative 
interpretations for each situation 
14 • Goal Attainment Check-In 
•  Catching Negative 
Thoughts 
• Continuation of Self-Maps 
• Talking back to the Muck 
Monster 
Catching Negative Thoughts 
Self-Map 
Talking Back to the Muck Monster- 
Therapist acts as participant’s muck 
monster, and each participant fights back 
using alternative interpretation. 
15 • Catch the Positive Check-In 
•  Catching Negative 
Thoughts 
• Continuation of Self-Maps 
• Introduction to What’s the 
Evidence? 
Catching Negative Thoughts 
Self-Map 
Taking Your Thoughts to Court- Using 
thought judge worksheet, participants 
provide clues for and against negative 
thoughts.  
16 • Goal Attainment Check-In 
•  Catching Negative 
Thoughts 
• Continuation of Self-Maps 
• Application of What’s the 
Evidence 
• Preparing for Termination 
Catching Negative Thoughts 
Self-Map 
Talking Back to Muck Monster- 
Participants practice using “What are the 
Clues?” to talk back to the therapist acting 
as the muck monster 
17 • Catch the Positive Check-In 
• Continuation of Self-Maps 
• Integration and Application 
of cognitive restructuring 
• Preparing for Termination 
Self-Map 
Muck Monster UNO- Participants practice 
talking back to their muck monster. Group 
members can choose to either draw cards 
or talk back when presented with a Draw 
two or Draw four card. 
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18 • Goal Attainment Check-In 
• Continuation of Self-Maps 
• Integration and Application 
of all skills 
• Preparing for Termination 
Self-Map 
Pull It All Together- Use combination of 
skills to work through personal situations 
19 • Catch the Positive Check-In 
•  Drawing conclusions from 
Self-Maps 
• Web Activity to empower 
participants 
• Prepare for Goodbye to 
Depression 
• Preparing for Termination 
Self-Map- Complete map is used to draw 
conclusions about self 
Web Activity- 4th web emphasized group 
support and ability to support self in 
preparation for separation 
Prepare to Say Goodbye to Depression- 
Participants write down most common 
negative thoughts in preparation to shred 
them. 
20 • Saying Goodbye to the 
group 
• Saying Goodbye to negative 
thoughts and feelings 
• Preparing for termination 
Goodbye Cards- Using cards, each group 
member writes down favorite positive 
memory of other members. 
Goodbye to Depression- Participants 
shred their negative thoughts and present 
new coping thought. 
 
 ACTION Parent Training. As mentioned above, parents of 43 of the participants 
were invited to complete parent training in addition to the ACTION group treatment. The 
focus of the parent training was on nurturing a strong and healthy relationship between 
the girls and their parents, teaching the parents the skills their children we learning so 
they could support the girls in using these skills, increasing positive reinforcement and 
decreasing punishment, and communicating with their daughters to reduce the girls’ 
negative thoughts and reinforce their positive thoughts. Specific skills in this training 
included effective communication techniques, empathic listening, conflict resolution, and 
positive behavior management strategies. The families were also taught the importance of 
spending time as a family doing fun activities together in order to strengthen their 
relationships with one another.  
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 The parent training component of the study consisted of eight weekly 90 minute 
group meetings and two individual family meetings that took place at the participants’ 
schools usually during evening hours. The families were all provided with dinner and 
child care during the meetings. For the group meetings, the parents of all the girls in an 
ACTION group met together. The girls attended every other meeting with their parents 
allowing a chance for the families to practice using skills together. The individual family 
meetings focused on creating and monitoring family goals for treatment, checking in on 
how the meetings were going for the family and the girl, monitoring the progress of the 
parents and children with the skills they were learning, and working on family problems 
that the family preferred to discuss individually instead of in the group.  
Training of Measures Administrators 
 Doctoral students with at least one year of experience working on the research 
project administered measures. The measures administrators were trained and supervised 
by the principal investigator and/or the project coordinator of the larger research study. 
Information about the administration and scoring instructions for each self report measure 
were taught to the measures administrators. At least one of the measures admini trators 
present at each assessment period was trained in the assessment of suicidal ri k. 
Training of Interviewers 
Parent and child K-SADS-IVR interviews were conducted by doctoral level 
GRAs in educational psychology. All interviewers had completed at least one year in the 
doctoral School Psychology program. Each interviewer received training in the 
administration and scoring of the K-SADS-IVR. This training was led by an advanced 
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doctoral student who had expertise in both diagnostic interview administration and child 
psychopathology. In addition, she was supervised by the principal investigator. Training 
of interviewers lasted approximately 6 months and about 50 hours of training was 
completed by each interviewer before he or she conducted interviews independently. 
Training consisted of listening to at least six previous interviews on audiotape and 
practicing rating symptoms, practicing interviews with volunteers and the trainer during 
training meetings, and learning general interview and clinical skills. In addition, each 
new interviewer was required to observe at least one interview conducted by a senior 
interviewer in person. Prior to conducting interviews on their own, each new interviewer 
had to demonstrate K-SADS-IVR competence in providing reliable symptom ratings. 
Interviewers were considered to have this competence when they could listen to an audio 
taped interview and accurately determine the absence, presence, and severity of 
symptoms of depressive disorders. Those interviewers who incorrectly identified the 
presence or absence of two or more depressive symptoms were provided with more 
training until they were able to meet this criterion. Once they met requirements, new 
interviewers administered their first interview with live supervision from a senior 
interviewer who provided them with feedback after the interview. All interviewers 
received weekly supervision on the administration and scoring of the interviews and 
individual supervision was provided on an as needed basis. In addition, the interview 
trainer reviewed the tapes of interviewers and provided feedback. Inter-rater eliability 
was computed for the modified total depression score before and after treatment, the 
CGAS score before and after treatment, and the total anxiety score before tr atment. The 
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inter-rater reliability for the modified total depression score at pre-treatm nt was .95 and 
at post-treatment was .91. The CGAS had an inter-rater reliability of .71 at pre-treatment 
and .89 at post-treatment. The inter-rater reliability for the continuous anxiety score at 
pre-treatment was .91. 
Training of Therapists 
 All of the therapists in this study were female doctoral level School Psychology 
students. All therapists completed a didactic course and a practicum in CBT prior to 
being a primary therapist for a group. Each therapist also participated in a trai ing 
program led by the primary investigator of the larger study and senior therapists. Thi  
training included watching videos and listening to audiotapes of previous child and parent 
groups, role playing different situations in group, and learning how to best meet the 
objectives of the treatment for each meeting while also individualizing the treatment to 
the needs of the participants. After the training, each new therapist shadowed a senior
therapist and observed all 20 group meetings and both individual meetings for all 
participants in a group. Once each new therapist completed the training and shadowing 
they either co-led a group with a senior therapist or led a group of girls in the minimal 
contact control condition with extensive supervision and feedback. Once the principal 
investigator determined that a therapist was qualified, she was assigned to run a therapy 
group. In addition, all therapists received weekly group and individual supervision from 
the principal investigator and audiotapes of the group and individual sessions were 
reviewed during these sessions. 
 




 The data for this study was collected as part of a larger NIMH-funded study that 
was completed in two school districts in central Texas. The present study was conducted 
in compliance with the ethical issues and standards of research set for by the University 
of Texas at Austin and the American Psychological Association. The larger research 
study had received approval from the Departmental Review Committee within the 
Department of Educational Psychology and the Institutional Review Board of the
University of Texas. The study was also approved by the superintendents of the two
school districts. Prior to conducting data analysis for the present study, the researcher 
received approval from the Departmental Review Committee within the Department of 
Educational Psychology and the Institutional Review Board of the University of Texas 
(IRB Protocol # 2007-12-0026). 




Data Analyses  
 The preliminary analyses and main analyses are described under each of the 
hypotheses. A set of secondary analyses and their associated preliminary analyses are 
also discussed in the secondary analyses section. Overall preliminary analyses and 
descriptive statistics are presented below. All analyses were performd using SPSS 
version 16.0 (SPSS Inc., 2007). 
Overall Preliminary Analyses 
Analyses were conducted to explore whether the pre-treatment total depression 
score, the pre-treatment total anxiety score, and the pre-treatment global functioning 
score (CGAS) were related to grade, age, or race/ethnicity. Preliminary analyses were 
conducted to determine whether the data met the assumptions of normality. The z-scor s 
for skewness and kurtosis for the pre-treatment continuous total depression score, the p -
treatment continuous total anxiety score, and the pre-treatment continuous global 
functioning score on the K-SADS-IVR were calculated to determine whether these 
variables met the assumption of normality. For the depression score, the z-score for 
skewness (1.73) and the z-score for kurtosis (-0.19) were acceptable since they were 
below the absolute value of 3.29 (Field, 2005). For the continuous total anxiety score, 
however, the z-scores for skewness (6.92) and kurtosis (10.46) were not acceptable and 
violated the assumption of normality. For the global functioning score, the z-score for 
skewness (-4.52) and the z-score for kurtosis (4.57) were also not acceptable since they 
were above the absolute value of 3.29 (Field, 2005). As a result, a non parametric 
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statistic, a Spearman’s correlation coefficient, was calculated for the correlations 
involving the continuous total anxiety score and the global functioning score. 
The Pearson correlation between the pre-treatment total depression score and age 
was not statistically significant (r = .17, p = .12), the Spearman correlation between pre-
treatment total anxiety and age was not statistically significant (rs =.12, p = .27), and the 
Spearman correlation between the pre-treatment CGAS score and age was not
statistically significant (rs =-.13, p = .25). According to Multivariate Analysis of 
Variance (MANOVA) results, pre-treatment total depression scores (F(3, 80)= 2.32, p = 
.08), pre-treatment CGAS scores (F(3, 80)= 1.53, p = .21), and pre-treatment total 
anxiety scores (F(3, 80)= 1.35, p = .26), were not significantly different by grade. 
Multivariate Analysis of Variance (MANOVA) results also suggested that pre-treatment 
total depression scores (F(5, 78)= .20, p = .96), pre-treatment CGAS scores (F(5, 78)= 
.80, p = .56), and pre-treatment total anxiety scores (F(5, 78)= 1.12, p = .34), were not 
significantly different by ethnicity. The results of the MANOVA investiga ing the 
relation between ethnicity and the three variables should be interpreted with caut on, 
however, given that there were large differences in group size between the differ nt 
ethnicity groups. 
 Additional analyses were conducted to assess the validity of using the presence of 
a comorbid anxiety diagnosis as a measure of comorbid anxiety. Analyses were 
conducted to ensure that the group of participants with a comorbid anxiety diagnosis 
differed significantly in terms of anxiety symptom presence and severity from the group 
of participants without a comorbid anxiety diagnosis. The continuous total anxiety score 
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from the K-SADS-IVR was used as a measure of the presence and severity of anxiety 
symptoms and a t-test was conducted to compare the continuous total anxiety scores of 
the two groups. Levene’s test was performed to determine whether the homogeneity of 
variance assumption was met for these data. According to Levene’s test, the variances of 
the two groups were significantly different, F(1, 82) = 13.90, p < .001. As a result, the 
“equal variances not assumed” t-test value was reported. An independent samples t-test 
was conducted to compare the pre-treatment mean continuous total anxiety scores for the 
girls with a comorbid anxiety disorder and depression and the girls with depression but 
no anxiety diagnosis. On average, the girls with anxiety disorders (M = 88.95, SE = 1.88) 
had higher pre-treatment continuous total anxiety scores on the K-SADS-IVR than the 
girls without anxiety disorders (M = 72.00, SE = .63). This difference was significant 
t(46.61) = -8.53, p < .001 and represented a large sized effect (r = .69). These results 
suggest that the group of girls with comorbid anxiety disorders had a significantly higher 
presence and severity of anxiety symptoms than those girls without a comorbid anxiety
diagnosis.  
Descriptive Statistics 
 Descriptive statistics including the means, standard deviations, Cronbach’s alpha 
scores, and correlation coefficients for each of the main variables are presented in Table 
5. All of the analyses discussed below used the total sample of 84 participants.  
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Table 5    
    












Pre-trtmt depression 1.00 .09a -.67b* .02a .46b* 
Post-trtmt depression .09a 1.00 -.10b -.62a* -.01b 
Pre-trtmt CGAS -.67b* -.10b 1.00 .12b -.36b* 
Post-trtmt CGAS .02a -.62a* .12b 1.00 -.19b 
Pre-trtmt anxiety .46b* -.01b -.36b* -.19b 1.00 
M 37.25 23.94 54.95 76.17 79.87 
SD 8.22 6.19 7.05 10.65 12.05 
α .74 .80 N/A N/A .89 
Note. aPearson's product-moment correlation coefficient. bSpearman's correlation coefficient. 
*Represents significance at the .001 level. Pre and post-treatment depression = continuous total 
depression score on the K-SADS-IVR. Pre and post-treatment CGAS = Children’s Global Assessment 





Hypothesis 1 predicted that depressed girls with a comorbid anxiety disorder as 
determined by meeting diagnostic criteria at pre-treatment for one or more anxiety 
disorders on the K-SADS-IVR would have a significantly higher continuous total 
depression score on the K-SADS-IVR prior to treatment than depressed girls without a 
comorbid anxiety disorder. 
 Hypothesis 1 Preliminary Analyses. Preliminary analyses were conducted to 
determine whether the data met the assumptions necessary to perform an indepedent 
samples t-test. The z-scores for skewness and kurtosis for the pre-treatment continuous 
total depression score on the K-SADS-IVR were calculated to determine whether this 
variable met the assumption of normality. For the girls with anxiety disorders, the z-score 
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for skewness (0.78) and the z-score for kurtosis (-1.24) were acceptable since they were 
below the absolute value of 3.29 (Field, 2005). The z-scores for skewness (0.56) and 
kurtosis (0.83) were also acceptable for the girls without anxiety. Levene’s test was 
performed to determine whether the homogeneity of variance assumption was met for 
these data. According to Levene’s test, the variances of the two groups were ignificantly 
different, F(1, 82) = 4.46, p < .05. As a result, the “equal variances not assumed” t-test 
value was reported.  
Hypothesis 1 Main Analyses. An independent samples t-test was conducted to 
compare the pre-treatment mean continuous total depression scores for the girlswith 
comorbid anxiety and depression and the girls with depression but no anxiety. 
On average, the girls with anxiety disorders (M = 40.31, SE = 1.40) had higher pre-
treatment continuous total depression scores on the K-SADS-IVR than girls without 
anxiety disorders (M = 34.6, SE = 1.01) (see Table 6). This difference was significant                








no anxiety 45 34.60 -5.71 1.01
anxiety 39 40.31 -5.71 1.40
Descriptive Statistics for Pre-treatment Total 









-3.31 71.31 .00 -5.71 1.73 -9.15 -2.27
Independent Samples t-test Comparing Pre-treatment Total Depression Score 
Across Anxiety Diagnosis Groups
95% Confidence Interval 
of the Difference
t-test for Equality of Means
df








Hypothesis 2 predicted that depressed girls with a comorbid anxiety disorder as 
determined by meeting diagnostic criteria at pre-treatment for one or more anxiety 
disorders on the K-SADS-IVR would have a significantly lower global functio ing score 
on the CGAS prior to treatment than depressed girls without a comorbid anxiety disorder. 
Hypothesis 2 Preliminary Analyses. Preliminary analyses were conducted to 
determine whether the data met the assumptions necessary to perform an indepedent 
samples t-test. The z-scores for skewness and kurtosis for the pre-treatment global 
functioning score (CGAS) on the K-SADS-IVR were calculated to determine whether 
this variable met the assumption of normality. For the girls with anxiety disorders, the z-
score for skewness (-2.84) and the z-score for kurtosis (1.31) were acceptable since they 
were below the absolute value of 3.29 (Field, 2005). The z-scores for skewness (-.13) and 
kurtosis (.41) were also acceptable for the girls without anxiety. Levene’s test was 
performed to determine whether the homogeneity of variance assumption was met for
this data. According to Levene’s test, the variances of the two groups were significantly 
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different, F(1, 82) = 6.55, p < .05. As a result, the "equal variances not assumed” t-t st
value was reported.  
Hypothesis 2 Main Analyses. An independent samples t-test was conducted to 
compare the pre-treatment global functioning scores for the girls with comorbid anxiety 
and depression and the girls with depression but no anxiety. On average, the girls with 
anxiety disorders (M = 52.23, SE = 1.30) had lower pre-treatment global functioning 
scores on the K-SADS-IVR than girls without anxiety disorders (M = 57.31, SE = .74) 
(see Table 8). This difference was significant t(61.22) = 3.40, p < .01 (see Table 9) and 









no anxiety 45 57.31 5.08 0.74
anxiety 39 52.23 5.08 1.30
Descriptive Statistics for Pre-treatment CGAS Score 






3.40 61.22 .00 5.08 1.49 2.09 8.07
Independent Samples t-test Comparing Pre-treatment CGAS Score Across 
Anxiety Diagnosis Groups
t-test for Equality of Means
t df

















 Hypothesis 3 predicted that the presence of a comorbid anxiety disorder at pre-
treatment as determined by meeting diagnostic criteria for one or more anxiety disorders 
on the K-SADS-IVR would be related to less reduction in depressive symptoms after 
treatment as measured by pre-treatment and post-treatment continuous total depression 
scores on the K-SADS-IVR. 
 Hypothesis 3 Preliminary Analyses. Preliminary analyses were conducted to 
determine whether the data met the assumptions necessary to perform a two-way repeated 
measures analysis of variance (ANOVA). The z-scores for skewness and kurtosis for the 
pre-treatment continuous total depression score on the K-SADS-IVR were alrady 
determined to meet the assumption of normality before performing the independent 
samples t-test discussed above. The z-scores for skewness and kurtosis for the post-
treatment continuous total depression score on the K-SADS-IVR were calculated to 
determine whether this variable met the assumption of normality. For the girls with 
anxiety disorders, the z-score for skewness (1.16) and the z-score for kurtosis (-1.13) 
were acceptable since they were below the absolute value of 3.29 (Field, 2005). The z-
score for skewness (2.67) and kurtosis (0.42) were also acceptable for the girls without 
anxiety. The assumption of sphericity is often tested when using repeated measures 
ANOVA, however, sphericity can only be evaluated when there are more than two 
conditions being compared (Field, 2005). Given that the analysis for hypothesis three 
involved only two conditions (anxiety and no anxiety), sphericity could not be tested. 
Levene’s test was performed to determine whether the homogeneity of variance 
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assumption was met for the post-treatment continuous total depression score. Accoding 
to Levene’s test, the variances of the two groups were not significantly different, F(1, 82) 
= .03, p = .86, suggesting that the post-treatment continuous total depression score met 
the homogeneity of variance assumption. The pre-treatment continuous total depression 
score, however, did not meet the homogeneity of variance assumption as discussed in the 
Hypothesis 1 analyses. According to Stevens (1999), ANOVA is robust to violations of 
homogeneity of variance when sample sizes are equal or close to equal which he defines 
as the largest group being less than one and a half times the size of the smallest group. 
Since the groups being compared in this analysis are very close to equal (39 and 45), the 
ANOVA should be robust to the violation of homogeneity of variance.  
 Hypothesis 3 Main Analyses. A two-way repeated measures analysis of variance 
was conducted to determine whether there was an interaction between the presence of a 
comorbid anxiety diagnosis and the time (pre and post) of the total depression score. 
There was a significant interaction between the presence of an anxiety diagnosis and time 
(pre and post depression scores), F(1,82) = 4.75, p < .05 (see Table 10) with a medium 
effect size (Partial Eta Square = .06). As demonstrated in Figure 2, on average, the irls 
with anxiety disorders had a larger decrease in their depression scores from pre-treatment 
(M = 40.31, SD = 8.73) to post-treatment (M = 24.54, SD = 6.09) compared to girls with 
no anxiety disorders (pre-treatment: (M = 34.60, SD = 6.78), post-treatment: (M = 23.42, 
SD = 6.29) (see Table 11). In addition, there was a significant within subjects effect of 
time F(1,82) = 163.66, p < .001 (see Table 10) suggesting that the mean post-treatment 
total depression score for the girls (M = 23.94, SD = 6.19) was significantly lower than 
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Time 7585.58 1 7585.58 163.66 .00
Time * Anxiety Diagnosis 220.23 1 220.23 4.75 .03
Error(Time) 3800.75 82 46.35
Within-Subjects Effects for Repeated Measures ANOVA for Pre and Post-





























Figure 2: Total Depression Score at Pre-treatment and Post-treatment for Participants 
With and Without Comorbid Anxiety Diagnoses 
 
 





Variable Anxiety Diagnosis N Mean
Std. 
Deviation
no anxiety 45 34.60 6.78
anxiety 39 40.31 8.73
total 84 37.25 8.22
no anxiety 45 23.42 6.29
anxiety 39 24.54 6.09







Descriptive Statistics for Pre-treatment and Post-trea ment Total 
Depression Scores Across Anxiety Diagnosis Groups
 
Hypothesis 4 
Hypothesis 4 predicted that the presence of a comorbid anxiety disorder at pre-
treatment as determined by meeting diagnostic criteria for one or more anxiety disorders 
on the K-SADS-IVR would be related to less improvement in global functioning after 
treatment as measured by pre-treatment and post-treatment scores on the CGAS. 
Hypothesis 4 Preliminary Analyses. Preliminary analyses were conducted to 
determine whether the data met the assumptions necessary to perform a two-way repeated 
measures analysis of variance. The z-scores for skewness and kurtosis for the pre-
treatment global functioning score (CGAS) on the K-SADS-IVR were already 
determined to meet the assumption of normality before performing the independent 
samples t-test as discussed in hypothesis 2. The z-scores for skewness and kurtosis for the 
post-treatment global functioning score (CGAS) on the K-SADS-IVR were calculated to 
determine whether this variable met the assumption of normality. For the girls with 
anxiety disorders, the z-score for skewness (-0.60) and the z-score for kurtosis (-0.67) 
were acceptable since they were below the absolute value of 3.29 (Field, 2005). The z-
    
  
121 
score for skewness (-2.22) and kurtosis (-0.37) were also acceptable for the girls without 
anxiety. Levene’s test was performed to determine whether the homogeneity of variance 
assumption was met for the post-treatment global functioning score (CGAS). According 
to Levene’s test, the variances of the two groups were not significantly different, F(1, 82) 
= .08, p = .78, suggesting that the post-treatment CGAS score met the homogeneity of 
variance assumption. The pre-treatment global functioning score (CGAS), however, did 
not meet the homogeneity of variance assumption, as discussed in hypothesis 2. 
According to Stevens (1999), ANOVA is robust to violations of homogeneity of variance 
when sample sizes are equal or close to equal which he defines as the largest group being 
less than one and a half times the size of the smallest group. Since the groups being 
compared in this analysis are very close to equal (39 and 45), the ANOVA should be 
robust to the violation of homogeneity of variance. 
Hypothesis 4 Main Analyses. A two-way repeated measures analysis of variance 
was conducted to determine whether there was an interaction between the presence of a 
comorbid anxiety diagnosis and the time (pre and post) of the global functioning score 
(CGAS). There was not a significant interaction between the presence of an anxiety 
diagnosis and time (pre and post treatment global functioning scores), F(1,82) = 0.08,p = 
.77 (see Table 12). As demonstrated in Figure 3, on average, the girls with anxiety 
disorders had similar differences between their pre-treatment (M = 52.23, SD = 8.10) and 
post-treatment (M = 73.05, SD = 10.80) scores compared to the girls with no anxiety 
disorders (pre-treatment: (M = 57.31, SD = 4.97), post-treatment: (M = 78.87, SD = 9.85)) 
(see Table 13). There was a significant within-subjects effect of time F(1,82) = 275.95, p 
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< .001 (see Table 12) meaning that the mean post-treatment global functioning score for 
the girls (M = 76.17, SD = 10.65) was significantly higher than the mean pre-treatment 






Squares df Mean Square F Sig.
Time 18758.98 1 18758.98 275.95 .00
Time * Anxiety Diagnosis 5.64 1 5.64 0.08 .77
Error(Time) 5574.43 82 67.98
Within-Subjects Effects for Repeated Measures ANOVA for Pre and Post-treatment 































Figure 3: CGAS Score at Pre-treatment and Post-treatment for Participants With and 
Without Comorbid Anxiety Diagnoses 




Variable Anxiety Diagnosis N Mean Std. Deviation
no anxiety 45 57.31 4.97
anxiety 39 52.23 8.10
total 84 54.95 7.05
no anxiety 45 78.87 9.85
anxiety 39 73.05 10.80
total 84 76.17 10.65
Descriptive Statistics for Pre-treatment and Post-trea ment CGAS Scores 




CGAS Score  
Hypothesis 5 
Hypothesis 5 predicted that the relation between the presence of a comorbid 
anxiety disorder at pre-treatment and the change in depressive symptoms after tre tment, 
as measured by pre-treatment and post-treatment continuous total depression scores, 
would be moderated by treatment condition. Participants were either in a CBT-only 
treatment condition or a CBT plus parent training treatment condition. 
Hypothesis 5 Preliminary Analyses. Preliminary analyses were conducted to 
determine whether the data met the assumptions necessary to perform a three-way 
repeated measures analysis of variance. The z-scores for skewness and kurtosis for the 
pre-treatment and post-treatment continuous total depression score on the K-SADS-IVR 
were already determined to meet the assumption of normality before performing the 
analyses discussed above. According to Levene’s test for the pre-treatment nd post-
treatment continuous total depression score, the variances between groups were not
significantly different, (pre-treatment: F(3, 80) = 2.49, p = .07; post-treatment: F(3, 80) = 
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.54, p = .65), suggesting that both the pre-treatment and post-treatment continuous total 
depression score met the homogeneity of variance assumption.  
 Hypothesis 5 Main Analyses. A three-way repeated measures analysis of variance 
was conducted to determine whether there was a three way interaction between treatment 
condition, the presence of a comorbid anxiety diagnosis, and the time (pre and post) of 
the total depression severity score. Although the figures representing the relation between 
the presence of a comorbid anxiety diagnosis and the time (pre and post) of the total 
depression severity score for each treatment condition appear slightly different (see 
Figures 4 and 5), there was not a significant three way interaction between treatment 
condition, the presence of a comorbid anxiety diagnosis, and the time (pre and post) of 
the total depression score, F(1,80) = .24, p = .63 (see Table 14). The means and standard 
deviations of the pre and post depression scores for the different groups are presented in 
Table 15. The within subjects effect of time was at the same significance level that was 
found for Hypothesis 3 (p < .001) (see Tables 10 and 14). The interaction between time 
(pre and post-treatment total depression) and comorbid anxiety was slightly different than 
what was found in hypothesis three with a difference in significance (p value) from .03 
(Hypothesis 3) to .04 (Hypothesis 5) (see Tables 10 and 14) which can most likely be 
accounted for by the difference in power that occurred by adding an additional variable to 
the analysis. 
 





























Figure 4: Total Depression Score at Pre-treatment and Post-treatment for Participants 
Who Received CBT and Parent Intervention by Comorbid Anxiety Diagnosis Group               
 





























Figure 5: Total Depression Score at Pre-treatment and Post-treatment for Participants 









Time 7515.48 1 7515.48 158.66 .00
Time * Anxiety Diagnosis 215.60 1 215.60 4.55 .04
Time * Treatment Condition .08 1 .08 .00 .97
Time *Anxiety Diagnosis * 
Treatment Condition 11.36 1 11.36 .24 .63
Error(Time) 3789.39 80 47.37
Within-Subjects Effects for Repeated Measures ANOVA for Pre and Post-


















CBT 19 34.37 8.17
CBT+P 26 34.77 5.73
Total 45 34.60 6.78
CBT 22 39.73 8.91
CBT+P 17 41.06 8.71
Total 39 40.31 8.73
CBT 41 37.24 8.89
CBT+P 43 37.26 7.62
Total 84 37.25 8.22
CBT 19 22.63 6.66
CBT+P 26 24.00 6.07
Total 45 23.42 6.29
CBT 22 24.45 5.53
CBT+P 17 24.65 6.92
Total 39 24.54 6.09
CBT 41 23.61 6.07
CBT+P 43 24.26 6.35
Total 84 23.94 6.19
anxiety 
total
Descriptive Statistics for Pre-treatment and Post-treatment Total Depression 















Hypothesis 6 predicted that the relation between the presence of a comorbid 
anxiety disorder at pre-treatment as determined by meeting diagnostic criteria for one or 
more anxiety disorders on the K-SADS-IVR and the change in global functioning scores
after treatment as measured by pre-treatment and post-treatment global functioning scores 
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on the CGAS would be moderated by treatment condition. Participants were either in a 
CBT only treatment condition or a CBT plus parent training treatment condition. 
Hypothesis 6 Preliminary Analyses. Preliminary analyses were conducted to 
determine whether the data met the assumptions necessary to perform a three-way 
repeated measures analysis of variance The z-scores for skewness and kurtosis for the 
pre-treatment and post-treatment global functioning scores were already d termined to 
meet the assumption of normality before performing the analyses discussed abov . The 
assumption of sphericity is often tested when running repeated measures ANOVA, 
however, sphericity can only be evaluated when there are more than two conditions being 
compared (Field, 2005). Hypothesis six compared only two conditions for both between-
subjects factors (anxiety and no anxiety; CBT and CBT with parent training), so 
sphericity could not be tested. Levene’s test was performed to determine whether t  
homogeneity of variance assumption was met for the pre and post-treatment CGAS 
scores. According to Levene’s test for the pre-treatment CGAS score, F(3, 80) = 2.06, p = 
.11, and post-treatment CGAS score, F(3, 80) = .23, p = .88, the variances between 
groups were not significantly different for either score. These results sugge ted that both 
the pre and post-treatment CGAS scores met the homogeneity of variance assumption. 
 Hypothesis 6 Main Analyses. A three-way repeated measures analysis of variance 
was conducted to determine whether there was a three way interaction between treatment 
condition, the presence of a comorbid anxiety diagnosis, and the time (pre and post) of 
the global functioning score. There was not a significant three-way interaction between 
treatment condition, the presence of a comorbid anxiety diagnosis, and the time (pre and 
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post) of the global functioning score, F(1,80) = .39, p = .54 (see Table 16). Figures 6 and 
7 illustrate that the relation between comorbid anxiety and the time (pre and post) of the 
global functioning score was very similar between treatment conditis. The means and 
standard deviations of the pre and post CGAS scores for the different groups are 
presented in Table 17. The within subjects effect of time was at the same significance 
level that was found for Hypothesis 4 (p < .001) (see Tables 12 and 16). The interaction 
between time (pre and post-treatment global functioning) and comorbid anxiety was 
slightly different than what was found in hypothesis 4 with a difference in significance (p 
value) from .77 (Hypothesis 4) to .80 (Hypothesis 6) (see Tables 12 and 16) which can 
most likely be accounted for by the difference in power that occurred by adding an 








Time 18575.70 1 18575.70 267.98 .00
Time * Anxiety Diagnosis 4.67 1 4.67 0.07 .80
Time * Treatment Condition 3.40 1 3.40 .05 .83
Time *Anxiety Diagnosis * 
Treatment Condition 26.83 1 26.83 .39 .54
Error(Time) 5545.36 80 69.32
Within-Subjects Effects for Repeated Measures ANOVA for Pre and Post-treatment 
CGAS Scores Across Anxiety Diagnosis Groups and Treatment Conditions
 


























Figure 6: CGAS Score at Pre-treatment and Post-treatment for Participants Who 
























Figure 7: CGAS Score at Pre-treatment and Post-treatment for Participants Who 
Received CBT Only by Comorbid Anxiety Diagnosis Group                                        














CBT 19 56.89 5.08
CBT+P 26 57.62 4.97
Total 45 57.31 4.97
CBT 22 50.95 8.26
CBT+P 17 53.88 7.83
Total 39 52.23 8.10
CBT 41 53.71 7.51
CBT+P 43 56.14 6.44
Total 84 54.95 7.05
CBT 19 79.05 10.34
CBT+P 26 78.73 9.68
Total 45 78.87 9.85
CBT 22 70.82 10.72
CBT+P 17 75.94 10.50
Total 39 73.05 10.80
CBT 41 74.63 11.22
CBT+P 43 77.63 9.98
Total 84 76.17 10.65
Descriptive Statistics for Pre-treatment and Post-treatment CGAS Scores 














 Secondary analyses were conducted to further explore the first four hypotheses. 
Analyses were conducted for these hypotheses using a continuous total anxiety scor  
from the K-SADS-IVR in place of comparing the group of girls who had a comorbid 
anxiety diagnosis to the group of girls without a comorbid anxiety diagnosis. This 
continuous total anxiety score was based on the presence and severity of anxiety 
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symptoms endorsed on the K-SADS-IVR. Correlation and regression analyses were 
conducted to further explore these hypotheses. 
Hypothesis 1 Secondary Analysis 
Based on the independent samples t-test conducted for Hypothesis 1, it would be 
expected that the pre-treatment continuous total depression score on the K-SADS-IVR 
would be significantly correlated with the pre-treatment continuous total anxiety score at 
pre-treatment. Preliminary analyses were conducted to determine whether t  data met 
the assumptions of normality. The z-scores for skewness and kurtosis for the pre-
treatment continuous total depression score and the pre-treatment continuous total anxiety 
score on the K-SADS-IVR were calculated to determine whether these variables met the 
assumption of normality. For the pre-treatment depression score, the z-score for skewness 
(1.73) and the z-score for kurtosis (-0.19) were acceptable since they were below the 
absolute value of 3.29 (Field, 2005). For the continuous total anxiety score, however, the 
z-scores for skewness (6.92) and kurtosis (10.46) were not acceptable and violated the 
assumption of normality. As a result, a non parametric statistic, a Spearman’s correlation 
coefficient, was calculated. The Spearman test suggested that the pre-treatm nt 
depression score and the pre-treatment anxiety score had a correlation of rs= .46,p < .001 
(see Table 18), which is consistent with the findings from the primary analysis of 
Hypothesis 1. 














Spearman's Correlation Between Pre-treatment Total 
Depression Score and Pre-treatment Total Anxiety 
Score
 
Hypothesis 2 Secondary Analysis 
Based on the independent samples t-test conducted for Hypothesis 2, it would be 
expected that the pre-treatment global functioning score (CGAS) on the K-SADS IVR 
would be significantly correlated with the pre-treatment continuous total anxiety score at 
pre-treatment. Preliminary analyses were conducted to determine whether t  data met 
the assumptions of normality. The z-scores for skewness and kurtosis for the pre-
treatment continuous global functioning score were calculated to determine whether t is 
variable met the assumption of normality. For the pre-treatment global functioni g score, 
the z-score for skewness (-4.52) and the z-score for kurtosis (4.57) were not acceptable 
since they were above the absolute value of 3.29 (Field, 2005). As determined in the 
Hypothesis 1 secondary analyses, the continuous anxiety score also violated the 
assumption of normality. As a result, a non parametric statistic, a Spearman’s correlation 
coefficient, was calculated. The Spearman test suggested that the pre-treatm nt global 
functioning score and the pre-treatment anxiety score had a correlation of rs = -.36, p < 
.01 (see Table 19), which is consistent with the findings from the primary analysis of 
Hypothesis 2. 













Spearman's Correlation Between Pre-treatment CGAS 
Score and Pre-treatment Total Anxiety Score
 
Hypothesis 3 Secondary Analysis 
Based on the two-way repeated measures ANOVA conducted for Hypothesis 3, it 
would be expected that there would be a significant interaction between the pre-treatment 
continuous total depression score and the pre-treatment continuous anxiety score with 
multiple regression analysis. Preliminary analyses were conducted to determine whether 
the data met the assumptions of regression. Previous preliminary analyses discus ed 
above suggested that there was not perfect multicollinearity between the predictors and 
the predictors were not correlated with grade, age, or race/ethnicity. A Durbin-Watson 
test was conducted on the data which produced a value of 1.85, suggesting that the 
assumption of independent errors was most likely met (Field, 2005). The scatterplot of 
residuals suggested that the assumptions of homescedasticity and linearity had been met 
as well (see Figure 8). The histogram and normal probability plot suggested that the d ta 
met the assumption of normally distributed errors (see Figures 9 and 10). Since the 
assumptions of multiple regression were met, a multiple regression analysis was 
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conducted. Pre-treatment depression scores, pre-treatment anxiety scores, and the cross-
product between pre-treatment depression and anxiety were entered as predictors and he 
dependent variable was post-treatment depression. As Table 20 illustrates, the interaction 
(cross-product) between pre-treatment depression and pre-treatment anxiety was not 
significant (p = .21), which is inconsistent with the results of the primary analysis of 
Hypothesis 3. 
 
Figure 8: Scatterplot of Residuals for the Post-treatment Total Depression Score 
 





Figure 9: Histogram of the Post-treatment Total Depression Score 
 
 




Figure 10: Normal Probability Plot for the Post-treatment Total Depression Score 
 







B Std. Error Beta
(Constant) 23.50 .76 30.91 .00
Pre-treatment Total 
Anxiety Score -.08 .08 -.15 -1.02 .31
Pre-treatment Total 






Scores .01 .01 .18 1.28 .21
Sig.
Summary of Multiple Regression Analysis for Pre-treatment Total Depression Score 






Hypothesis 4 Secondary Analysis 
Based on the two-way repeated measures ANOVA conducted for Hypothesis 4, it 
would be expected that there would not be a significant interaction between the pre-
treatment global functioning score and the pre-treatment continuous total anxiety score 
with a multiple regression analysis. Preliminary analyses were conducted to determine 
whether the data met the assumptions of regression. Previous preliminary analyses 
discussed above suggested that there was not perfect multicollinearity between the 
predictors and the predictors were not correlated with external variables. A Durbin-
Watson test was conducted on the data which produced a value of 2.01, suggesting that 
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the assumption of independent errors is most likely met (Field, 2005). The scatterplot of 
residuals suggested that the assumption of linearity had been met, however, the 
scatterplot suggested heteroscedasticity (see Figure 11). The histogram and normal 
probability plot suggested that the data met the assumption of normally distributed errors 
(see Figures 12 and 13). Since the assumption of homoscedasticity was violated, the 
results of the regression analyses should be interpreted with caution. Pre-treatment global 
functioning scores, pre-treatment anxiety scores, and the interaction between pre-
treatment global functioning and anxiety were entered as predictors and the dependent 
variable was post-treatment global functioning. As Table 21 illustrates, the interaction 
between pre-treatment global functioning and pre-treatment anxiety was not sig ificant (p 
= .51), which is consistent with the results of the primary analysis of Hypothesis 4. 




Figure 11: Scatterplot of Residuals for the Post-treatment CGAS Score 
                                 
 




Figure 12: Histogram of the Post-treatment CGAS Score 
 
 




Figure 13: Normal Probability Plot for the Post-treatment CGAS Score 
 






B Std. Error Beta
(Constant) 76.50 1.25 61.29 .00
Pre-treatment Total 
Anxiety Score .16 .18 .11 .87 .39
Pre-treatment Total 






Scores .01 .01 .08 .66 .51
Summary of Multiple Regression Analysis for Pre-treatment CGAS Score and Pre-











Overview of Findings and Integration with Previous Research 
Summary of Findings 
 The results of the present study build on existing research to improve our 
understanding of the symptomatology, functioning, and treatment response of girls with 
comorbid anxiety and depression. Findings from this study provide further evidence that 
both the presence and severity of comorbid anxiety are related to more severe depr ssiv  
symptoms and lower functioning in depressed early adolescent girls. The results al o 
suggested that comorbid anxiety was not related to negative treatment outcomes for early 
adolescent girls with depression. In fact, the findings of this study highlighted that 
although the girls with comorbid anxiety started out much worse before treatment, they 
experienced significantly larger reductions in depression severity and comparable gains 
in global functioning to girls without anxiety during treatment. The presence of parent 
intervention did not appear to significantly change the relation between comorbid anxiety 
and treatment outcome. The findings from this study have major implications for both the 
understanding of comorbid anxiety and depression and the treatment of girls expeiencing 
depression and anxiety. The remainder of this section presents the results for the different 
hypotheses explored in this study and includes a discussion of how these results relate to 
previous research findings. 
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Depression Severity and Global Functioning Before Treatment (Hypotheses 1 and 2)  
 As hypothesized, the results of the present investigation suggested that the 
presence of comorbid anxiety was related to depressive symptom severity and global 
functioning prior to treatment. The girls who met diagnostic criteria for comorbid anxiety 
disorders appeared to experience more severe depressive symptoms and lower global 
functioning before treatment compared to the girls without anxiety disorders. In addition, 
the secondary analyses of hypotheses 1 and 2 suggested that there was a significant 
relation between the severity of anxiety symptoms and both the severity of depressive 
symptoms and global functioning scores before treatment. It appears that as t e presence 
and severity of anxiety symptoms increase in early adolescent girls, the everity and 
presence of depressive symptoms increase and overall global functioning becomes w rse. 
The findings of this investigation provide additional evidence of the strong relation 
between depression and anxiety in early adolescent girls and the negative impl cations of 
having both depression and anxiety. 
The results of hypothesis 1 are consistent with previous research findings and 
provide further evidence suggesting that youth with comorbid depression and anxiety 
have more severe depressive symptoms than depressed youth without anxiety (Mitchell et 
al., 1988; Rohde et al., 2001; Stark et al., 1993; Young et al., 2006). The significant 
correlation found between depression and anxiety severity in the secondary analysis of 
hypothesis one is also consistent with the results of Ghaziuddin et al.’s (2000) study 
whose results suggested that anxiety symptom severity was correlated with depression 
severity in a sample of adolescents.  
    
  
146 
Hypothesis 2 was exploratory because there was limited research exploring g bal 
functioning in youth with comorbid anxiety and depression. The results of the analyses 
for hypothesis 2, however, are consistent with what is currently understood about 
comorbid depression and anxiety and depression comorbidity in general. Rohde et al.’s 
(2001) investigation found that depressed youth who reported comorbidity during their 
lifetimes had lower functioning than depressed youth without a history of comorbidity. 
Previous research has also suggested that depressed youth with comorbid anxiety 
experience earlier depression onset, increased suicidal ideation, more severe depr ssion, 
and more depressive symptomatology than children without comorbid anxiety 
(Ghaziuddin et al., 2000; Kendall et al., 1992; Kovacs et al., 1989; Mitchell et al., 1988; 
Rohde et al., 2001; Stark et al., 1993; Young et al, 2006). Given that comorbid anxiety is 
related to so many negative outcomes in depressed youth, it makes sense that the resuls 
of this study suggested that the presence of a comorbid anxiety diagnosis and the severity 
of anxiety symptoms were related to the overall functioning of girls with depression. 
The results of the current investigation along with the findings of previous 
research suggest that depressed youth with comorbid anxiety are at risk formore severe 
depression and lower global functioning. These findings further illustrate the importance 
of developing effective interventions for these youth. 
Comorbid Anxiety and Treatment Outcome (Hypotheses 3 and 4) 
The results of the analyses for hypotheses 3 and 4 were significantly different 
from what was expected based on previous research with older adolescents. It was 
hypothesized that the early adolescent girls with comorbid anxiety that participated in this 
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study would not benefit from the treatment as much as the girls without comorbid 
anxiety, similarly to the older adolescents with comorbid anxiety that partici ted in 
several previous treatment studies (Brent et al., 1998, Clarke et al., 1992, Curry et al., 
2006). Instead, the results of the present study suggested that comorbid anxiety was not
related to worse treatment outcome, in terms of depression severity or global functioning. 
In fact, the primary analysis of hypothesis 3 suggested that the girls with comorbid 
anxiety experienced significantly more change in depression severity du ng treatment 
than girls without comorbid anxiety.  
The results of the primary analysis of hypothesis 3 suggested that the girls with 
both anxiety and depression started treatment with significantly more severe depression 
but were able to reduce their depression severity scores even more than the girls without 
anxiety disorders during treatment. Conversely, the secondary analysis of hypothesis 3 
suggested that severity of anxiety symptoms was not a significant predicto  of hange in 
depression severity during treatment. Interpreting both the primary analysis nd 
secondary analyses of hypothesis 3 together would suggest that girls with a comorbid 
anxiety disorder may have been more likely to experience larger changes in depression 
severity over the course of treatment than girls without a comorbid anxiety disorder, 
however, the severity of anxiety symptoms was not related to changes in depression 
severity during treatment. Despite the complexity of this distinction, one result was clear 
from both the primary and secondary analyses of hypothesis 3, comorbid anxiety was not 
related to worse treatment outcome for depressed early adolescent girls.  
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The results of both the primary and secondary analyses for hypothesis 4 were 
more straightforward. Neither the presence of comorbid anxiety nor the severity of 
anxiety symptoms were related to changes in global functioning during treatment. Th  
girls with comorbid anxiety in the study did not make less improvement in terms of their 
global functioning than the girls without comorbid anxiety, but they also did not make 
more improvement.  
Although the results of the analyses for hypotheses 3 and 4 were significantly 
different from the results of the studies by Brent et al. (1998), Clarke et al. (1992), and 
Curry et al. (2006), the results were very consistent with the findings of Rohde et al. 
(2001). Rohde et al.’s study findings were difficult to interpret because the study had 
several limitations that influenced the validity of their findings. The reseach rs used 
measures of lifetime comorbidity instead of current comorbidity and excluded people 
currently experiencing common anxiety disorders including GAD and Panic Disorder 
from their study. As a result, their study results did not provide information about the 
influence of current anxiety comorbidity on treatment outcome. Despite the differences in 
how comorbidity was measured between the Rohde et al. study and the current study, the 
results were very similar. Similarly to the current study, in Rohde et al.’s investigation 
the adolescents with comorbid anxiety started out with higher pre-treatment depression 
severity but had a significantly greater reduction in depression severity after treatment 
than those without anxiety. 
It is important to determine why the results of the present study may be differnt 
from the results of the studies by Brent et al. (1998), Clarke et al. (1992), and Curry et al. 
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(2006). There are several possible explanations for the differing results. One possible 
explanation, suggested by Brent et al.’s (1998) study, is that CBT could be an 
intervention that is not as negatively influenced by comorbid anxiety as other 
interventions. The adolescents in Brent et al.’s (1998) study received either CBT, 
systemic behavioral family therapy (SBFT), or nondirective supportive therapy (NST) 
(Brent et al., 1997). Although Brent et al. (1998) found that overall the presence of a 
comorbid anxiety disorder at intake predicted depression at the end of treatment, their 
results also suggested that the adolescents with comorbid anxiety benefited more fro  the 
CBT treatment than the two other treatments. As a result, it may be possible that the 
relation between comorbid anxiety and worse treatment outcome may not have been as 
strong if all of the adolescents had received CBT. The findings by Jayson et al. (1998) 
and Young et al. (2006) provide further support for the idea that CBT may be more 
robust to comorbid anxiety than other treatments. Young et al. found that comorbid 
anxiety was related to worse treatment outcome (changes in depression severity) for 
adolescents receiving Interpersonal Psychotherapy for Depressed Adolescents (IPT-A), 
however, Jayson et al. found that comorbid anxiety did not influence depression 
remission for youth receiving individual CBT interventions. These results suggest that 
different treatment interventions may be differentially influenced by comorbid anxiety 
and that CBT may be less negatively influenced by comorbid anxiety than other 
treatments. This explanation may help to explain why Brent et al.’s (1998) study found 
that comorbid anxiety was related to worse treatment outcome for adolescents re iving 
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several different interventions and the current study found that comorbid anxiety was not 
related to worse treatment outcome when only a CBT intervention was used.  
Results from studies by Clarke et al. (1992) and Curry et al. (2006) suggested that 
comorbid anxiety can be related to negative treatment outcome even when a CBT 
intervention is used, but that the specific components of the intervention may influence 
the relation between comorbid anxiety and treatment outcome. Curry et al. tried to 
determine why youth with comorbid anxiety appeared to benefit more from the CBT 
intervention in Brent et al.’s (1998) study compared to the studies by Curry et al and
Clark et al.. Curry et al. noted that the CBT treatment that was used in the Curry et al. 
study and the treatment used in the Clark et al. study both focused more on skill building 
and less on cognitive restructuring than Brent et al.’s study. Curry et al. hypothesized that 
cognitive restructuring may be especially important for youth with comorbid depression 
and anxiety because the restructuring may reduce cognitions that lead to anxie y which 
may reduce the negative influence of anxiety on treatment outcomes. This hypothesis 
could help to explain why anxiety did not have a negative influence on treatment 
outcome in the current study given that this study used an intervention that heavily 
emphasized cognitive restructuring. Overall, the different results found between studies 
that were based on different treatment modalities and included different components, 
including the current study, suggest the need for further research into what components of 
treatment may make an intervention more robust to the negative influence of comorbid 
anxiety.  
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Another possible explanation for the differences found between the studies may 
result from the way treatment outcome was defined between studies. Previous research 
suggests that comorbid anxiety may be related to certain indices of treatment outcome but 
not to others in the same study (Brent et al., Clark et al.). Clarke et al.’s investigation 
found that although anxiety was related to treatment recovery for depressed youth, 
anxiety was not related to changes in depression severity. Brent et al.’s study found that 
the presence of a comorbid anxiety disorder at intake predicted depression at the end of 
treatment but not post-treatment levels of functional impairment. Similarly, the current 
study found that comorbid anxiety was significantly related to treatment outcome as 
defined by depression severity but not global functioning. These results suggest the 
importance of looking at several different indices of treatment outcome when exploring 
the possible relation between anxiety and treatment outcome in depressed youth.  
Comorbid anxiety was also measured in different ways between and within 
studies. Brent et al. (1998) and Curry et al. (2006) measured comorbid anxiety as the 
presence of a current comorbid anxiety disorder, whereas Clark et al. (1992) measured 
comorbid anxiety as the severity of state anxiety before treatment and Rohde et al. 
measured comorbidity as the presence of a comorbid anxiety disorder sometime during a 
participant’s lifetime. In the current study comorbid anxiety was measur d in two ways, 
the presence of a current comorbid anxiety disorder and the severity of anxiety symptoms 
before treatment. The fact that different investigations of the relation between comorbid 
anxiety and treatment outcome have measured comorbid anxiety differently may help to 
explain some of the different findings between studies. In future research it will be 
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important to compare how different measures of comorbid anxiety may be different ally 
related to treatment outcome. 
It is important to highlight that another possible explanation for the different 
results of the current study compared to several previous investigations may be that the 
participants of this study were significantly younger than those in the studies by Brent et 
al. (1998), Clarke et al. (1992), and Curry et al. (2006). In addition, the participants of the 
current study were all female, unlike the previous studies. It is possible that being 
younger or being female may somehow make depressed youth more resilient to the 
influence of comorbid anxiety on treatment outcome. It is important that future research 
examines age and gender as possible moderators of the relation between comorbid 
anxiety and treatment outcome in youth. 
Parent Training as a Moderator of the Relation Between Comorbid Anxiety and 
Treatment Outcome (Hypotheses 5 and 6) 
Results from the analyses completed to investigate hypotheses 5 and 6 also 
differed from what was originally expected. The relation between comorbid anxiety and 
treatment outcome (as defined by both depression severity and global functioning) was 
not moderated by receiving parent intervention. It was hypothesized that youth with both 
depression and anxiety may especially benefit from parent intervention give  that the co-
occurrence of anxiety and MDD has been associated with many negative famly factors 
(Stark et al., 1990) and that children with anxiety have been found to benefit from 
receiving parent intervention (Barrett et al., 1996; Thienemann et al., 2006). The results 
from this study, however, suggested that parent intervention did not provide an additional 
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benefit to participants with comorbid anxiety and depression. Similarly to the results of 
previous hypotheses, the results of hypotheses 5 and 6 were consistent with the resul s of 
the Rohde et al. (2001) study which did not find differences between the treatment 
conditions (CBT alone and CBT with parent training) for the relation between lifetime 
anxiety comorbidity and treatment outcome.  
There are some possible explanations for why parent intervention did not 
significantly moderate the relation between comorbid anxiety and treatment outcome 
even though there may have been some minor differences between treatment conditions. 
One explanation may be that the girls in the study experienced such significant changes 
from pre to post treatment in terms of depression severity and global functionig. This is 
illustrated by the within-subjects effect of time for both outcomes which were significant 
at the p < .001 level. The fact that the participants improved so much may have created a 
type of ceiling effect so that even if the parent intervention provided an additional benefit 
for the girls with comorbid anxiety it may not have been possible to detect this change 
above and beyond the improvement made in the CBT only condition. Future research 
should continue to explore whether the presence of parent intervention changes the 
relation between comorbid anxiety and treatment outcome both for CBT interventions 
and other treatment modalities. 
Limitations 
There were several limitations of the current study that should be considered 
when interpreting these results. One important limitation was that comorbid diagnoses 
that were not anxiety disorders were not addressed in this study. Some study participants 
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met diagnostic criteria for other comorbid diagnoses, including Eating Disorders (n= 1), 
Oppositional Defiant Disorder (n= 3), and Attention Deficit Disorders (n= 9) and it is 
possible that these other comorbid conditions may have influenced the depression 
severity and global functioning for girls with and without comorbid anxiety diagnoses.  
Future investigations should explore the relation between other comorbid conditions and 
treatment outcome for depressed youth and whether other comorbid disorders moderate 
the relation between comorbid anxiety and treatment outcome. 
The symptom similarities between depressive and anxiety disorders and between 
different anxiety disorders also may have influenced the results of this study. The 
diagnostic interview used in this study (KSADS-IV-R) included all of the sympto s for 
each of the depressive and anxiety diagnoses. As a result, there was some symptom 
overlap between different diagnoses. For this study, all diagnostic symptoms for each 
disorder, even those that were overlapping symptoms, were included in the calculation of 
the total depression and anxiety scores. The decision was made to include all of these 
symptoms in order to maintain construct validity, however, it may be possible that 
including overlapping symptoms may have artificially increased the relation between 
depression and anxiety in this study.  
Another major limitation of the present study was that participant’s anxiety 
symptoms and anxious cognitions may have been addressed differently across therapi ts 
and across participants. The way in which anxious symptoms may have been addressed in 
therapy could have significantly influenced the treatment outcome of the girls with 
comorbid anxiety and depression. In addition, changes in anxiety symptoms during 
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treatment were not explored in this investigation and it may be possible that changes in 
anxiety severity during treatment may have moderated the relation between pre-treatment 
anxiety severity and treatment outcome. Future research should explore how anxiety is 
addressed during treatments for depression and whether differences in how anxiety is 
addressed influences treatment outcomes, in terms of depression and anxiety severity.
This information could add to our understanding of how interventions work for these 
youth and help us to determine the possible benefits of specifically addressing anxiety
symptoms as part of interventions designed to treat depression. 
A final limitation of this study was that the participants of this study were all early 
adolescent girls so the results of this study can not be applied to boys or to girls who are 
younger than 9 or older than 13. This limitation also did not allow for an examination of 
whether gender or age moderated the relation between comorbid anxiety and treatment 
outcome. The specific age group of the participants was also a unique strength of this 
study, however, because younger adolescents have rarely been included in previous 
research investigating the relation between comorbidity and treatment outcome. 
Implications 
The results of the current study have major implications regarding our 
understanding of comorbid depression and anxiety and how to most effectively provide 
interventions for youth with both of these disorders. The first set of findings from this 
study suggested that prior to treatment, the presence of a comorbid anxiety disorder and 
the severity of anxiety symptoms were related to higher depression severity and lower 
global functioning. These findings were consistent with previous research. The results 
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from this study and previous research suggest that girls with both depression and anxiety 
are at risk for experiencing more severe depressive symptoms and lower functioning 
without treatment. These results emphasize the importance of developing effectiv  
interventions for these youth. 
The strong relation between anxiety and depression severity found prior to 
treatment in this study also has implications for the debate about whether anxiety d 
depression are truly separate disorders or whether they may actually be the same disorder 
as suggested by Finch et al. (1989). Given that the results of this study indicated that 
anxiety and depression severity were very highly correlated, this does rais the question 
of whether they are truly different disorders. It is important that future res arch continue 
to explore this issue. Investigating the relation between depression and anxiety over the 
course of treatment could provide further clues as to whether depression and anxiety are 
the same or different disorders. Research exploring the pattern of changes during 
treatment for depressive and anxiety symptoms may help to determine whether t se two 
types of symptoms have similar patterns of change or whether they are different. I  
depressive and anxiety symptoms follow very similar patterns of change, this could 
provide further evidence that depression and anxiety may actually be the same disord r. 
The next set of findings from this study provided important information about the 
relation between comorbid anxiety and treatment outcome for depressed youth. The 
results suggested that girls with comorbid depression and anxiety were able to make 
improvements during treatment that were comparable to or larger than girls without 
comorbid anxiety. In fact, the girls with comorbid anxiety and depression started out with 
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more severe depression severity before treatment but also had a larger decrease in 
depression severity over treatment. In addition, the severity of anxiety symptoms was not 
related to poorer treatment outcome for the participants. Finding that the participants with 
comorbid depression and anxiety may be at risk for more severe depression and lower 
functioning without treatment but are just as likely to benefit from treatment as those 
without anxiety illustrates the importance of finding and utilizing effectiv  interventions 
for youth with comorbid depression and anxiety. 
Comparing the results of this study with previous research provides important 
clues regarding what may make interventions more or less effective for youth with 
comorbid depression and anxiety. Previous research has suggested that CBT may be 
more robust to the influence of comorbid anxiety than other interventions (Brent et al., 
1998) and that including cognitive restructuring as a major focus of treatment may be 
especially important in the treatment of youth with comorbid depression and anxiety 
(Curry et al., 2006). Given that the participants of the current study all received a CBT
intervention with a major focus on cognitive restructuring, this may help to explain why 
this study found that comorbid anxiety was not related to poor treatment outcome 
whereas many previous studies have found the opposite (Brent et al., 1998; Clarke et al., 
1992; Curry et al., 2006). It is very important that future research continue to explore how 
youth with comorbid depression and anxiety respond to different interventions with 
different components so that we have a better understanding of which treatments have he 
potential to provide the most benefit for youth with depression and anxiety. 
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This study also explored whether parent intervention moderated the relation 
between comorbid anxiety and treatment outcome. Although the results suggested that 
the presence of parent intervention was not a significant moderator for this particular 
group of participants and this intervention, it is important that future research continue to 
explore the impact of parent intervention for participants of different ages and with 
different interventions. 
The findings of this study also have implications for the treatment of early 
adolescents specifically. Past research on comorbidity and treatment outcome has focused 
almost completely on older adolescents so little was known about the relation between 
comorbid anxiety and treatment outcome for the age range focused on in the present 
study. This study suggested that at least for the specific intervention used in this study, 
comorbid anxiety diagnoses and anxiety symptom severity were not related to nega ive 
treatment outcomes. Some previous research has suggested that comorbid anxiety 
negatively influences treatment outcome for older adolescents (Brent et al., 1998; Clarke 
et al., 1992; Curry et al., 2006), however, these studies also used different interventions 
than the treatment used in the current study. As a result, it is unclear whether t re are 
differences in the relation between comorbid anxiety and treatment outcome between 
early adolescents and older adolescents or whether the differences in results are due to 
treatment differences. Future research should explore these questions to determine 
whether treatments may be more or less effective for youth with comorbid depression and 
anxiety at different ages or developmental stages. 
 




The main goals of the current study were to explore whether comorbid anxiety 
was related to treatment outcome for depressed girls receiving a cognitive behavioral 
intervention and whether the addition of a parent intervention changed the relation 
between comorbid anxiety and treatment outcome. The relation between comorbid 
anxiety and pre-treatment depression severity and global functioning were also explored 
to determine whether depressed youth with comorbid anxiety differed from those without 
anxiety before they received treatment. The findings of this study have major 
implications for the treatment of youth with comorbid depression and anxiety. 
The results of this study suggested that early adolescent girls with comorbid 
depression and anxiety or higher anxiety severity began treatment with higher depr ssion 
severity and lower global functioning. The girls with comorbid anxiety, however, were
able to make changes in treatment that were comparable to or better than the girls without 
comorbid anxiety. The treatment condition that the participants were in (group CBT only 
or group CBT with parent intervention) did not appear to impact the relation between 
anxiety and treatment outcome.  
The finding that the participants of this study with comorbid anxiety started out 
with more severe symptoms and lower functioning was consistent with previous research 
and provides further evidence of the need for effective treatments for youth with 
comorbid depression and anxiety. The other results of this study which suggested that 
comorbid anxiety was not negatively related to treatment outcome differed rom several 
previous studies. These findings are very positive because they suggest that although 
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youth with comorbid depression and anxiety may experience more severe 
psychopathology without treatment, they have the potential to benefit from treat ent just 
as much, if not more, than those without anxiety. Since this study and previous studie
have found differing results regarding the relation between comorbid anxiety and 
treatment outcome, this suggests that different interventions may be more robust to the 
influence of comorbid anxiety or certain participants may be less impacted by comorbid 
anxiety during treatment. It is imperative that future research continue to explore which 
interventions are most effective for youth with both anxiety and depression. This 
information can be used to help clinicians and researchers to design interventions that can
be most beneficial for youth experiencing comorbid depression and anxiety. 





 DSM-IV (APA, 2000) Criteria for Major Depressive Disorder and Major Depressiv 
Episode  
 
DSM-IV Criteria for Major Depressive Disorder 
A. Presence of one or more Major Depressive Episodes (to be considered separate 
episodes, there must be an interval of two consecutive months in which criteria are 
not met for a Major Depressive Episode). 
B. Major Depressive Episode is not better accounted for by Schizoaffective Disorder and 
is not superimposed on Schizophrenia, Schizophreniform Disorder, Delusional 
Disorder, or Psychotic Disorder Not Otherwise Specified. 
C. There has never been a Manic Episode, Mixed Episode, or Hypomanic Episode. 
 
DSM-IV Criteria for Major Depressive Episode 
A. Five (or more) of the following symptoms must be present during the same two-week 
period and represent a change from previous functioning; at least one of the 
symptoms is either (1) depressed mood, or (2) loss of interest or pleasure. 
1. Depressed mood most of the day, nearly every day, as indicated by either 
subjective report (e.g., feels sad or empty) or observation made by others (e.g., 
appears tearful). Note: in children and adolescents, can be irritable mood. 
2. Markedly diminished interest or pleasure in all, or almost all, activities most 
of the day, nearly every day (as indicated by either subjective account or 
observation made by others). 
3. Significant weight loss when not dieting or weight gain (e.g., a change of 
more than 5% of body weight in a month), or decrease or increase in appetite 
nearly every day. Note: in children, consider failure to make expected 
weight gains. 
4. Insomnia or hypersomnia nearly every day. 
5. Psychomotor agitation or retardation nearly every day (observable by others, 
not merely subjective feelings of restlessness or being slowed down). 
6. Fatigue or loss of energy nearly every day. 
7. Feelings of worthlessness or excessive or inappropriate guilt (which may be 
delusional) nearly every day (not merely self-reproach or guilt about being 
sick). 
8. Diminished ability to think or concentrate, or indecisiveness, nearly every day 
(either by subjective account or as observed by others). 
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation 
without a specific plan, or a suicide attempt or a specific plan for committing 
suicide.  
B. The symptoms do not meet criteria for a Mixed Episode. 
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C. The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.  
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition (e.g., hypothyroidism). 
E. The symptoms are not better accounted for by Bereavement, i.e., after the loss of a 
loved one, the symptoms persist for longer than two months or are characterized by 
marked functional impairment, morbid preoccupation with worthlessness, suicidal 









DSM-IV (APA, 2000) Criteria for Dysthymic Disorder 
A. Depressed mood for most of the day, for more days than not, as indicated either by 
subjective account or observation by others, for at least two years. Note: in children 
and adolescents, mood can be irritable and duration must be at least one year. 
B. Presence, while depressed, of two (or more) of the following: 
1. Poor appetite or overeating 
2. Insomnia or hypersomnia 
3. Low energy or fatigue 
4. Low self-esteem 
5. Poor concentration or difficulty making decisions 
6. Feelings of hopelessness 
C. During the two-year period (one year for children or adolescents) of the disturbance, 
the person has never been without the symptoms in Criteria A and B for more than 
two months at a time. 
D. No Major Depressive Episode has been present during the first two years of the 
disturbance. 
E. There has never been a Manic Episode, a Mixed Episode, or a Hypomanic Episode, 
and criteria have never been met for Cyclothymic Disorder. 
F. The disturbance does not occur exclusively during the course of a chronic Psychotic 
Disorder, such as Schizophrenia or Delusional Disorder. 
G. The symptoms are not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition (e.g., hypothyroidism). 
H. The symptoms cause clinically significant distress or impairment in social, 
























DSM-IV (APA, 2000) Criteria for Depressive Disorder Not Otherwise Specified 
 
A. A mood disturbance, defined as follows: 
1. At least two (but less than five) of the following symptoms have been present 
during the same two-week period and represent a change from previous 
functioning; at least one of the symptoms is either (a) or (b): 
a. Depressed mood most of the day, nearly every day, as indicated by 
either subjective report (e.g., feels sad or empty) or observation made 
by others (e.g., appears tearful). Note: in children and adolescents, 
can be irritable mood. 
b. Markedly diminished interest or pleasure in all, or almost all, activities 
most of the day, nearly every day (as indicated by either subjective 
account or observation made by others). 
c. Significant weight loss when not dieting or weight gain (e.g., a change 
of more than 5% of body weight in a month), or decrease or increase 
in appetite nearly every day. Note: in children, consider failure to 
make expected weight gains. 
d. Insomnia or hypersomnia nearly every day. 
e. Psychomotor agitation or retardation nearly every day (observable by 
others, not merely subjective feelings of restlessness or being slowed 
down). 
f. Fatigue or loss of energy nearly every day. 
g. Feelings of worthlessness or excessive or inappropriate guilt (which 
may be delusional) nearly every day (not merely self-reproach or guilt 
about being sick). 
h. Diminished ability to think or concentrate, or indecisiveness, nearly 
every day (either by subjective account or as observed by others). 
i. Recurrent thoughts of death (not just fear of dying), recurrent suicidal 
ideation without a specific plan, or a suicide attempt or a specific plan 
for committing suicide.  
2. The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.  
3. The symptoms are not due to the direct physiological effects of a substance 
(e.g., a drug of abuse, a medication) or a general medical condition (e.g., 
hypothyroidism). 
4. The symptoms are not better accounted for by Bereavement. 
B. There has never been a Major Depressive Episode, and criteria are not met for 
Dysthymic Disorder. 
C. There has never been a Manic Episode, a Mixed Episode, or a Hypomanic Episode, 
and criteria are not met for Cyclothymic Disorder.  
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D. The mood disturbance does not occur exclusively during Schizophrenia, 
Schizophreniform Disorder, Schizoaffective Disorder, Delusional Disorder, or 
Psychotic Disorder Not Otherwise Specified. 






DSM-IV (APA, 2000) Criteria for Adjustment Disorders 
 
A. The development of emotional or behavioral symptoms in response to an identifiable 
stressor(s) occurring within 3 months of the onset of the stressor(s).  
B. These symptoms or behaviors are clinically significant as evidenced by either of the 
following:  
1. Marked distress that is in excess of what would be expected from exposure to 
the stressor.  
2. Significant impairment in social or occupational (academic) functioning. 
C. The stress-related disturbance does not meet the criteria for another specific Axis I 
disorder and is not merely an exacerbation of a preexisting Axis I or Axis II disorder. 
D. The symptoms do not represent Bereavement. 
E. Once the stressor (or its consequences) has terminated, the symptoms do not persist 
for more than an additional 6 months.  





DSM-IV (APA, 2000) Criteria for Generalized Anxiety Disorder 
 
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than 
not for at least 6 months, about a number of events or activities (such as work or school 
performance).  
 
B. The person finds it difficult to control the worry.  
 
C. The anxiety and worry are associated with three (or more) of the following six 
symptoms (with at least some symptoms present for more days than not for the past 6 
months). Note: only one item is required in children.  
 
    (1) restlessness or feeling keyed up or on edge  
    (2) being easily fatigued  
    (3) difficulty concentrating or mind going blank  
    (4) irritability  
    (5) muscle tension  
    (6) sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying sleep)  
 
D. The focus of the anxiety and worry is not confined to features of an Axis I disorder, 
e.g., the anxiety or worry is not about having a Panic Attack (as in Panic Disorder), being 
embarrassed in public (as in Social Phobia), being contaminated (as in Obsessive-
Compulsive Disorder), being away from home or close relatives (as in Separation 
Anxiety Disorder), gaining weight (as in Anorexia Nervosa), having multiple physical 
complaints (as in Somatization Disorder), or having a serious illness (as in 
Hypochondriasis), and the anxiety and worry do not occur exclusively during 
Posttraumatic Stress Disorder.  
 
E. The anxiety, worry, or physical symptoms cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning.  
 
F. The disturbance is not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition (e.g., hyperthyroidism) and 












DSM-IV (APA, 2000) Criteria for Posttraumatic Stress Disorder 
A. The person has been exposed to a traumatic event in which both of the following were 
present:  
1. The person experienced, witnessed, or was confronted with an event or events 
that involved actual or threatened death or serious injury, or a threat to the 
physical integrity of self or others  
2. The person's response involved intense fear, helplessness, or horror. N te: in 
children, this may be expressed instead by disorganized or agitated 
behavior  
 
B. The traumatic event is persistently re-experienced in one (or more) of the f llowing 
ways:  
1. Recurrent and intrusive distressing recollections of the event, including 
images, thoughts, or perceptions. Note: in young children, repetitive play 
may occur in which themes or aspects of the trauma are expressed.  
2. Recurrent distressing dreams of the event. No e: in children, there may be 
frightening dreams without recognizable content.  
3. Acting or feeling as if the traumatic event were recurring (includes a sense of 
reliving the experience, illusions, hallucinations, and dissociative flashback 
episodes, including those that occur on awakening or when intoxicated). Note: 
in young children, trauma-specific reenactment may occur.  
4. Intense psychological distress at exposure to internal or external cues that 
symbolize or resemble an aspect of the traumatic event. 
5. Physiological reactivity on exposure to internal or external cues that 
symbolize or resemble an aspect of the traumatic event.  
 
C. Persistent avoidance of stimuli associated with the trauma and numbing of general
responsiveness (not present before the trauma), as indicated by three (or more) of the 
following:  
 
1. Efforts to avoid thoughts, feelings, or conversations associated with the 
trauma 
2. Efforts to avoid activities, places, or people that arouse recollections of the 
trauma  
3. Inability to recall an important aspect of the trauma  
4. Markedly diminished interest or participation in significant activities  
5. Feeling of detachment or estrangement from others  
6. Restricted range of affect (e.g., unable to have loving feelings) 
7. Sense of a foreshortened future (e.g., does not expect to have a career, 
marriage, children, or a normal life span)  
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D. Persistent symptoms of increased arousal (not present before the trauma), as indicated 
by two (or more) of the following:  
 
    (1) difficulty falling or staying asleep  
    (2) irritability or outbursts of anger  
    (3) difficulty concentrating  
    (4) hypervigilance 
    (5) exaggerated startle response  
 
E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 1 month.  
 
F. The disturbance causes clinically significant distress or impairment in soc al, 
occupational, or other important areas of functioning.  
 
Specify if:  
 
Acute: if duration of symptoms is less than 3 months  
Chronic: if duration of symptoms is 3 months or more  
 
Specify if:  
 


















DSM-IV (APA, 2000) Criteria for Panic Attacks and Panic Disorder With and Without 
Agoraphobia 
 
DSM-IV Criteria for Panic Attacks 
A discrete period of intense fear or discomfort, in which four (or more) of the following 
symptoms developed abruptly and reached a peak within 10 minutes:  
1. palpitations, pounding heart, or accelerated heart rate  
2. sweating  
3. trembling or shaking 
4. sensations of shortness of breath or smothering  
5. feeling of choking 
6. chest pain or discomfort 
7. nausea or abdominal distress 
8. feeling dizzy, unsteady, lightheaded, or faint  
9. derealization (feelings of unreality) or depersonalization (being detached from 
oneself 
10. fear of losing control or going crazy 
11. fear of dying 
12. paresthesias (numbness or tingling sensations)  
      13. chills or hot flushes 
 
DSM-IV Criteria for Panic Disorder With or Without Agoraphobia 
A. Both (1) and (2):  
1. recurrent unexpected Panic Attacks 
2. at least one of the attacks has been followed by 1 month (or more) of one (or 
more) of the following:  
a. persistent concern about having additional attacks  
b. worry about the implications of the attack or its consequences (e.g., losing 
control, having a heart attack, "going crazy")  
c. a significant change in behavior related to the attacks  
 
B. Presence or Absence of Agoraphobia.  
 
C. The Panic Attacks are not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or a general medical condition (e.g., hyperthyroidism).  
 
D. The Panic Attacks are not better accounted for by another mental disorder, such as 
Social Phobia (e.g., occurring on exposure to feared social situations), Specific Phobia 
(e.g., on exposure to a specific phobic situation), Obsessive-Compulsive Disorder (e.g., 
on exposure to dirt in someone with an obsession about contamination), Posttraumatic 
Stress Disorder (e.g., in response to stimuli associated with a severe stressor), or 
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Separation Anxiety Disorder (e.g., in response to being away from home or close 
relatives). 






DSM-IV (APA, 2000) Criteria for Separation Anxiety 
A. Developmentally inappropriate and excessive anxiety concerning separation f om 
home or from those to whom the individual is attached, as evidenced by three (or more) 
of the following:  
(1) recurrent excessive distress when separation from home or major attachment 
figures occurs or is anticipated  
(2) persistent and excessive worry about losing, or about possible harm befalling, 
major attachment figures  
(3) persistent and excessive worry that an untoward event will lead to separation 
from a major attachment figure (e.g., getting lost or being kidnapped) 
(4) persistent reluctance or refusal to go to school or elsewhere because of fear of 
separation  
(5)  persistently and excessively fearful or reluctant to be alone or without major
attachment figures at home or without significant adults in other settings  
(6)  persistent reluctance or refusal to go to sleep without being near a major 
attachment figure or to sleep away from home  
(7) repeated nightmares involving the theme of separation  
(8) repeated complaints of physical symptoms (such as headaches, stomachaches, 
nausea, or vomiting) when separation from major attachment figures occurs 
or is anticipated  
 
B. The duration of the disturbance is at least 4 weeks.  
 
C. The onset is before age 18 years.  
 
D. The disturbance causes clinically significant distress or impairment in social, 
academic (occupational), or other important areas of functioning.  
 
E. The disturbance does not occur exclusively during the course of a Pervasive 
Developmental Disorder, Schizophrenia, or other Psychotic Disorder and, in adolescents 
and adults, is not better accounted for by Panic Disorder With Agoraphobia.  
 
Specify if:  










DSM-IV (APA, 2000) Criteria for Specific Phobia 
A. Marked and persistent fear that is excessive or unreasonable, cued by the presence or 
anticipation of a specific object or situation (e.g., flying, heights, animals, receiving an 
injection, seeing blood).  
 
B. Exposure to the phobic stimulus almost invariably provokes an immediate anxiety 
response, which may take the form of a situationally bound or situationally predisposed 
Panic Attack. Note: in children, the anxiety may be expressed by crying, tantrums, 
freezing, or clinging.  
 
C. The person recognizes that the fear is excessive or unreasonable. Note: in children, 
this feature may be absent. 
 
D. The phobic situation(s) is avoided or else is endured with intense anxiety or distress.  
 
E. The avoidance, anxious anticipation, or distress in the feared situation(s) interferes 
significantly with the person's normal routine, occupational (or academic) functioning, or 
social activities or relationships, or there is marked distress about having the phobia.  
 
F. In individuals under age 18 years, the duration is at least 6 months.  
 
G. The anxiety, Panic Attacks, or phobic avoidance associated with the specific object or 
situation are not better accounted for by another mental disorder, such as Obsessive-
Compulsive Disorder (e.g., fear of dirt in someone with an obsession about 
contamination), Posttraumatic Stress Disorder (e.g., avoidance of stimuli associated with 
a severe stressor), Separation Anxiety Disorder (e.g., avoidance of school), Social Phobia 
(e.g., avoidance of social situations because of fear of embarrassment), Panic Disorder 
with Agoraphobia, or Agoraphobia Without History of Panic Disorder.  
 
Specify type: 
Animal Type  
Natural Environment Type (e.g., heights, storms, water)  
Blood-Injection-Injury Type  
Situational Type (e.g., airplanes, elevators, enclosed places)  
Other Type (e.g., phobic avoidance of situations that may lead to choking, vomiting, or 










DSM-IV (APA, 2000) Criteria for Social Phobia (Social Anxiety Disorder) 
 
A. A marked and persistent fear of one or more social or performance situations in which 
the person is exposed to unfamiliar people or to possible scrutiny by others. The 
individual fears that he or she will act in a way (or show anxiety symptoms) that will be 
humiliating or embarrassing. Note: in children, there must be evidence of the capacity 
for age-appropriate social relationships with familiar people and the anxiety must 
occur in peer settings, not just in interactions with adults.  
 
B. Exposure to the feared social situation almost invariably provokes anxiety, which may 
take the form of a situationally bound or situationally predisposed Panic Attack. Note: in 
children, the anxiety may be expressed by crying, tantrums, freezing, or shrinking 
from social situations with unfamiliar people.  
 
C. The person recognizes that the fear is excessive or unreasonable. Note: in children, 
this feature may be absent.  
 
D. The feared social or performance situations are avoided or else are ndured with 
intense anxiety or distress.  
 
E. The avoidance, anxious anticipation, or distress in the feared social or performance 
situation(s) interferes significantly with the person's normal routine, occupational 
(academic) functioning, or social activities or relationships, or there is marked distress 
about having the phobia.  
 
F. In individuals under age 18 years, the duration is at least 6 months.  
 
G. The fear or avoidance is not due to the direct physiological effects of a substnce (e.g., 
a drug of abuse, a medication) or a general medical condition and is not better accounted 
for by another mental disorder (e.g., Panic Disorder With or Without Agoraphobia, 
Separation Anxiety Disorder, Body Dysmorphic Disorder, a Pervasive Developmental 
Disorder, or Schizoid Personality Disorder).  
 
H. If a general medical condition or another mental disorder is present, the fear in 
Criterion A is unrelated to it, e.g., the fear is not of stuttering, trembling in Parkinson's 











DSM-IV (APA, 2000) Criteria for Obsessive Compulsive Disorder 
A. Either obsessions or compulsions:  
 
Obsessions as defined by (1), (2), (3), and (4):  
(1) recurrent and persistent thoughts, impulses, or images that are experienced, at 
some time during the disturbance, as intrusive and inappropriate and that cause 
marked anxiety or distress  
(2) the thoughts, impulses, or images are not simply excessive worries about real-life 
problems  
(3)  the person attempts to ignore or suppress such thoughts, impulses, or images, or 
to neutralize them with some other thought or action  
(4) the person recognizes that the obsessional thoughts, impulses, or images are a 
product of his or her own mind (not imposed from without as in thought insertion)  
 
Compulsions as defined by (1) and (2):  
(1) repetitive behaviors (e.g., hand washing, ordering, checking) or mental acts (e.g., 
praying, counting, repeating words silently) that the person feels driven to 
perform in response to an obsession, or according to rules that must be applied 
rigidly  
(2) the behaviors or mental acts are aimed at preventing or reducing distress or 
preventing some dreaded event or situation; however, these behaviors or mental 
acts either are not connected in a realistic way with what they are designed to 
neutralize or prevent or are clearly excessive  
 
B. At some point during the course of the disorder, the person has recognized that the 
obsessions or compulsions are excessive or unreasonable. Note: this does not apply to 
children.  
 
C. The obsessions or compulsions cause marked distress, are time consuming (take more 
than 1 hour a day), or significantly interfere with the person's normal routine, 
occupational (or academic) functioning, or usual social activities or relationships.  
 
D. If another Axis I disorder is present, the content of the obsessions or compulsions is 
not restricted to it (e.g., preoccupation with food in the presence of an Eating Disorders; 
hair pulling in the presence of Trichotillomania; concern with appearance in the presence 
of Body Dysmorphic Disorder; preoccupation with drugs in the presence of a Substance 
Use Disorder; preoccupation with having a serious illness in the presence of 
Hypochondriasis; preoccupation with sexual urges or fantasies in the presence of a 
Paraphilia; or guilty ruminations in the presence of Major Depressive Disorder).  
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E. The disturbance is not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition. 
 





Initial Screening Consent Letter 
 





SCHOOL is teaming up with Kevin Stark, Ph.D. from the University of Texas to evaluate 
a coping skills training program for girls called ACTION. The ACTION program is 
designed to teach girls how to manage their emotions and stress, solve problems, and 
think more positively about themselves. While we believe that all students could benefit
from this program, currently, only girls who are experiencing high levels of distress will 
be able to participate. We are asking for permission from all parents of girls in GRADES 
for their daughters to participate in a screening that will help identify girls who are 
experiencing distress. Girls who participate in the screening will fill out a questionnaire 
that takes approximately 10 minutes to complete. Doctoral psychology students with 
appropriate training will supervise the completion of the questionnaires. At this time we 
do not anticipate any discomfort in completing the ACTION questionnaire.  
 
Girls who report having more than a typical number symptoms of distress will be 
interviewed about specific symptoms of depression to determine if they are experiencing 
high levels of distress. The brief symptom interview will be conducted by trained 
graduate students or project staff under the supervision of Dr. Stark. If a girl in the study 
is reporting distress on the questionnaire or brief symptom interview, the parents will be 
contacted by phone to ensure the girl’s well-being. ACTION staff or the school ounselor 
may discuss your child’s further participation in this research project at that ime. For all 
girls who complete the questionnaire or interview and do not show significant symptoms 
of distress, parents will receive a letter stating those findings. 
 
The purpose of the project is to determine whether the ACTION coping skills program is 
more effective than no counseling, and whether parent participation makes the program 
more effective. In addition, we are trying to learn whether adding follow-up meetings 
prevents future distress. The benefits to participants include possible participation n the 
ACTION program and helping advance our understanding of how to best help young 
girls manage emotions and stress, solve problems and feel better about themselves. 
 
Participation in the project will not cost you anything and there will not be any financial 
compensation for participation. There are not any risks of harm from completing the 
questionnaire. There are no anticipated risks from completing the brief symptom 
interview. In fact, the procedure is designed to quickly identify and assist children who 
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are in distress. All materials and forms will be stored in locked file cabinets in a ecure 
office at UT to protect confidentiality.  
 
If a child reports that she is at risk of hurting herself or others, her parents would be 
immediately informed and she would immediately talk with her school counselor. In 
addition, she would be evaluated by one of the consulting psychiatrists at no cost to the 
family.  
 
If you choose to participate, you or your daughter may stop participation at any time. 
Participation in the study is entirely voluntary. You are free to say that you do not want to 
participate by returning this form indicating on the back of this page that you do not want 
to participate. You can refuse to participate without penalty or loss of benefits to which 
you and your daughter are otherwise entitled. It will not affect your relationship with 
your child’s school or the University of Texas.  
 
Researchers are required by Texas state law and professional ethics codes to report to 
Child Protective Services (or other appropriate regulatory agency) all inst nces of alleged 
child abuse and neglect. Please note that if your child completes the screening 
questionnaire or interview and is believed to be at risk for emotional, psychological or 
possible physical harm or neglect, then the investigator will report this information to the 
attending physician, Child Protective Services, and any other necessary regulatory 
agencies. Please note when a child reports neglect or being harmed, participants canno  
stop the referral of their child’s case to the authorities and any subsequent actions taken. 
 
If you have any questions about the study, you can call Kevin Stark, Ph.D. at (512) 471-
0267, your school counselor, or principal. 
 
If you have questions about your rights as a participant, please contact Lisa Leiden, 
Ph.D., Chair, The University of Texas at Austin Institutional Review Board for the 




_______________________________                                      









PLEASE    KEEP   THIS   LETTER   FOR   YOUR   RECORDS 





PARENT/GUARDIAN   SCREENING   PROCEDURE   CONSENT 
 
 
Please check the appropriate box indicating that YES you have read this letter and are 
giving permission for your daughter to participate in the ACTION project at your child’s 
school by completing the screening questionnaire and brief symptom interview, or NO, 
you have read this letter and you do not want your daughter to complete the questionnaire 
or interview. Regardless of your decision, please sign this form and return it to your 
child’s teacher.  
 
PLEASE RETURN THIS FORM TO YOUR CHILD’S SCHOOL WITH YOUR 
PREFERENCE NOTED BELOW: 
 
 
______YES  I give my permission for my daughter to participate by completing 
the screening questionnaire and brief symptom interview. 
 
 
_______NO  I do not give my permission for my daughter to participate by 
completing the screening questionnaire or brief symptom interview 
 
 
    
 Parent’s Signature  Date 
 
   
 Child’s Name (please print)       
 
We will provide feedback for all participants. Please provide information below if your 
child will be participating. 
 
Parent/adult guardian name(s): __________________________ 
 




Parent phone number(s) in case we need to reach you with a concern about your child: 
 
Home__________________cell_______________________work_______________ 
           
Revised JLH 8/29/05 




Child Assent Form 
I agree to complete a questionnaire about my thoughts, feelings, and behaviors. This 
questionnaire has been explained to my parent or guardian and he or she has given 
permission for me to participate. I may decide at any time that I do not wish to participate 
and that it will be stopped if I say so. My specific responses will not be shared with 
anyone. However, general information about how I am doing and feeling may be shared 
with my parent. 
 
When I sign my name to this page I am indicating that I read this page and that I am 
agreeing to participate. 
 
_______________________________________  _______________________ 
      Your Signature       Date 
 
_____________________________________ 
      Please print your Name 
 
Date of Birth ____________________________ 
  Month  Day  Year 
 
ETHNICITY 
(1) Do you consider yourself to be Hispanic or Latino?  Please put an X in the box 
that best describes you. 
 Hispanic or Latino 
 Not Hispanic or Latino 
 
RACE 
(2) What race do you consider yourself to be?  You may be more than one race. 
Please put an X in the box for each race that you believe you are. For example, if 
you believe you are White, you put an X in that box. If you believe you are White 
and Black, then you put an X in both the White and in the Black or African 
American box. 
 American Indian or Alaska Native 
 Asian 
 Black or African American 
 Native Hawaiian or Other Pacific Islander 
 White 
 Check here if you do not wish to provide some or all of the above information 
 



















We would like to thank you for giving your daughter permission to complete the 
screening measures as part of the collaborative project between UT and your child’s 
school district. The screening measures have been scored and you will be glad to know 
that your daughter did not report experiencing a significant level of distress o  other signs 
of stress. If you question these results or would like additional information, please feel 
free to call Kevin Stark, Ph.D. at 471-0267, or contact your school counselor. 
 
We will be conducting the screener on a periodic basis throughout the district. Since life 
circumstances can change, and adolescence can be a difficult time in a girl’s life, we hope 
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Letter to Parents if Screening Score is Higher than Cutoff but DSM Interview Do s Not 












We would like to thank you for giving your daughter permission to complete the 
screening questionnaires and the interview as part of the collaborative research project 
between UT and your child’s school district. On the screening questionnaires your 
daughter reported experiencing some stress. Due to concern that she may be in distr ss,
our research staff conducted an individual brief interview to assess her stress level. 
However, on the individual brief interview she indicated that she was not experiencing a 
significant level of distress. Typically, this is an indication that her reaction to stress is 
within normal range or that she had some misunderstanding of the items on the first 
questionnaire. If you question these results or would like additional information, please 
feel free to call Kevin Stark, Ph.D., licensed psychologist and principal investigator (512- 
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Per our contact with you regarding your daughter’s responses to the screening 
questionnaire and brief symptom interview, we are requesting permission for you and 
your daughter to complete a more comprehensive interview that will help us determine 
more accurately whether she is experiencing serious emotional concerns or whether she 
was not feeling well on the days that she completed the questionnaire and brief interview. 
The interviews will be conducted by trained doctoral psychology students under the 
supervision of Kevin Stark, Ph.D., licensed psychologist. The interview of your daughter 
will be completed in a room at school that will protect her privacy. It takes 45 to 90 
minutes to complete and asks specific questions about how your daughter is feeling,
thinking and behaving and a range of experiences she may have encountered. The 
interview with you will cover the same topics and can be conducted in person or over the 
phone if that is preferable, at a time that is convenient for you. Participation in the 
interview will not cost you anything and there will not be any financial compensatio  for 
participation. Completed interviews will be stored in locked file cabinets in a secure 
office at UT to protect confidentiality. If she is, she may be eligible for participating in 
the ACTION program. If this wouldn’t be the best program for her, we will provide you 
with possible resources from within the school and the community.  
 
If a child reports that she is at risk of hurting herself or others, her parents would be 
immediately informed and she would immediately talk to her school counselor. In 
addition, she would be interviewed by Kevin Stark, Ph.D., a licensed psychologist, or one 
of the consulting psychiatrists at no cost to the family. If a child reports that he is being 
hurt, the school’s standard procedures for reporting such instances to the relevant state 
agency would be followed.  
 
The purpose of the project is to determine whether the ACTION coping skills program is 
helpful, and whether parent participation makes the program more effective. In addition, 
we are trying to learn whether adding follow-up meetings prevents future distss. If you 
have any questions about the study, you can call Kevin Stark, Ph.D. at (512) 471-0267 
your school counselor, or principal.  
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If you choose to participate, you or your daughter may stop participation at any time. 
Participation in the study is entirely voluntary. You are free to say that you do not want to 
participate by returning this form indicating that you do not want to participate. You can 
refuse to participate and this decision will not affect your relationship with your child’s 
school or the University of Texas.  
 
Researchers are required by Texas state law and professional ethics codes to report to 
Child Protective Services (or other appropriate regulatory agency) all inst nces of alleged 
child abuse and neglect. Please note that if your child completes the screening 
questionnaire or interview and is believed to be at risk for emotional, psychological or 
possible physical harm or neglect, then the investigator will report this information to the 
attending physician, Child Protective Services, and any other necessary regulatory 
agencies. Please note when a child reports neglect or being harmed, participants canno  
stop the referral of their child’s case to the authorities and any subsequent actions taken. 
 
If you have questions about your rights as a participant, please contact Lisa Leiden, 
Ph.D., Chair, The University of Texas at Austin Institutional Review Board for the 
Protection of Human Subjects, (512-471-8871). Let him know that you are enquiring 
about the study entitled “Helpfulness of the ACTION Coping Skills Program with and 
Without Parent Participation.” 
 
Please check the appropriate box indicating that YES you have read this letter and are 
giving permission for you and your daughter to participate by completing the interview, 
or NO you do not want to complete the interview nor do you want your daughter to 
complete the interview. Regardless of your decision, please sign this form and return it to 
your child’s teacher. You will be given a copy of this permission letter to keep for your 
records. 
 
  YES  I give my permission for my daughter and I to participate by completing 
the interview. 
 
  NO  I do not give my permission for my daughter and I to participate by 
completing the interview. 
 
    
 Parent’s Signature  Date 
 
    
 Researcher’s Signature  Date 
 
    
 Principal’s Signature  Date 
 
Revised KDS 8/29/05 















Based on results of the screening and interview that you and your daughter have 
participated in so far, we are requesting permission for you and your daughter to continue 
and participate in the evaluation of the ACTION coping skills program. If you give your 
permission for your daughter to participate, she will be randomly assigned to one of three 
groups: (1) ACTION coping skills program, (2) ACTION coping skills program plus 
parent participation, or (3) wait to receive the program in about 12 weeks.  
 
If your daughter is randomly assigned to the ACTION coping skills program, she will meet 
20 times over the next twelve to sixteen weeks with a group of girls to participate in a 
counseling program that is designed to teach her problem solving, coping skills for 
managing her emotions and stress, and strategies for thinking more positively about herself 
and things in general.  
 
If your daughter is randomly assigned to the counseling plus parent participation, she will 
meet 20 times over the next twelve to sixteen weeks with a group of girls to participate in a 
counseling program that is designed to teach her problem solving, coping skills for 
managing her emotions and stress, and strategies for thinking more positively about herself 
and things in general. In addition, you would be asked to attend a total of 10 meetings over 
this period that will last about an hour and a half. The parent meetings will be held at 
school after hours and daycare and refreshments will be provided at no expense. During 
these meetings parents will have a chance to learn the skills that their daughter is learning, 
and parents will learn strategies for helping their daughter to use the skills. 
 
The girls will meet in a small group during an elective class. Each meeting will last one 
class period. Steps have already been taken to ensure that she will receive any class 
materials that she misses. The group meetings will be led by a trained doctoral psychology 
student or Ph.D. level therapist and a counselor from your daughter’s school. The group 
leaders will be supervised by Kevin Stark, Ph.D. It is not expected that your daughter will 
experience any discomfort or risks from participating in the ACTION coping skills 
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program. In fact, past experience with the program indicates that the girls enjoy 
participating and benefit from it.  
 
If your daughter is randomly assigned to wait to receive counseling in about 12 weeks, we 
will take the following steps to ensure that she is okay. A doctoral psychology student will 
meet with her each week to monitor how she is doing, she will be discreetly observed in 
school at lunch or recess for about fifteen minutes per wek, and the staff member will 
check-in with her teacher each week. In addition, every other week, the staff member will 
check with you to see if you have any concerns. At the end of the waiting period, she will 
have the opportunity to participate in the coping skills program. If at any point during this 
waiting period she reports feeling worse or you would like to seek counseling elsewhere, 
we will provide you with information about community and school resources. You have the 
option at anytime to seek additional services including consultation with one of the 
project’s consulting psychiatrists at no cost to you.  
 
We will be monitoring each girl’s progress and report this information to two psychiatrists 
who are being paid by us to oversee each child’s welfare. I  a participant is not improving 
as a result of the program, then parents will be informed and we will meet with you to 
discuss other options for providing your daughter with help. If you would like information 
about medications that might be of assistance, the psychiatrists are available to meet with 
you and discuss these options at no cost to you.  
 
To determine whether the ACTION coping skills program is helpful, we are asking you 
and your daughter to complete some questionnaires that help guide, and evaluate the 
effectiveness of the ACTION program. The questionnaires will take your daughter about 
one hour to complete. It will take you about 30 minutes to complete your questionnaires. 
We are asking you to complete the questionnaires so that we can determine whether 
participation in the ACTION program also benefits you and your family. The 
questionnaires have been completed by other children and adults without any discomfort. 
In order to assess the potential benefits of ACTION on school performance, our staff 
collects the following general education information: grades from reporting periods, 
attendance, and discipline information for participants. 
 
For one year after completion of the ACTION program, your daughter will have the 
opportunity to meet with her group and apply the skills to the new problems and stresses 
that she faces as she grows up and navigates her way through the many difficulties of being 
a teenager. The groups will meet three times a semester over the rest of the course of the 
study. In addition, to determine if your daughter needs additional help, once a year, we will 
ask you and your daughter to complete the interview and the questionnaires to determine 
whether we have achieved the goal of preventing the difficulties from recurring. Each time 
in the future that you and your daughter are asked to complete the measures, you will be 
paid $25.00 and your daughter will be paid $20.00. 
 
    
  
187 
If a participant reports at any time that she is feeling like she would like to hurt herself or 
someone else, then, she would be immediately interviewed by a trained staff member and 
the school counselor. In addition, if there is concern about a child’s safety, the staff 
member would immediately contact the parents and Kevin Stark, Ph.D. or one of the 
consulting psychiatrists. If at all possible, the psychiatrist on call would be available to 
meet with the girl and her parents to further evaluate the si uation and to provide you with 
information about resources from within the community that could be of help. If it is not 
possible to immediately meet with one of the mental healt professionals, then it would be 
recommended that the child and parents pursue the conventional pr cedure of driving to the 
emergency room of a local hospital. If a participant reports that she is being hurt, then the 
staff member and school counselor would follow the school’s standard procedures for 
reporting such instances to the relevant state agency. 
 
All of the services that we provide are available to you at no cost to your family. 
 
The benefits to you and your daughter are that she may learn skills and strategies that will 
help her to be happy and healthy throughout adolescence. Similarly, you may learn 
strategies for helping her to successfully make it through adolescence. The benefit to 
society is that it will help us to determine whether teaching girls who are exp riencing 
depression these skills helps to reduce the depression and whether it is even more helpful 
to involve parents. Furthermore, since girls are at very high risk for becoming depressed 
between the ages of 13 to 15, the results of this study will help us learn whether there is a 
procedure for preventing this from occurring. 
 
The ACTION program meetings are audiotaped for quality assurance purposes. T  
ensure confidentiality, the following steps will be taken: (a) the cassette  will be coded so 
that no personal identifying information is visible on them; (b) they will be kept in a 
locked file cabinet in a secure office at UT; (c) they will be reviewed only f r research 
purposes by the relevant research staff; and (d) they will be erased after they are checked 
and the study has been completed. Identifying information will be removed from all f 
the assessment materials completed during the study and the materials will be stored in a 
locked file cabinet in a locked research office at UT. 
 
Participation in the ACTION coping skills program is entirely voluntary. You are free 
to refuse to be in the study, you are free to discontinue participation for any reason at 
any time, and your refusal or discontinuation will not influence current or future 
relationships with The University of Texas at Austin or your child’s school district 
 
Researchers are required by Texas state law and professional ethics codes to report to 
Child Protective Services (or other appropriate regulatory agency) all inst nces of alleged 
child abuse and neglect. Please note that if your child is believed to be at risk for 
emotional, psychological or possible physical harm or neglect, then the investigator will 
report this information to the attending physician, Child Protective Services, and any 
other necessary regulatory agencies. Please note when a child reports neglect or being 
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harmed, participants cannot stop the referral of their child’s case to the authorities and 
any subsequent actions taken. 
 
If you have any questions about the study, you can call Kevin Stark, Ph.D. at (512) 
471-4407, your school counselor, or principal. You may also contact the project 
coordinator, Jennifer L. Hargrave, Ph.D., with questions, concerns, or to withdraw from 
the study at any time at (512) 471-0218. 
If you have questions about your rights as a participant, please contact Lisa Leiden, 
Ph.D., Chair, The University of Texas at Austin Institutional Review Board for the 
Protection of Human Subjects, (512) 471-8871. Let her know that you are enquiring 
about the study entitled “Helpfulness of the ACTION Coping Skills Program with and 
Without Parent Participation.” 
 
Please check the appropriate box indicating that YES you have read this letter and are 
giving permission for you and your daughter to participate in the ACTION coping skills 
program and to complete the questionnaires, or NO you do not want to participate in the 
ACTION coping skills program and you do not want to complete the questionnaires. 
Regardless of your decision, please sign this form and return it to your child’s counselor. 
With this permission letter, you should have received a copy to keep for your records. 
 
NOTE: TWO COPIES OF THIS LETTER ARE PROVIDED; ONE IS TO KEEP FOR 
YOUR RECORDS 
 
PLEASE RETURN ONE COPY OF THIS PORTION TO THE SCHOOL 
COUNSELOR 
 
  YES  I give my permission for my daughter, ________________________,  
and me to participate in the ACTION coping skills program and to complete the 
questionnaires. This includes permission for ACTION staff to access report card 
information, discipline referrals, and attendance records during participation. 
 
  NO  I do not give my permission for my daughter, ____________________,  
to continue any further with the ACTION project. 
 
    
 Parent’s Signature  Date 
 
 
    
 Kevin D. Stark, Ph.D.  Date 
 
NOTE: TWO COPIES OF THIS LETTER ARE PROVIDED; ONE IS TO KEEP FOR 
YOUR RECORDS 





ACTION Treatment Integrity Rating Form 
 
 




School:     Cohort:   
 
Ratings: 
0 = Not Covered During Meeting 2 = Adequately Covered  
1 = Minimally Covered During Meeting 3 = Completely Covered 
 
 
Objectives Specific to Meeting 1 
 
Discuss the parameters of the meetings. 
 
0 1 2 3 
 
 
Introduce the counselors and participants 
 
0 1 2 3 
 
 
Establish rationale for treatment: sunglasses activity 
 
0 1 2 3 
 
 
Educate clients about confidentiality 
 
0 1 2 3 
 
 
Establish group rules 
 
0 1 2 3 
 
 
Build group cohesion/connections 
 
0 1 2 3 
 
 
Establish within group incentive system 
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Provide positive interpersonal behavior review 0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 2 
 
Introduce participants to chat time 
 
0 1 2 3 
 
 
Introduce the agenda 
 
0 1 2 3 
 
 
Establish pragmatics of completing practice 
 
0 1 2 3 
 
 
Introduction to the mood meter 
 
0 1 2 3 
 
 
Introduction to the 3 B’s 
 
0 1 2 3 
 
 
Introduction to Take Action List: Link mood to doing 
fun things 
 
0 1 2 3 
 
 
Complete a within meeting coping skill/activity 
 




Provide positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
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Objectives Specific to Meeting 3 
 
Discuss the importance of thinking about the 
meetings and completing their practice 
 
0 1 2 3 
 
 
Focusing on the positive: Rock Candy Activity 
 
0 1 2 3 
 
 
Introduction to the Catch the Positive Diaries 
 
0 1 2 3 
 
 
Educate clients about the 3 B’s 
 
0 1 2 3 
 
 
Introduction to the 5 categories of coping strategies 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 
0 1 2 3 






Objectives Specific to Individual Meeting #1 
 
Review therapeutic concepts 
 
0 1 2 3 
 
 
Development of treatment goals 
 




Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 




Objectives Specific to Meeting 4 
 
Extend group cohesion through Connections Activity-
2 
 
0 1 2 3 
 
 
Review each participant’s goals and strategies for 
obtaining the goals 
 
0 1 2 3 
 
 
Introduction to the 5 general coping strategies and 
application of the coping strategies to hypothetical 
situations 
 
0 1 2 3 
 
 
Complete a coping skills activity 
 






0 1 2 3 
 




Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 5 
 
Review participants’ experiences with the Catch the 
Positive Diaries—importance of positive self-
monitoring 
 
0 1 2 3 
 
 
Experience the impact of a coping skills activity 
 
0 1 2 3 
 
 
Introduction to problem solving: Rock Candy 
Activity--2 
 
0 1 2 3 
 
 
Extension of problem solving: Problem identification  
 
0 1 2 3 
 
 
Application of problem solving: Extension of 
understanding of each of the 5 steps 
 
0 1 2 3 
 
 
Introduction to brainstorming: Solution Round Robin 
Activity 
 
0 1 2 3 
 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 6 
 
Goal attainment check-in 
 
0 1 2 3 
 
 
Demonstrate the role of cognition in emotion and 
behavior: Thought bubble activity 
 
0 1 2 3 
 
 
Introduction to thought feeling-coping thought 
worksheet 
 
0 1 2 3 
 
 
Enactment of a coping skills activity  
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 




Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 7 
 
Review participants’ experiences with the Catch the 
Positive Diaries—importance of positive self-
monitoring 
 
0 1 2 3 
 
 
Apply problem solving to real-life situations 
 
0 1 2 3 
 
 
Practice brainstorming activity: Solution Race 
 
0 1 2 3 
 
 
Experience a coping skills activity 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 





Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 






Objectives Specific to Meeting  8 
 
Goal attainment check-in 
 
0 1 2 3 
 
 
Application of problem solving to teasing or a real-
life situation 
 
0 1 2 3 
 
 
Experience a coping skills activity 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 
0 1 2 3 
 





Objectives Specific to Meeting  9 
 
Review participants’ experiences with the Catch the 
Positive Diaries—importance of positive self-
monitoring 
 
0 1 2 3 
 
 
Apply problem solving to interpersonal problems 
 
0 1 2 3 
 
 
Experience a coping skills activity 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Individual Meeting 2 
 
Review of therapeutic concepts 
 
0 1 2 3 
 




Goal attainment check-in 
 
0 1 2 3 
 
 
Identification of common negative thoughts 
 
0 1 2 3 
 
 
Individualizing the Catch the Positive Diaries 
 
0 1 2 3 
 
 
Introduction to cognitive restructuring 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 10
 
Goal attainment check-in 
 
0 1 2 3 
 
 
Web Activity III: Preparing for cognitive restructuring 
 
0 1 2 3 
 




Experience a coping skills activity 
 
0 1 2 3 
 
 
Talking back to the Muck Monster  
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 11
 
 Catch the positive diaries check-in 
 
0 1 2 3 
 
 
Story telling Activity:  We construct our own 
perceptions 
 
0 1 2 3 
 
 
Illustration of how depression distorts thinking: 
sunglasses activity-II 
 
0 1 2 3 
 
 
The negative thoughts that comprise my sunglasses: 
Provide rationale for identifying and changing negative 
 
0 1 2 3 
 








0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 





Objectives Specific to Meeting 12
 
Goal attainment check-in 
 
0 1 2 3 
 
 
Catching negative thoughts of group members: 
Description of unwanted outcomes. 
 
0 1 2 3 
 
 
Introduction to Self-Mapping activity 
 
0 1 2 3 
 
 
Talking back to the Muck Monster  Activity 
 
0 1 2 3 
 




Catch the Positive  Activity:  Turn compliments into 










0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 13
 
Catch the positive diary check-in 
 
0 1 2 3 
 
 
Catching negative thoughts of group members: 
Description of unwanted outcomes. 
 
0 1 2 3 
 
 
Continuation of Self-Mapping activity 
 
0 1 2 3 
 
 
Introduction to Alternative Interpretation 
 
0 1 2 3 
 




Using the thought judge question What’s another way 
to look at it? 
 
0 1 2 3 
 
 
Alternative Interpretation Round Robin Activity: 
Applying Alternative Interpretation 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 14
 
Goal attainment check-in 
 
0 1 2 3 
 
 
Catching negative thoughts of group members: 
Description of unwanted outcomes. 
 
0 1 2 3 
 
 
Continuation of Self-Mapping activity 
 
0 1 2 3 
 
 
Applying Alternative Interpretation: Talking back to 
the Muck Monster Activity 
 
0 1 2 3 
 







0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 






Objectives Specific to Meeting 15
 
Catch the positive diary check-in 
 
0 1 2 3 
 
 
Catching negative thoughts of group members: 
Description of unwanted outcomes. 
 
0 1 2 3 
 
 
Continuation of Self-Mapping activity 
 
0 1 2 3 
 
 
Introduction to What’s the evidence? 
 
0 1 2 3 
 
Taking your thoughts to court activity: Application of 
What’s the evidence. 
 
0 1 2 3 
 







0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 








Objectives Specific to Meeting 16
 
Goal attainment check-in 
 
0 1 2 3 
 
 
Catching negative thoughts of group members: 
Description of unwanted outcomes. 
 
0 1 2 3 
 
 
Continuation of Self-Mapping activity 
 
0 1 2 3 
 
 
Application of What’s the evidence 
 
0 1 2 3 
 




Preparation for termination 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 






Objectives Specific to Meeting 17
 
Catch the positive diary check-in 
 
0 1 2 3 
 
 
Continuation of Self-Mapping activity 
 
0 1 2 3 
 
 
Integration and application of cognitive restructuring: 
Muck Monster Uno Activity 
 
0 1 2 3 
 
 
Preparation for termination 
 
0 1 2 3 
 







0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 18
 
Goal attainment check-in 
 
0 1 2 3 
 
 
Continuation of Self-Mapping activity 
 
0 1 2 3 
 
 
Integration and application of all the skills to bring 
about an improvement in mood. 
 
 
0 1 2 3 
 
 
Recognition of the smiley face ball as a symbol of 
participants’ new ability to “catch the positive.” 
 
 
0 1 2 3 
 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 19
 
Final catch the positive diary check-in 
 
0 1 2 3 
 
 
Drawing conclusions from filling in the bubbles to the 
Self-Mapping activity 
 
0 1 2 3 
 
 
Web Activity IV: Empower participants—Taking 
responsibility for change 
 
0 1 2 3 
 
 
Preparation for Goodbye to Depression Recycling 
activity 
 
0 1 2 3 
 
 
Preparation for termination 
 
 






0 1 2 3 
 




Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 
 
Review and summarize meeting 
 
0 1 2 3 
 
 
Explain and assign practice 
 




Objectives Specific to Meeting 20
 
Saying good-bye to the group: Activity 
 
0 1 2 3 
 
 
Saying good-bye to negative thoughts and feelings 
 
0 1 2 3 
 
 
Preparing for termination: Discuss feelings and 
reactions to termination 
 






0 1 2 3 
 
 
Provide chat time 
 
0 1 2 3 
 
 
Discuss the practice from the last meeting 
 
0 1 2 3 
 
 
Positive interpersonal behavior review 
 
0 1 2 3 
 




Review and summarize meeting 
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